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Background 
Fish consumption is an important source of proteins, minerals and especially omega-3 
fatty acids such as EPA and DHA. Dietary guidelines, including the advice of weekly 
consumption of fatty fish,1 are designed for an adequate intake of nutrients and to 
protect against diet-related diseases. Nevertheless, fish also contains environmental 
contaminants, which might counteract the positive effects of fish or even cause adverse 
health effects.  
In the Netherlands, the main rivers, including the Rhine-Meuse delta, are highly 
contaminated due to a high degree of urbanization and industrialization along these 
rivers. Lipophilic contaminants do not dissolve in water and therefore accumulate in the 
sediments of these rivers and estuaries. Consequently, predators living closely to these 
sediments are more exposed to lipophilic contaminants than other fish. Eel is a bottom 
dwelling carnivorous animal and enters the Netherlands as glass eel after a long journey 
from the Sargasso Sea. Once settled down, eel stays at the same location for a long time. 
They have a long life span, and do not spawn at their settled location, but only produce 
offspring after their long return journey to the Sargasso Sea. During reproduction, a 
substantial amount of the lipophilic contaminants are passed on to the offspring. The 
absence of spawning, together with the other characteristics and high lipid content, 
make eel particularly prone to bioaccumulation of lipophilic contaminants resulting in 
high levels.2-4 Although many contaminant levels are declining in the environment, due 
to the long half-lives it is estimated that it will take until 2200 until certain contaminant 
levels in the river Rhine will disappear under the detection levels.2 This indicates that 
these contaminants will pose a problem for the environment and fish quality for still a 
long time. Smoking eel is a popular tradition in the Netherlands, but eel consumption 
might be an important pathway of exposure to contaminants, such as persistent organic 
pollutants (POPs). Authorities were therefore concerned about the implications for 
human health due to consumption of contaminated eel, as risk assessors showed in 2007 
that safe levels could be exceeded.5 A ban on eel fishing in certain high-polluted areas 
was implemented in 2011 after the broadcasting of a documentary about this topic. 
However, there is a continuous debate about the necessity of this ban, the actual 
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accumulation of these contaminants in eel consumers and the potential adverse health 
effects. 
 
Categories of persistent organic pollutants (POPs) and health effects 
POPs are mainly men-made chemicals that have in common that they resist degradation 
through environmental processes, remaining intact for long periods of time. Due to their 
persistence and semi-volatile properties, facilitating long-range transport, these 
compounds are ubiquitously present in the environment and also found in remote 
places where there is no human activity nor chemical sources. Most POPs are lipophilic, 
enabling bioaccumulation in fatty tissues. Over 90% of human exposure to POPs comes 
from food consumption,6 with high contributions from fish caught in polluted areas (Fig. 
1).7,8 Due to biomagnification especially marine top predators have very high levels of 
POPs. Therefore, the highest exposed populations are found around the artic, where 
traditional foods include marine mammals, such as seal and whale blubber.9-11 In the 
Netherlands, the waste incinerations used to be a main distributing source of POP-
exposure (mainly dioxins, explained in next paragraph). This caused elevated levels in 
cow’s milk and subsequently considerably high dioxin levels in the Dutch population.12 
Nowadays, dairy products are still the main exposure sources to POPs, although fish has 
the highest pollution level based on product basis.8,13 The highest POP levels are 
measured in shrimp, eel and herring, and therefore especially frequent fish consumers 
may accumulate POPs above safe levels.5,7,8 The following paragraphs will describe 
different POP categories and adverse health effects related to these POPs. 
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Figure 1. Schematic overview of sources of persistent organic pollutants (POPs). Some 
POPs, such as TBT and PFOS, are used in pesticides which might be sprayed but can 
also be used in paint, e.g. for boats. A major source of POPs used to be industrial 
production, but POPs can also originate as an unwanted by-product in waste 
incineration or fossil fuel combustion. PFOS was used in fire-fighting foams, but also in 
protective coatings in furniture and carpet. Flame retardants are also used in furniture 
and in electrical equipment. The arrows indicate the POPs entering the environment, 
where they settle down in sediments and subsequently accumulate in eel and other 
organisms. 
 
Dioxins and PCBs 
Dioxins refer to a group of 75 polychlorinated dibenzo-p-dioxins (PCDD) congeners and 
135 polychlorinated dibenzofurans (PCDF) congeners, of which 17 are of toxicological 
concern. Furthermore, there are 209 different polychlorinated biphenyls (PCB) 
congeners, from which 12 have properties similar to dioxins (DL-PCBs). The 
toxicological active dioxins and dioxin-like compounds share a common mechanism 
involving binding to a cytoplasmic receptor protein called the aryl hydrocarbon (AH) 
receptor, although with different potencies.13 Therefore toxic equivalency factors (TEFs) 
have been introduced that indicate the relative potency compared to 2,3,7,8-
tetrachlorodibenzodioxin (TCDD) which is the most potent dioxin.14  
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Dioxins and DL-PCBs have received considerable attention from the European 
Commission, which are regulated as one class because the congeners are present in the 
environment and food as mixtures. Toxic equivalents (TEQ) were introduced to sum up 
the toxicity, using the TEF values, of all these congeners. The maximum level for the 
sum of PCDD/Fs and DL-PCBs in eel was set at 10 pg TEQ/g wet weight (ww) in 2012, 
while other seafood items have to comply to 6.5 pg TEQ/g ww.15 The majority of the eel 
from the Rhine-Meuse delta does not comply with the maximum levels,4,16 and risk 
assessors concluded that consumption of one portion eel per month would lead to 
accumulation of the compounds in humans above estimated safe levels.5 The safe level 
is derived from animal reproduction and developmental studies and set to protect the 
developing unborn child. 
Dioxins have been referred to as ‘the most toxic man-made compounds’ and, therefore, 
have generated much concern regarding their potential health risks. TCDD and certain 
PCBs are classified as a ‘known human carcinogen’,17 and these compounds are also 
related to endocrine disruption, neurological disorders, and immune impairment.18 
PCBs are slowly metabolized by phase I enzymes intro hydroxylated (OH-) PCBs and by 
phase II enzymes into e.g. methylsulfony-PCBs (MeSO2-PCBs). These metabolites are 
not lipophilic, however, some OH-PCBs are retained in blood19 and can bind to thyroid 
transport proteins explaining effects on thyroid hormones.20 
PFAS 
Perfluoroalkyl substances (PFAS) are fluorinated organic compounds that have the 
unique property that they contain both lipid- and water-repellent characteristics. PFASs, 
especially perfluorooctanoic acid (PFOA) and perfluoroctane sulphonate (PFOS), were 
therefore widely used in industrial and consumer applications, including stain-resistant 
coatings for fabrics and carpets, oil-resistant coatings for paper products approved for 
food contact, fire-fighting foams, and insecticides.21 Unlike other POPs, PFASs bind to 
blood proteins and are mainly stored in the liver, kidneys, and biliary system.22 Adverse 
health effects include developmental toxicity, thyroid disturbance and altered lipid 
metabolism.23 
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Brominated flame retardants 
Flame retardants include a diverse group of compounds used to prevent or slow down 
the development of fires. Two major classes of brominated flame retardants include 
polybrominated diphenyl ethers (PBDEs) and hexabromocyclododecanes (HBCDs). The 
lower brominated congeners (between 1 and 5 bromine-substitutions per molecule) have 
a higher bioavailability than the higher brominated congeners.24 PBDEs are generally 
used as mixtures containing multiple PBDEs. HBCD is composed of three stereoisomers: 
α-, β-, and γ-HBCD, which have high capacity of bioaccumulation. The main target for 
these compounds is the liver and thyroid hormone homeostasis, but also reproductive 
and nervous system effects are important. For PBDEs also the OH-metabolites are 
important, as they have a high similarity with thyroid hormones.24 
Organotin 
Organotins, such as tributyltin (TBT) and triphenyltin (TPT), have been widely used as 
heat stabilizers, wood preservatives and pesticides. TBT got considerably more attention 
when the phenomenon of imposex was reported, meaning that male sex characteristics 
were superimposed on normal female gastropods. Organotins can exert endocrine 
disruption due to inhibition of aromatase, but have also immunological, neurotoxic and 
obesity-related effects.25,26 
Mercury 
The main source of the widespread mercury is coal combustion, where mercury is 
present in trace amounts. Mercury is not bioavailable, whereas methylmercury (MeHg) 
can be adsorbed by the gastrointestinal tract and cross the blood-brain barrier. The bulk 
of MeHg within natural systems originates from methylation of mercury by bacteria 
within aquatic sediments.27 MeHg bioaccumulates mainly in muscle tissue due to 
protein binding, rather than fatty tissue. MeHg exposure is related to nervous system 
damage in adults and impaired neurological development in infants, to an impaired 
immune system, and endocrine disruption.28 
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Considerations of test compounds for thesis 
Eight different POPs present in the human seafood chain, and especially eel, were 
chosen to represent the different POP groups and were included in the experiments 
described in this thesis. Within the different groups the compounds were chosen based 
on their relative abundance in polluted fish species (Table 1 and Fig. 2). These include 
the dioxin TCDD and the dioxin-like PCB126;29 the non-dioxin-like PCB153;2 PFOS;3 
BDE-47;30 HBCD;31 TBT;32 and the organometallic MeHg.33 Most of these POPs are 
nowadays strictly regulated within Europe and other countries, however, restriction and 
regulation is in general less strict in less developed countries. Furthermore, due to the 
persistence of these POPs, they are only slowly degraded and these POPs will remain in 
the environment for still a long time. Most of these POPs also have long half-lives in 
humans, indicating there are slowly excreted from the human body (Table 1). 
 
Table 1. POPs representing the most abundant contaminants in eel within different POP 
groups. 
Compound Use Half-life in 
humans 
Stockholm 
Conventiona 
Restriction / 
elimination Europe 
TCDD By-product 8 years34 Annex C Emission requirements 
(1987)35,36 
PCBs Industrial 10-15 years37,38 Annex A / C Restricted (1985), 
disposal close system 
(2010)39 
PFOS Industrial 4-10 years40 Annex B Forbidden (2008)41 
BDE-47 Flame retardant 
(electronic 
devices / 
upholstery) 
2-5 years42 Annex A Forbidden (2004)43 
HBCD Flame retardant 
(polystyrene 
foams / textile) 
0.2 years42 Annex A (with 
certain exemptions) 
Forbidden (2015), 
authorized use allowed44 
TBT Biocide ? - Banned in anti-fouling 
paints (2008)45 
Forbidden for new, but 
not existing products 
(2010)46 
MeHg Natural + by-
product 
0.3 years47 - Emission requirements, 
restriction mercury 
(2008)48 
a Annex A: Elimination of the production and use; Annex B: Restricted production and use; 
Annex C: Reduction of unintentional release. 
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Figure 2: Molecular structures of the tested POPs.49 Eight different POPs present in the 
human seafood chain were chosen based on their relative abundance in polluted eel and 
different mechanisms of action. 
  
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 3,3’,4,4’,5-pentachlorobiphenyl (PCB126)
2,2’,4,4’,5,5’-hexachlorobiphenyl (PCB153) Heptadecafluorooctanesulfonic acid (PFOS)
Hexabromocyclododecane (HBCD) 2,2’,4,4’-tetrabromodiphenyl ether (BDE-47)
Tributyl chlorotin (TBT) Methylmercury(II) chloride (MeHg)
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Mechanism of action behind adverse health effects 
The adverse health effects of POPs, described in the previous sections, can be attributed 
to different mechanisms of action. Although some of these mechanisms are clear, like 
dioxins binding to the AH receptor,13 hydroxylated metabolites binding to thyroid 
transport proteins,20 and PFASs resembling fatty acids,50 various long-term or delayed 
adverse health effects cannot be explained by these mechanisms of action. Exposure to 
POPs may for example increase the risk of certain cancers, however, POPs are not 
genotoxic and the exact mechanism is not elucidated.17 Also, exposure of POPs in adults 
has been associated with an increased risk of the metabolic syndrome.51 Furthermore, 
prenatal exposure can cause immunological disturbances later in life indicating long-
lasting effects at the stem cell level.52 
Epigenetic phenomena, such as DNA methylation, have been proposed as a possible 
molecular mechanism underlying adverse health effects.53 Already in 1989, the role of 
DNA methylation in dioxin response was suggested.54 Nevertheless, this possible 
mechanism of action in relation to adverse health effects is still not elucidated. In this 
thesis, we therefore hypothesized that epigenetic mechanisms causing persistent 
changes in biological functions might explain described long-lasting or delayed adverse 
health effects of POPs. 
Epigenetics 
Epigenetics is an emerging field of science that studies heritable or stable, long-term 
changes caused by the activation and deactivation of genes without any change in the 
underlying DNA. The word epigenetics is of Greek origin and literally means over or 
above (epi) the genome. 
Epigenetics is important in determining phenotype and packaging of the DNA. There 
are three major epigenetic modifications that work together: DNA methylation, histone 
modifications and non-coding RNAs (ncRNAs).55 DNA methylation is the most stable 
epigenetic modification and therefore of high interest as a possible mechanism of action 
for long-lasting adverse health effects, while both histone modifications and ncRNAs are 
more flexible marks. Histone modifications play an important role in chromatin state, 
subsequently facilitating or blocking gene expression.56 ncRNAs are involved in 
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transcriptional and post-transcriptional silencing, e.g. by affecting mRNA stability or 
targeting mRNA for degradation.57 
DNA methylation 
DNA methylation refers to the addition of a methyl group to cytosine in a CpG 
dinucleotide. DNA methylation marks are transmitted to daughter cells during somatic 
cell division, and possibly also from one generation to the next.58 DNA methylation has 
long been considered to be a stable, persistent and heritable mark that can arise by 
adding methyl groups, but cannot be removed. More recently the removal of the methyl 
group by active demethylation enzymes was shown.59 CpG dinucleotides tend to cluster 
in regions called CpG islands (CGIs), but there are also CpGs outside these CpG-rich 
areas in low-CpG-dense areas (referred to as open sea). 
Methylation of DNA can change the functional states of regulatory regions and has a 
complicated relationship with gene expression. Methylation is involved in many forms 
of stable epigenetic repression, such as imprinting, X chromosome inactivation and 
silencing of repetitive DNA.60 Global DNA methylation is essential for stabilization of 
the genome, and loss of global methylation (hypomethylation) has been related to 
diseases such as cancer, psychiatric disorders and atherosclerosis.61 
DNA methylation close to the promoter region or transcription start site (TSS) is 
expected to decrease gene expression, and severe hypermethylation of these regions can 
fully inhibit the gene function.60,62 When the promoter region is not methylated, gene 
expression is regulated by transcription factors. It is important to note that some genes 
have CGIs at their TSSs, while other genes are CpG-poor at the TSS. CpG density might 
influence fluctuations in methylation levels and subsequently affect gene regulation in 
different ways.60 The quantitative relationship between promoter methylation and gene 
expression is thus more complicated than once assumed and the details have not been 
fully worked out. 
DNA methylation is in general more abundant in the gene body compared to the TSS, 
indicating that transcription initiation but not elongation seems to be sensitive to 
silencing through DNA hypermethylation. Methylation in the gene body is currently 
considered to affect gene expression by stimulating transcription elongation or by 
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influencing alternative splicing, and can both result in an increase or decrease of gene 
expression.63 
The role of DNA methylation in intergenic regions (IGR) is poorly understood,60 but it 
may be relevant for cell-type discriminatory patterns.64 Furthermore, about half of the 
enhancers are present in IGRs,65 and DNA methylation in the enhancer region can exert 
different effects because enhancers can regulate multiple genes. Enhancers might 
activate a promoter from a distance, but therefore both methylation states are relevant. 
Differential methylation in enhancers therefore does not have a straightforward 
relationship with gene expression, however, the variable DNA methylation state in 
enhancers suggest an important role of DNA methylation in altering expression of 
multiple genes.66,67 Furthermore, for many genes the enhancers are not yet identified, 
and enhancers can be thousands of kilobases away from their target genes, resulting in 
a highly complex relationship between DNA methylation and gene expression.68 
When exposure to POPs affect DNA methylation, this might cause a persistent change 
in biological functions due to affected gene regulation. To date, there are multiple 
observational studies relating global methylation levels to POP exposure, but the results 
are not consistent (Table 2). Global methylation is difficult to interpret because an 
overall loss of DNA methylation might occur together with gene-specific increases in 
DNA methylation. POP-induced changes in gene-specific DNA methylation is measured 
for only a couple of genes in human studies, but experimental animal studies (Table 3) 
and in vitro experiments (Table 4) suggest that POPs might affect gene-specific DNA 
methylation, although the consequence of this aberrant DNA methylation it is not yet 
elucidated. 
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Table 2. Human observational studies measuring global or gene-specific DNA 
methylation associated with levels of persistent organic pollutants (POPs). 
 
↑ increase, ↓ decrease, ↔ no change 
a Alu and LINE-1 elements are repetitive elements that can be used as a surrogate marker for global DNA 
methylation. 
b LUminometric Methylation Assay (LUMA) measures global DNA methylation levels. 
c Enzyme-Linked Immuno Sorbent Assay (ELISA) measures global DNA methylation levels.  
  
Compound Tissue DNA methylation Method n Group (origin) 
Mixture of 
POPs69 
Whole 
blood 
↓ Global Alu elementsa 70 Adults 
(Greenlandic Inuit) 
Mixture of 
POPs70 
Whole 
blood 
↓ Global Alu elementsa 86 Adults (South-
Korea) 
Total TEQ 
levels71 
Blood ↑ Global LUMAb 524 Adults (Sweden) 
OC 
pesticides72 
Leukocytes ↓ Global LUMAb 403 Adult women 
(Japan) 
OC pesticides 
PCBs73 
Whole 
blood 
↓ MGMT 
U-shaped MGMT 
Methylation-
specific PCR 
368 Adults (South-
Korea) 
PCB15374 Sperm ↔ Global Repetitive 
elements 
209 Adult men 
(Greenland, 
Poland, Ukraine) 
PCBs75 Placenta ↔ Global 
↔ IGF2/H19 
LUMAb + 
Pyrosequencing 
109 Fetoplacental 
(USA) 
PFOS76 Leukocytes ↑ Global LINE-1a elements 685 Adults (USA) 
PFOA77 Umbilical 
cord serum 
↓ Global ELISAc 113 Newborns (USA) 
PFASs78 Sperm ↔ Global Repetitive 
elements 
209 Adult men 
(Greenland, 
Poland, Ukraine) 
BDE-4779 Cord blood 
leukocytes 
↓ TNFα promoter PCR and 
sequencing 
46 Newborns (African-
American) 
PBDE80 Blood clot ↔ Global Alu and LINE-1 
elementsa 
358 Children (Mexican-
American) 
PBDEs75 Placenta ↑ Global 
 ↔IGF2/H19 
LUMAb + 
Pyrosequencing 
108 Fetoplacental 
(USA) 
Mercury81 Buccal 
mucosa 
↓ SEPP1 promoter Pyrosequencing 131 Adults (USA) 
MeHg82 Cord blood 
clot 
↓TCEANC2 Methylation 
array (CHARM) 
141 Newborns (USA) 
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Table 3. Experimental animal studies assessing the relationship between gene-specific 
DNA methylation and persistent organic pollutants (POPs). 
↑ increase, ↓ decrease, ↔ no change 
a Methylated DNA immunoprecipitation (MeDIP) is used to enrich methylated DNA sequences.  
Compound DNA methylation Method Health effects Species 
(organ) 
TCDD83,84 50 DMRs MeDIPa Tiling 
Array 
Sexual maturation Rats (sperm) 
TCDD85 ↓ Ddx54 ↑ Ill7rd, Bank1, 
Zfp128, Ralgds 
Arbitrarily Primed 
PCR 
Suppressed immune 
response 
Mice 
(splenocytes) 
TCDD86 ↔ Snrpn, Peg3, Igf2r 
(sperm) 
↑ Igf2r (muscle) 
↑ Igf2r + Peg3 (liver) 
Pyrosequencing Decreased sperm 
count 
Mice (sperm, 
liver, tibialis 
anterior 
muscle) 
TCDD87 ↔ αGSU, LHβ Restriction 
enzymes, PCR 
Attenuated 
steroidogenesis 
Rats (fetal 
pituitary) 
TCDD88 ↓ lrata, thumpd1 
↑ tjp1, usp5, krt5, spryd4, 
adra2a, col2a1 (liver) 
↓cdhr1↑ taar20p 
(embryo) 
CpG island tiling 
array 
Larvae died post 
hatching 
Zebrafish (liver 
or embryo) 
TCDD89 ↓Cpne4 ↑ Kcnk13, Abcg1, 
Ubash3b, Ly86, Dscaml1,  
Fbxl16 
MeDIPa Array - Rat (liver) 
TCDD90 ↓ Igf2 (body) 
↑  Igf2 (enhancer 
blocking region) 
Bisulfite 
sequencing 
Decreased liver 
weight, elevated 
AST 
Rats (liver) 
TCDD91 ↓ c-fos ↑ ahrr ↔ ahr2 Bisulfite PCR - Zebrafish 
(embryos) 
TCDD92 ↑ H19/Igf2 Bisulfite 
sequencing 
↓ fetal weight Mice embryos 
TCDD93 ↑ Brca1 Methylated-
specific PCR 
Disrupted 
mammary gland 
morphology 
Rat (mammary 
tissue) 
PCBs94 ↓↑ Cdkn2a-p16INK4a Pyrosequencing Hepatic 
inflammation 
Rat (liver) 
PCBs95 ↔ AR Bisulfite PCR - Rats (liver) 
BDE-4796 ↓ Mt-co2, L1Rn, Bdnf   
↑ Nr3c1 
↔ Majority of genes 
Pyrosequencing - Rats (frontal 
lobe brain) 
TBT97 ↓ Fabp4 ↔ Pparg2 Restriction 
enzymes, PCR 
Increased lipid 
accumulation 
Mice 
(mADSCs) 
TBT98 ↑ vtg1, cyp19a2 ↔ vasa Pyrosequencing Embryo-toxicity Zebrafish 
(embryos) 
PFOS99 ↑ GSTP promoter 
↔ p16 
Sequencing Decreased body 
weight 
Rats (liver) 
MeHg94 ↓↑ Cdkn2a-p16INK4a Pyrosequencing Hepatic 
inflammation 
Rats (liver) 
MeHg100 ↑ BDNF promoter PCR, primer 
extension 
Impaired behavior Mice 
(hippocampus) 
MeHg88 ↓ 32 genes ↑ no genes 
(liver) 
↓20 genes ↑ 5 genes 
(embryo F1) 
CpG island tiling 
array 
- Zebrafish (liver 
or embryo) 
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Table 4. In vitro experiments investigating the relationship between gene-specific DNA 
methylation and persistent organic pollutants (POPs). 
↑ increase, ↓ decrease, ↔ no change  
a Methylation-Sensitive High Resolution Melting (MS-HRM) analysis is based on a net temperature shift 
with different methylation levels.  
Compound DNA methylation Method Health related effects Cell type 
(origin) 
TCDD101 ↑ p16INK4a promoter Methylation-
specific PCR 
Diminished senescence HEK (human 
keratinocytes) 
TCDD102 ↓ Foxp3  
↑ Il-17 
Methylation-
specific PCR 
Increased regulatory T 
cells 
Primary mice T 
lymphocytes 
TCDD103 ↑ BRCA1 Methylation-
specific PCR 
- MCF-7 (human 
breast cancer 
cells) 
BDE-47104 ↓ Pparg2 
↔ Lep 
MS-HRMa ↑ adipocyte 
differentiation 
3T3-L1 (mouse 
preadipocytes) 
HBCD105 ↔ 10 genes Methylation-
specific PCR 
- Primary human 
hepatocytes and 
HepG2 cells 
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Thesis outline 
Frequent consumption of eel might cause accumulation of POPs to levels that are not 
regarded safe and could potentially affect DNA methylation. The aim of this thesis is to 
elucidate whether seafood-related POPs can induce aberrant DNA methylation in high-
exposed eel consumers, potentially causing adverse health effects. Understanding the 
mechanism of action of POPs can facilitate risk assessment and give more insight in 
health effects associated with chronic exposure. 
The main objectives of this thesis were to: 
1) Study whether frequent consumption of eel from polluted areas would lead 
to POP levels above regarded safe levels 
2) Investigate mechanisms of action of POPs focusing on gene expression and 
DNA methylation (using in vitro studies) 
3) Determine aberrant DNA methylation between eel consumers from high-
polluted areas compared to consumers from low-polluted areas 
This chapter, chapter 1, presents background information, a short summary about the 
different POPs tested, information about DNA methylation and its function, the 
objectives of the studies, and the outline of the thesis. 
Chapter 2 describes the effects of the POPs, including two mixtures, on steroidogenesis 
and focusses on functional effects (hormone levels) of altered gene regulation. DNA 
methylation was not measured due to the short exposure time, which was expected not 
to be sufficient for long-term epigenetic marks. 
Therefore, in chapter 3, a differentiation experiment was performed enabling long-term 
exposure to POPs. Human mesenchymal stem cells (hMSCs) were differentiated into 
mature adipocytes and the association between functional endpoints (differentiation 
proficiency), gene expression, and DNA methylation was assessed. Because it was still 
unclear how DNA methylation would be affected by the differentiation process, DNA 
methylation profiles were first established in unexposed cells before and after 
differentiation (chapter 3A). We subsequently measured DNA methylation in 
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differentiated adipocytes that were continuously (11 days) exposed to different POPs 
(chapter 3B). 
We performed a human study to investigate the accumulation of POPs in frequent eel 
consumers of low- and high-polluted areas (chapter 4). After establishing which POP 
levels were elevated in the men consuming eel from high-polluted areas, we investigated 
differences in DNA methylation profiles and measured biomarkers related to potential 
adverse health outcomes (chapter 5). 
At the end, the data obtained in this thesis is discussed together with data available in 
the literature (chapter 6). Suggestions for future research are provided as well as 
implications of our research for eel consumers and policy makers. 
Finally, chapter 7 summarizes the content of this thesis in English and in Dutch.  
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Abstract  
Persistent organic pollutants (POPs) such as 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), polychlorobiphenyl (PCB) 126 and 153, perfluorooctanesulfonic acid (PFOS), 
hexabromocyclododecane (HBCD), 2,2′,4,4′-tetrabromodiphenyl ether (BDE-47), 
tributyltin (TBT), and methylmercury (MeHg) can be accumulated in seafood and then 
form a main source for human exposure. Some POPs have been associated with changes 
in steroid hormone levels in both humans and animals. This study describes the in vitro 
effects of these POPs and mixtures thereof in H295R adrenocortical carcinoma cells. 
Relative responses for 13 steroid hormones and 7 genes involved in the steroidogenic 
pathway, and CYP1A1, were analyzed. PFOS induced the most pronounced effects on 
steroid hormone levels by significantly affecting 9 out of 13 hormone levels measured, 
with the largest increases found for 17β-estradiol, corticosterone, and cortisol. 
Furthermore, TCDD, both PCBs, and TBT significantly altered steroidogenesis. 
Increased steroid hormone levels were accompanied by related increased gene 
expression levels. The differently expressed genes were MC2R, CYP11B1, CYP11B2, and 
CYP19A1 and changes in gene expression levels were more sensitive than changes in 
hormone levels. The POP mixtures tested showed mostly additive effects, especially for 
DHEA and 17β-estradiol levels. This study shows that some seafood POPs are capable of 
altering steroidogenesis in H295R cells at concentrations that mixtures might reach in 
human blood, suggesting that adverse health effects cannot be excluded. 
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Introduction 
Environmental persistent organic pollutants (POPs), either historical or currently in use, 
accumulate in fatty tissues causing seafood to be a main source for human exposure.1-3 
This is of major concern, because many of these marine POPs have been related to 
negative health effects such as reduced cognitive development, immune toxicity, 
neurological disorders, cancer, and endocrine disruption.4,5 In addition to the well-
known mechanism for dioxin-like compounds via the aryl hydrocarbon receptor 
(AhR),6,7 other mechanisms of toxic action have been suggested to cause adverse health 
effects, including disruption of thyroid8 and steroid hormone systems.9 Such 
mechanisms can be inappropriate activation or antagonism of the nuclear steroid 
receptors, modulating nuclear receptor coactivators, or interference with key enzymes 
involved in steroid hormone synthesis and metabolism.10 Several POPs have been shown 
to affect hormone levels in humans and animals.11-13 To date, most studies focused on 
the effects of single POPs on levels of only a few different steroid hormones,14-16 or 
extracted mixtures of only partially identified POPs were tested.17,18 Investigating single 
compounds is important to elucidate the mechanisms of action as different compounds 
may counteract each other’s mechanisms. Humans, on the other hand, are exposed to 
mixtures so it is important to elucidate combined actions as well.  
In this study we investigated the effects of single POPs and mixtures thereof on 
steroidogenesis. Eight different POPs present in the human seafood chain were chosen 
based on their relative abundance in polluted fish species. These include the dioxin-like 
compounds TCDD and PCB 126;19 the non-dioxin-like PCB 153;20 the perfluorinated 
compound heptadecafluorooctanesulfonic acid (PFOS);21 the brominated flame 
retardants hexabromocyclododecane (HBCD)22 and 2,2′,4,4′-tetrabromodiphenyl ether 
(BDE-47);23 the biocide tributyl chlorotin (TBT),24 and the organometallic MeHg.25 The 
composition of mixtures to which people are exposed depends on the origin and type of 
polluted seafood that is consumed. Therefore, there is not one mixture that is most 
relevant to test, but still it is important to test whether compounds in a mixture can 
induce interactive effects. The in vitro model used was the H295R human adrenocortical 
carcinoma cell line, chosen because it expresses all hormones found in the adult adrenal 
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cortex and the gonads and all key enzymes involved in steroidogenesis.26 The 
functionality of this bioassay is consistent with most results observed in vivo.27 The 
endpoints we studied with the H295R model are corticosteroid synthesis and the 
production of sex steroid hormones. The assay has been fully validated to evaluate 
effects on testosterone and estradiol production.28 However, more elaborate approaches 
provide a screen for endocrine disruption and can identify potential targets of the test 
compound.29 In this study we measured steroidogenesis disruption as hormone 
production of 13 steroid hormones plus expression levels of 7 key steroidogenic genes 
for 8 individual POPs and mixtures thereof. 
 
Materials and methods 
Chemicals 
TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, CAS 1746-01-6) was purchased from 
AccuStandard (New Haven, USA) and PCB 153 (2,2′,4,4′,5,5′-hexachlorobiphenyl, CAS 
35065-27-1), PFOS (heptadecafluorooctanesulfonic acid potassium salt, CAS 2795-39-3), 
TBT (tributyl chlorotin, CAS 1461-22-9), and MeHg (methylmercury(II) chloride, CAS 
115-09-3) were obtained from Sigma-Aldrich (Zwijndrecht, The Netherlands). PCB 126 
(3,3',4,4',5-pentachlorobiphenyl, CAS 57465-28-8) was purchased from Promochem 
(Wesel, Germany). HBCD (hexabromocyclododecane, technical mixture) and BDE-47 
(2,2′,4,4′-tetrabromodiphenyl ether, CAS 5436-43-1) were kindly provided by Professor 
Åke Bergman (Stockholm University, Sweden) within the framework of the EU FIRE 
project.30 Forskolin (CAS 66575-29-9) and prochloraz (CAS 67747-09-5) were obtained 
from Sigma-Aldrich (St. Louis, MO, USA). Stock solutions for all chemicals were 
prepared in dimethylsulfoxide (DMSO) (Acros Organics, Belgium). Pregnenolone, 17α-
OH-pregnenolone, progesterone, 17α-OH-progesterone, dehydroepiandrosterone 
(DHEA), androstenedione, testosterone, 11-deoxycorticosterone, corticosterone, 11-
deoxycortisol and cortisol were obtained from Steraloids (Newport, RI, USA). The 
deuterium labelled internal steroid standards were from CDN isotopes (Point-Claire, 
Canada). Derivatisation reagent consisted of 1 mg 4-dimethyl-aminopyridine, 5 mg 2-
methyl-6-nitrobenzoic anhydride and 3 mg picolinic acid in 1 mL tetrahydrofuran after 
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which 10 μL of triethylamine was added. All were purchased from Sigma-Aldrich (St. 
Louis, MO, USA). 
Cell culture and exposure 
H295R human adrenocortical carcinoma cells were obtained from the American Type 
Culture Collection (ATCC, Manassas, VA, USA) and were cultured according to the 
standardized protocol approved by the OECD.28 Briefly, cells were routinely grown in 
75cm2 culture flasks containing DMEM/F12 (without phenol-red, Sigma, Zwijndrecht, 
The Netherlands) supplemented with 1.2g/l NaHCO3, 1% Insulin Transferrin Selenium 
(ITS+ premix), and 2.5% NuSerum (BD Biosciences, Bedford, MA) at 37°C and 5% CO2 
atmosphere. Cells were subcultured when 80% confluency was reached. For 
subcultivation, cells were washed twice with PBS, detached using trypsin-EDTA 
(0.25/0.05%, v/v) (Difco, NJ), and seeded in a 1:3 ratio. After thawing frozen stocks 
(passage 5), cells were cultured for at least four additional passages prior to testing and 
cells were not used after passage 13. For experiments, 3 ml of 3 × 105 cells/ml was seeded 
in 6-well plates (Greiner bio-one, Frickenhausen, Germany). After 24h, medium was 
replaced by 2 mL exposure medium containing a single POP or a mixture thereof 
dissolved in DMSO. The final concentration of DMSO in the medium was 0.25%. Three 
independent experiments were performed and in each experiment three concentrations 
were tested for both the single POPs and POP mixtures. Concentrations were chosen in 
two steps, a first selection of concentrations was based on literature study, followed by 
cytotoxicity testing to ensure experiments were performed at non-toxic concentrations. 
Two mixtures of different combinations of these compounds were tested, one with only 
four compounds which all affected steroidogenesis (mixture A) and one with all eight 
compounds (mixture B). Mixtures A1 and B1 consist of the middle concentration of the 
concentration range chosen for the individual POP tests based on the absence of 
cytotoxicity. So mixture A1 consisted of TCDD (30 nM), PCB 126 (3 μM), PCB 153 (3 μM) 
and PFOS (100 μM) and mixture B1 consisted of these 4 POPs and HBCD (300 nM), 
BDE-47 (300 nM), TBT (10 nM), and MeHg (30 nM). Mixture A1 or B1 were 3 times 
diluted to obtain mixture A3 or B3 and 10 times diluted to obtain mixture A10 or B10. 
Forskolin, a known adenylate cyclase inducer, and prochloraz, a known inhibitor of 
multiple CYPs involved in steroidogenesis such as CYP17, were run as positive and 
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negative controls. After 48h of exposure, as suggested by the OECD, the medium was 
collected and stored at −80°C until hormone analysis. The cells were immediately lysed 
in Trizol (Invitrogen, Breda, The Netherlands), transferred to a fresh vial, and stored at 
−80°C until RNA extraction. 
Cell viability assays 
For cytotoxicity testing, cells were seeded in a 96-well plate using 100 μL of 3 × 105 
cells/ml. After 24h, medium was replaced by 200 μL medium containing the individual 
POPs or mixtures thereof in triplicate. The highest concentrations tested were 100 nM 
for TCDD, 10 μM for both PCBs, 600 μM for PFOS, 1 μM for HBCD, 1 μM for BDE-47, 
100 nM for TBT, 100 nM for MeHg, and the highest test concentration of both mixtures. 
Cytotoxic effects from three independent experiments were compared to the solvent 
control (SC) and Triton X-100 (0.1%) was included as a positive control. After 48h, 
cytotoxic effects of the test compounds were evaluated with two cytotoxicity assays that 
measure different endpoints. The assays applied were the WST-1 cytotoxicity assay 
(Roche Diagnostics, Mannheim, Germany) based on the activity of mitochondrial 
dehydrogenase enzymes and the ATPlite assay (PerkinElmer, Groningen, The 
Netherlands) based on the principle that ATP is present in all metabolically active cells. 
For the WST-1 assay, 20 µl of WST-1 reagent (WST-1 kit content) was added, and after 
1h absorbance was measured at 450 nm using a Synergy HT multi-detection microplate 
reader (BioTek Instruments Inc.). For the ATPlite assay, 100 µl medium was removed 
from every well, and 50 µl mammalian cell lysis buffer (ATPlite kit content) was added. 
After 5-min incubation on an orbital plate shaker, 50 µl of substrate solution (ATPlite 
kit content) was added, and the plate was shaken again for 5 min. After 10-min 
incubation in the dark, luminescence was measured at 590 nm using the same 
microplate reader. To ensure that further experiments would not be performed at 
cytotoxic concentrations, the highest concentrations included did not deviate more than 
20% from the SC in either the WST-1 or the ATPlite assay. 
LC-MS/MS hormone analysis 
Hormone levels of pregnenolone, 17α-OH-pregnenolone, progesterone, 17α-OH-
progesterone, DHEA, androstenedione, testosterone, 11-deoxycorticosterone, 
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corticosterone, 11-deoxycortisol, and cortisol were measured in the cell culture medium 
following a method previously described.31 Calibration standards were prepared by 
spiking 900 µl of supplemented DMEM/F12 medium with a mix of steroid standards, 
resulting in concentrations of 0; 10; 25; 50; 100; 250; 500; 1000; 2500; 5000; 10,000; 
25,000; 50,000 and 100,000 pg/mL. Standards as well as samples (also 900 μL) were 
spiked with 22.5 μL 13C labelled internal standard mix (10 ng/mL) and filled up to 1 mL 
with MilliQ water. Calibration standards and samples were subjected to solid-phase 
extraction (SPE) using OASIS HLB cartridges (Waters, 60 mg) in 96-wells format 
previously conditioned with methanol and Milli-Q water. After washing with Milli-Q 
water, methanol/water/acetic acid (55:43:2, v/v/v %), methanol/water/25% ammonia 
(30:62:8, v/v/v %), and acetonitrile/water (35:65, v/v %) the free steroids were eluted 
with acetone. The eluate was evaporated to dryness at 45°C under nitrogen, and 
picolinoyl derivatisation was achieved by incubating the dried sample extracts with 35 
µL of derivatisation reagent (see chemicals section) for 45 min at room temperature. The 
reaction was terminated by adding a 5% ammonia solution and samples were directly 
analyzed on the LC-MS/MS as described by Blokland et al,32 with a change in the 
gradient of the LC mobile phase. The gradient was: 0-0.2 min 5% B (90/10 v/v-% 
acetonitrile/0.1% formic acid), 0.2-0.5 min, linear increase to 20% B, 0.5-3.5 min, linear 
increase to 80% B, 3.5-3.6 min, increase to 95% B with a hold of 0.45 min, after which 
the gradient returned in 0.05 min to 5% B with a final hold of 0.9 min. For 
androstenedione and 11-deoxycortisol analysis samples were diluted with 200 μL 
tetrahydrofuran/ammonia (35:50, v/v %) before measurement. Steroid hormone 
concentrations were calculated using a linear calibration curve and corrected for loss 
during the sample extraction based on the isotope labelled internal standard. Accuracy 
was calculated by dividing the mean of the determined concentration by the actual 
concentration times 100% and should be between 70 – 130%. The precision of the 
method was calculated as the coefficient of variation (CV) and should not exceed 30%. 
The range was set at the concentrations of the calibration curve where the method could 
operate with acceptable accuracy, precision, within the linear range of the curve (r2 > 
0.99), and with a signal-to-noise (S/N) ratio greater than 10. The limit of quantification 
(LOQ) was set at the lowest value of the range and samples with an S/N ratio lower than 
10 were assigned a value equivalent to the LOQ in order to calculate fold changes.  
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Hormone measurement EIAs 
17β-Estradiol and aldosterone levels in medium were analyzed using enzyme 
immunoassays (EIAs) according to the manufacturer’s recommendations. Cross-
reactivity of the 17β-estradiol kit (Oxford Biochemical Research) reported by the 
manufacturer was 1.0% for testosterone and lower for other hormones. Cross-reactivity 
for the aldosterone measurement (Cayman Chemical) was reported to be 1.1% for 
corticosterone and lower for other hormones. Prior to hormone analysis, the medium 
samples were thawed and kept on ice. The kits were modified by replacing the standard 
curve with standards prepared in cell culture medium. Data were linearized using a logit 
transformation followed by a linear regression fit. Accuracy and precision (see LC-
MS/MS hormone analysis) were calculated for both assays. 
RNA isolation and cDNA synthesis 
Total RNA was isolated according to the manufacturer’s (Invitrogen) instructions using 
a chloroform / isopropyl alcohol extraction. RNA was dissolved in Milli-Q water and the 
RNA concentration was measured using a NanoDrop ND-1000 UV–vis 
spectrophotometer (Isogen, Maarssen, The Netherlands). Samples with a 260/280 value 
around 2.0 and with a 260/230 ratio > 2.0 were regarded to be of good quality resulting 
in good PCR results. First-strand cDNA was synthesized from 1 μg of total RNA using 
RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific, Germany) following the 
supplier’s protocol. 
Real-Time quantitative PCR 
Primer sequences for CYP1A1 and 7 key enzymes involved in steroidogenesis were 
retrieved from literature or from the Harvard PrimerBank (http://pga.mgh.harvard.edu 
/primerbank) (Table S1). Primers were tested for specificity by BLAST analysis using 
NCBI PrimerBLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast). Real-time 
quantitative PCR (qPCR) was performed using SensiMix SYBR (GC Biotech, Alphen A/D 
Rijn, The Netherlands) and a CFX384 Real-Time PCR detection system (Bio-Rad 
laboratories BV, Veenendaal, The Netherlands). 2 µL cDNA was used in a total volume 
of 8 µL, with a primer concentration of 600 nM. The following thermal cycling 
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conditions were used: 10 min at 95°C, followed by 40 cycles of 95°C for 10s and 60°C for 
15s. Melting curve analysis was performed to assure no non-specific signals were 
detected. Relative expression was calculated using a three-fold dilution series of pooled 
cDNA to correct for the efficiency of the PCR reaction. The reactions were performed in 
duplicate and all samples were normalized to HPRT (hypoxanthine 
phosphoribosyltransferase) expression. Relative changes in gene expression levels were 
expressed as fold change compared to the SC. 
Statistical analysis 
Statistical significance of reduced cell viability was calculated using an unpaired 
Student’s t-test. Differences between treatments and SCs for hormone levels and gene 
expression analysis were calculated as fold change compared to the SC and evaluated 
using a one way ANOVA followed by a two-sided Dunnett’s test. Differences were 
considered significant at a p-value < 0.05 and highly significant at a p-value < 0.01. 
Statistical analyses were performed with IBM SPSS Statistics version 20. 
 
Results 
Cell viability 
Upon exposure of H295R cells no decrease in cell viability was observed with either the 
WST-1 or the ATPlite assay for any of the concentrations tested for TCDD, PCB 126, PCB 
153, HBCD, BDE-47, TBT, MeHg, and both mixtures. PFOS showed decreased viability 
for concentrations ≥ 300 μM (data not shown). The highest non-cytotoxic concentration 
of PFOS in our experimental setup (200 μM) was used for further experiments. 
Quality controls 
The basal hormone productions in H295R cells exposed for 48h to the SC can be found 
in Table 1. Production was highest for 11-deoxycortisol (200 ng/mL), followed by 
androstenedione (43 ng/mL), and lowest for 17β-estradiol (143 pg/mL) and progesterone 
(600 pg/mL). The LOQ, reported as the lower range, was low enough for all hormones 
to significantly determine down-regulation compared to the SC (Table 2A and Fig. 1).  
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Table 1. Hormone production in H295R cells (absolute and as percentage of the total 
hormone production) and the range, precision and accuracy of the measurements from 
three independent experiments.  
Hormone Range 
standard curve 
(pg/mL)a 
Maximum 
RSDb (%) 
Mean 
accuracy 
(%) 
Hormone 
levels (pg/mL)c 
Relative 
hormone 
levels (%)d 
Pregnenolone 2,500 – 25,000 12 100 – 125 5,229 ± 274 1.7 ± 0.2 
17α-OH-
Pregnenolone 
2,500 – 25,000 13 89 – 105 9,640 ± 472 3.1 ± 0.3 
Progesterone 50 – 10,000 29 81 – 111 600 ± 52 0.2 ± 0.0 
17α-OH-
Progesterone 
25 – 25,000 26 87 – 130 4,360 ± 221 1.4 ± 0.1 
DHEA 1,000 – 25,000 31 94 – 127 3,538 ± 154 1.2 ± 0.1 
Androstenedionee 500 – 100,000 8 78 – 105 42,897 ± 4073 14 ± 2.3 
Testosterone 100 – 10,000 9 94 – 118 1,689 ± 305 0.6 ± 0.2 
17β-Estradiolf 20 – 2,000 16 94 – 112 143 ± 8 0.04 ± 0.0 
11-Deoxycortico-
sterone 
50 – 10,000 11 93 – 125 9,383 ± 163 3.1 ± 0.1 
Corticosterone 500 – 25,000 24 93 – 117 3,616 ± 515 1.2 ± 0.3 
Aldosteronef 7.8 – 1,000 17 97 – 108 606 ± 104 0.2 ± 0.1 
11-Deoxycortisole 2,500 – 100,000 11 89 – 108 200,451 ± 13,120 66 ± 7.4 
Cortisol 250 – 25,000 30 92 – 107 24,402 ± 5,704 8.0 ± 3.2 
a Range was determined as those concentrations of the calibration curve where the method could 
operate with acceptable precision, accuracy and within the linear range of the curve (r2 > 0.99), and with 
a signal-to-noise (S/N) ratio greater than 10. 
b Relative standard deviation (RSD) is calculated as a measurement of precision. 
c Basal hormone levels measured in culture medium after 48h exposure to the solvent control (0.25% 
DMSO) (mean ± SE). 
d Relative hormone levels (%) compared to the sum of all measured basal hormones levels.  
e Androstenedione and 11-deoxycortisol levels were measured after dilution of the samples. 
f 17β-Estradiol and aldosterone levels were measured using an EIA kit. 
 
 
The hormone measurements for 17β-estradiol and testosterone were in compliance with 
the requirements of the OECD guidelines regarding LOQ, fold change, precision and 
accuracy.28 Forskolin significantly induced the levels of all hormones, except 
progesterone, as well as the gene expression levels of all measured genes involved in 
steroidogenesis (Table 2A and 2B). Prochloraz significantly reduced all hormone levels, 
except for pregnenolone and 11-deoxycorticosterone, while none of the gene expression 
levels were decreased (Table 2A and 2B). 
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Table 2A. Hormone production in H295R cells exposed for 48h to 10 µM forskolin or 1 
µM prochloraz from three independent experiments. 
 Forskolin Prochloraz 
Hormone Fold changea SE Fold changea,b SE 
Pregnenolone 2.1* 0.2 1.2 0.1 
17α-OH-Pregnenolone 6.4** 1.0 < -5.1*  1.2 
Progesterone 1.3 0.1 10.0** 0.6 
17α-OH-Progesterone 3.8** 0.8 -2.0** 0.4 
DHEA 28.8** 9.6 < -5.8* 2.3 
Androstenedione 6.5** 1.1 -31.9** 5.5 
Testosterone 3.6* 0.8 < -17.9* 6.1 
17β-Estradiol 11.0** 1.6 -2.6** 0.4 
11-Deoxycorticosterone 2.6** 0.1 -1.1 0.1 
Corticosterone 6.6** 1.9 < -7.1** 1.9 
Aldosterone 3.9** 0.7 -3.5** 0.3 
11-Deoxycortisol 3.1** 0.6 -16.0** 4.6 
Cortisol 4.8** 0.7 < -57.1* 17.7 
a Fold changes are calculated compared to the DMSO solvent control. 
b Fold induction indicating smaller than (<) are calculated using the limit of quantification. 
* p value < 0.05 ** p value < 0.01 
 
 
Table 2B. Gene expression changes in H295R cells exposed for 48h to 10 μM forskolin 
or 1 μM prochloraz from three independent experiments. 
 Forskolin Prochloraz 
Gene Fold changea SE Fold changea SE 
CYP1A1 1.5 0.3 6.7** 1.5 
MC2R 29.5** 11.7 2.2 1.1 
StAR 6.4** 0.6 -1.1 0.1 
CYP11A1 3.1** 0.1 1.0 0.1 
HSD3B2 28.4** 5.0 1.2 0.2 
CYP11B1 131.2** 40.3 1.1 0.3 
CYP11B2 29.1** 7.3 2.0 0.4 
CYP19A1 18.4** 3.9 1.8* 0.2 
a Fold changes are calculated compared to the DMSO solvent control. 
* p value < 0.05 ** p value < 0.01 
 
Effects of POPs on Steroid Synthesis 
Three POPs (HBCD, BDE-47 and MeHg) did not significantly influence any of the 
hormone levels (Fig. 1 and Table S2). Interestingly, PFOS had the most pronounced 
effects of all POPs tested and altered almost all hormones of the steroid biosynthesis 
pathway. The hormones at the end of the pathway, aldosterone, cortisol, testosterone 
and 17β-estradiol, as well as corticosterone and androstenedione, were up-regulated 
after exposure to PFOS. Hormones in the beginning of the pathway, 17α-OH-
pregnenolone, pregnenolone and 11-deoxycorticosterone were significantly down-
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regulated. TCDD and PCB 126 significantly up-regulated progesterone (1.4-fold) and 17β-
estradiol (1.8-fold), respectively. PCB 153 and TBT did not up-regulate any hormone 
levels, but decreased several hormone levels. PCB 153 had the most pronounced effect 
on 17α-OH-progesterone (1.8-fold down-regulation) and testosterone (1.5-fold down-
regulation). TBT down-regulated pregnenolone (-1.7-fold), progesterone and 17α-OH-
progesterone (both -1.5-fold). Mixtures A and B had comparable effects and each raised 
or lowered levels of several of the hormones produced (Fig. S1). 17α-OH-Pregnenolone 
and DHEA were significantly down-regulated after exposure to mixtures of POPs, and 
progesterone, 17β-estradiol and corticosterone levels were significantly increased. In 
addition, mixture B decreased pregnenolone levels and raised aldosterone levels. 
 
Figure 1. Heat map showing changes in individual hormone levels after exposure of 
H295R cells for 48h to eight POPs and two mixtures thereof as determined by LC-
MS/MS or EIA. Color scale ranges from increased (red) to decreased (green) steroid 
levels. The brightest color intensity indicates ≥ 2 fold change; black spots represent a 
fold change between -1.3 and 1.3. Colored boxes with a strikethrough represent non-
significant changes in hormone levels, red or green boxes without strikethrough indicate 
statistically significant changes (p < 0.05). Values represent three independent 
experiments. 
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Figure . Gene expression changes in HR cells exposed for h to eight POPs and 
mixtures A and B. Gene expression levels were normalized for HPRT expression. Values 
represent fold change (mean + SE) compared to the solvent control (*.% DMSO) from 
three independent experiments. * p-value < *.* ** p-value < *.*1 
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Effects of POPs on Steroid Related Gene Expression Levels 
Fig. 2 gives an overview of the changes in gene expression levels found. CYP1A1, an 
indicator for exposure to AhR agonists such as dioxin-like compounds, was up-regulated 
after exposure to TCDD, PCB 126 and both mixture A and B. Expression levels of the 
steroid related genes MC2R (3-9 fold change), CYP11B1 (3-27 fold change), and CYP11B2 
(6-81 fold change) were up-regulated by PCB 126 (10 µM), PFOS (200 µM) and both 
mixtures (highest concentration). Furthermore, PCB 126 and mixture A and B up-
regulated CYP19A1 resulting in a 2.9-, 3.9-, and 2.3-fold induction, respectively. No 
significant changes in expression levels were found for StAR, CYP11A1, and HSD3B2 after 
exposure to any of the tested POPs (Fig. S2).  
 
Discussion 
The effects of persistent organic pollutants (POPs) and two mixtures thereof on 
steroidogenesis were studied using the enhanced H295R screening assay. For this 
purpose, 13 steroid hormone levels and 7 steroid-related genes were measured.  
In absolute quantities the H295R cells produced higher levels of adrenal steroids than 
of sex steroids, which is in accordance with the basal hormone levels reported by Xing 
et al.33 Forskolin and prochloraz also gave comparable changes in hormone levels and 
gene expression levels as reported in previous studies,27,34 with the exception that 
prochloraz did not decrease gene expression levels after 48h exposure. Earlier research 
reported small decreases in expression levels of steroidogenic related genes, but not for 
all genes a dose-response relationship was observed.35 In our study prochloraz, which is 
a known AhR agonist, did induce CYP1A1 as was reported before.36 The main endocrine 
modulating mode of action of prochloraz, however, is not by inducing CYP1A1 but by 
decreasing CYP17 and CYP21 activity.35 All three test concentrations of both dioxin-like 
compounds (TCDD and PCB126) induced CYP1A1 expression approximately ten-fold, 
suggesting that the lowest concentrations already induced maximal AhR activation. 
Since TCDD and PCB 126 induced very different steroidogenic profiles, this suggests that 
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the hormone alteration mechanisms in H295R cells are not, at least not solely, AhR 
related. This observation is in agreement with previous research.37 
The compounds HBCD, BDE-47, and MeHg did not significantly alter any hormone 
level, which is in accordance with the finding that they hardly changed expression of 
genes involved in steroidogenesis. Previous research showed that metabolites of BDE-
47 can affect steroidogenesis in H295R cells.38,39 It is known that H295R cells possess 
little CYP1B activity,40 which is apparently not enough to produce metabolites of BDE-
47 for measurable effects on steroidogenesis. The limited production of OH-metabolites 
in vitro has been shown before.41 In our experiments MeHg (up to 100 nM) had no effect, 
while Knazicka et al42 reported lowered testosterone production in H295R cells exposed 
to ≥ 1 μM mercury chloride. It cannot be excluded that the MeHg concentrations in our 
study (up to 100 nM) were below effect levels.  
TCDD had little effect in the H295R cells, while TCDD exposure in humans is negatively 
correlated with testosterone levels.43,44 In vivo TCDD has been shown to decrease 
hormone production in mouse antral follicles45 and the number and size of Leydig cells 
in rats, which is likely to affect testosterone production.46 TCDD might affect 
steroidogenesis by interfering with the hypothalamic-pituitary-adrenal (HPA) axis, but 
these effects cannot be investigated by the current H295R cell model. 
PCB 126 exposure increased CYP19A1 expression which corresponds with previous 
research.47 This also is in agreement with the increased 17β-estradiol levels we found, 
comparable to another study, exposing H295R cells for 48h to 4 μM PCB126.15 In 
addition, Kraugerud and colleagues reported increased aldosterone and small increases 
in cortisol and progesterone levels. In a different study, exposing H295R cells for 10 days, 
the cortisol and aldosterone levels increased time-dependently.48 Therefore, the 48h 
exposure in the current study could have been too short. In our study PCB 153 not only 
decreased testosterone levels, which is in accordance to earlier research in H295R cells,15 
but also androstenedione, 17α-OH-progesterone, and 11-deoxycortisol levels.  
PFOS induced the most pronounced effects of the tested POPs on steroid hormone 
levels and gene expression. Earlier studies reported similar effects of PFOS on 17β-
estradiol, at lower concentrations (up to 300 nM),49 and testosterone, at higher 
Chapter 2 
 
44 
 
concentrations (up to 600 μM).16 At lower concentrations than we tested (300 nM), 
PFOS was shown to decrease testosterone levels in H295R cells.49 Kraugerud et al. 
reported no change in cortisol levels after exposure to PFOS,16 which we did find, but 
this could also be due to their less sensitive detection method using a radioimmunoassay 
with cross-reactivity, which is not a problem in LC-MS/MS measurements as we 
applied.50 Levels of PFOS in human serum of occupationally exposed workers were as 
high as 114 μg/mL (= 212 μM), but for the general population median values are not 
higher than 53 ng/mL (around 100 nM).51 Indeed, PFOS is negatively associated with 
serum testosterone levels in humans, but no effects on other reproductive hormones 
have been shown.52 Already our lowest test concentration (30 μM) affected steroid 
hormone production, and this is the first study to show that PFOS has the ability to alter 
most of the steroid hormone levels and gene expression levels in H295R cells.  
The effects of TBT on hormone production and gene expression have, to the best of our 
knowledge, not been shown before in H295R cells. TBT lowered pregnenolone, 17α-OH-
progesterone, and progesterone levels significantly, but in bovine adrenal cells increased 
17α-OH-progesterone levels have been seen.53 The fact that CYP19A1 gene expression 
levels were not significantly altered in our study was to be expected, as our exposure 
concentrations were lower (up to 30 nM) than reported for inhibition of aromatase 
activity by TBT.54 The TBT levels reported for human blood, as high as 85 ng/mL (261 
nM) with a geometric mean of 6.6 ng/mL (20 nM),55 are higher than the lowest observed 
effect concentration of 10 nM in the H295R cells. As in vivo studies also indicate that 
TBT targets multiple steroidogenic tissues, including testosterone levels and 
steroidogenic enzymes in the testes,56 endocrine disruption in humans by TBT cannot 
be excluded. 
DHEA levels were significantly decreased after exposure to either of both mixtures, but 
were not significantly changed after exposure to any of the single POPs. As no 
cytotoxicity was observed, this suggests an additive effect if this effect can be replicated. 
Also for 17β-estradiol the mixture effect of the compounds was additive. Mixture B 
consisted of mixture A plus HBCD, BDE-47, and MeHg that individually did not alter 
hormone levels, and TBT that individually decreased pregnenolone, 17α-OH-
progesterone, and progesterone. The latter were also decreased by exposure to mixture 
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B, suggesting that TBT is responsible for the difference in response between the mixtures 
A and B. Aldosterone levels, which were only induced with the highest PFOS 
concentration tested (200 μM), were significantly increased after exposure to mixture B 
(PFOS concentration of 100 μM) and not mixture A. Although synergistic effects in 
mixture B cannot be excluded, the effects might also be explained by addition of effects 
of the individual compounds just below the level of quantification.  
An overview of how POPs modulated the steroidogenic pathway is presented in Figs. 3A 
and S3. Increased expression of steroidogenesis related genes did not always correspond 
to increased hormone levels, but only when the gene expression changes were relatively 
high (>10 fold for CYP11B1 and CYP11B2), indicating that gene expression changes might 
be more sensitive to POP exposure than changes in hormone levels. Many steroidogenic 
related genes are still up-regulated after 48h exposure, except HSD3B2 which was shown 
to return to basal levels after 48h.57 Increased hormone levels were always accompanied 
by increased gene expression levels, suggesting that increased hormone levels are, at 
least partly, caused by increased gene expression levels which is biologically plausible. 
On the other hand, decreased hormone levels did not coincide with decreased gene 
expression levels. This is not surprising, as a decrease in hormone levels is not necessarily 
due to decreased hormone production, but could also be the consequence of increased 
conversion into subsequent steroid hormones further down the pathway. This was also 
shown by the enzyme conversion flows in Fig. 3B. PFOS clearly up-regulates the enzymes 
toward the end of the pathway (e.g. 11β-hydroxylase and 18-hydroxylase) without 
lowering the total hormone levels as shown by the stable cholesterol side-chain enzyme. 
This suggests that PFOS lowers hormone levels by increasing the conversion towards 
subsequent hormones. 
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Figure 3A. Steroidogenic pathway in H295R cells exposed for 48h to POPs. Hormones 
and genes between brackets were not measured. Arrows indicate increased or decreased 
hormone or gene expression levels after exposure to A) PFOS; B) PCB 153; and C) Mix B1 
from three independent experiments. 
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Figure 3B. Heat map showing changes in groups of hormone levels. For each enzyme 
involved in steroidogenesis, the corresponding hormone levels are grouped. For 
example, the enzyme encoded by CYP11A1 (cholesterol side-chain cleavage enzyme) is 
relevant for all steroid hormones, so the sum of all measured hormones is used in this 
heat map. The HSD17B enzyme (17β-hydroxysteroid dehydrogenase) is only relevant for 
17β-estradiol and testosterone production, so only the sum of these two hormones was 
calculated. The fold change was then calculated compared to the solvent control. 
Color scale ranges from increased (red) to decreased (green) enzyme conversion. The 
brightest color intensity indicates ≥ 2 fold change; black spots represent a fold change 
between -1.3 and 1.3. Colored boxes with a strikethrough represent non-significant 
changes in hormone levels, red or green boxes without strikethrough indicate 
statistically significant changes (p < 0.05). Values represent groups of hormones 
measured in three independent experiments. Absolute numbers are provided in Table 
S2. 
 
Most in vitro studies, including the H295R assay, lack certain in vivo features such as the 
formation of POP metabolites and feedback mechanisms at the level of the HPA axis. 
For example, in our study melanocortin 2 receptor (MC2R) gene expression levels were 
induced by PCB 126 and PFOS. This receptor is activated by adrenocorticotropic 
hormone (ACTH)58 which is not produced by H295R cells. Therefore up-regulation of 
MC2R in this study is not expected to result in a functional effect. Up-regulation of 
MC2R in vivo, however, could result in over-stimulation of the adrenocortical cells in the 
presence of ACTH, leading to an unbalanced steroid hormone synthesis. These, and 
other indirect effects among different tissues, make development of an in vitro battery 
of tests to study endocrine disruption with relevance for the in vivo situation very 
challenging, but not impossible as has been reasoned for studying thyroid hormone 
disruption.41 In addition to multiple effect mechanisms, also multiple xenobiotic 
compounds, including their bioactive OH-metabolites, are present together in real life 
and, as shown in this study, may lead to additive effects. For example, average PCB serum 
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levels in humans are around 210 ng/mL (approximately 0.6 μM),59 which is only about 
10 times lower than the lowest observed effect concentration of 10 μM in our 
experiments for the individual compounds PCB 126 and PCB 153. Therefore, it cannot be 
excluded that human steroidogenesis can be affected by PCBs and related (OH-) POPs, 
present as mixtures at effect levels.3 
In conclusion, this study shows that ubiquitous seafood POPs, such as TCDD, PCB 126, 
PCB 153, PFOS, TBT and mixtures thereof, are capable of altering steroidogenesis in 
H295R cells at non-cytotoxic and relevant concentrations. The overall effects of the 
mixtures in this study suggest additivity, not synergy. As POPs have been reported to 
affect steroidogenesis via several mechanisms in different tissues, adverse effects in 
humans cannot be excluded. 
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Supporting Information 
Primer sequences and their product length are provided in Table S1. Hormone levels 
measured after exposure to the POP mixtures are presented in Fig. S1. Gene expression 
data of genes not affected by any of the POPs are displayed in Fig. S2. Table S2 contains 
information of all tested POPs and their corresponding hormone levels, which is the 
basis of both heat maps (Figs. 1 and 3B). Supplementary data associated with this article 
can be found, in the online version, at http://dx.doi.org/10.1016/j.tiv.2015.03.002.  
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Abstract 
Insight into the processes controlling adipogenesis is important in the battle against the 
obesity epidemic and its related disorders. The transcriptional regulatory cascade 
involved in adipocyte differentiation has been extensively studied, however the 
mechanisms driving the transcription activation are still poorly understood. In this 
study we explored the involvement of DNA methylation in transcriptional regulation 
during adipocyte differentiation of primary human mesenchymal stem cells (hMSCs). 
Genome-wide changes in DNA methylation were measured using the Illumina 450K 
BeadChip. In addition, expression of 84 adipogenic genes was determined, of which 43 
genes showed significant expression changes during the differentiation process. Among 
these 43 differentially expressed genes, differentially methylated regions (DMRs) were 
detected in only 3 genes. By comparing genome-wide DNA methylation profiles in 
undifferentiated and differentiated adipocytes 793 significant DMRs were detected. 
Pathway analysis revealed the adipogenesis pathway as the most statistically significant, 
although only a small number of genes were differentially methylated. Genome-wide 
DNA methylation changes for single probes were most often located in intergenic 
regions, and underrepresented close to the transcription start site. In conclusion, DNA 
methylation remained relatively stable during adipocyte differentiation, implying that 
changes in DNA methylation are not the underlying mechanism regulating gene 
expression during adipocyte differentiation.  
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Introduction 
Obesity, a condition characterized by excessive accumulation of adipose tissue, is a 
critical issue, causing a wide range of adverse health effects. Adipose tissue accumulation 
results from an increased size as well as number of adipocytes. Adipocyte numbers 
increase when stem cells are triggered to differentiate into the adipogenic pathway.1 
Adipocytes mainly arise from mesenchymal stem cells (MSCs) through a well-
orchestrated process of transcriptional regulation. C/EBPA and PPARG are key 
regulators that are responsible for the activation of a number of adipocyte-specific 
genes.2 The exact mechanisms underlying transcriptional activation are only partially 
elucidated. In embryonic stem cells, DNA methylation is associated with differentiation3 
and de novo methylation rapidly silences genes related to pluripotency.4 Less is known 
about the mechanisms responsible for adult stem cell differentiation. DNA methylation 
is known to be related to gene expression, but its causality in this relationship is yet not 
fully understood. In general, it is thought that methylation in the immediate vicinity of 
the transcription start site (TSS) blocks initiation, but this is dependent on which 
transcription factors are binding.5,6 Methylation in the gene body is currently considered 
to influence gene expression by stimulating transcription elongation and alternative 
splicing.7 The role of DNA methylation in intergenic regions (IGR) is only poorly 
understood, but methylation in repetitive regions is considered important for genomic 
stability.5 
DNA methylation changes during adipocyte differentiation have been reported, 
indicating this might be one of the underlying mechanisms of transcriptional 
regulation.8 CpG dinucleotides located in the LEP,9-11 the GLUT4,12 and the PPARG2 
promoter10,13 become hypomethylated during differentiation. The fact that obesity is 
associated with DNA methylation changes14,15 implies that DNA methylation changes 
can be relevant for human health. To our knowledge, only one genome-wide study was 
performed addressing DNA methylation in relation to gene expression during the 
differentiation into adipocytes.16 Takada et al. found methylation changes when adipose 
derived stem cells were induced to become pluripotent stem cells, but only few changes 
were detected upon differentiation. In our study we tested cells from a different origin, 
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namely pluripotent MSCs which can differentiate into adipocytes, chondrocytes, and 
osteoblasts. When MSC differentiate into adipocytes they first go through the so called 
‘commitment phase’ where the cells become preadipocytes. Subsequently the 
preadipocytes enter the actual differentiation phase where they mature into functional 
adipocytes. Fully understanding the normal development of MSCs into mature 
adipocytes is crucial to study the suggested role of environmental and lifestyle factors 
(e.g. diet, exercise, pollutants) in triggering of and interfering with adipocyte 
differentiation, possibly resulting in obesity and adverse health effects.  
In this paper we report for the first time genome-wide DNA methylation profiles in 
primary bone marrow-derived human MSCs (hMSCs) preceding through both the 
commitment and differentiation phase of adipocyte differentiation. Compared to 
previous research we focused not mainly on DNA methylation close to the promoter 
region or in single CpG sites, but emphasized the identification of differentially 
methylated regions (DMRs), without predefining these regions. DMRs are stretches of 
DNA with different methylation patterns compared to the control samples, and can 
provide insight into important biological processes. Furthermore, we determined the 
relationship between DNA methylation and gene expression of 84 relevant adipogenic 
genes. 
 
Materials and methods 
Cell culture and differentiation 
PoieticsTM human mesenchymal stem cells (hMSC; Lot No 2F3478) were obtained from 
Lonza Walkersville Inc. at passage 2. These cells were cultured in MSCGM (Lonza, 
Walkersville, USA) growth medium, which contained fetal bovine serum (FBS) and L-
glutamine, in a humidified incubator with 5% CO2 at 37°C. Cells were subcultured once 
per week and medium was refreshed once a week. For the differentiation experiments, 
only cells from passage 9 were used, because DNA methylation profiles were shown to 
depend of the number of passages.17 Differentiation experiments were repeated four 
times to make sure independent results were obtained. Cells were seeded with a density 
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of 3.800 cells/cm2 and grown for four days until fully confluent. Differentiation reagents 
were purchased from Sigma-Aldrich, Zwijndrecht, the Netherlands, unless otherwise 
specified. Exposure to 5-aza-2′-deoxycytidine (5-aza-dC, 1 μM), used as a positive control 
for DNA hypomethylation and dissolved in DMSO, was started within 24h after seeding 
and was continuously present during differentiation (Fig. 1A). Differentiation was 
induced (at day 0) with an adipogenic induction medium for hMSCs consisting of 
DMEM supplemented with L-glutamine (1%), FCS (10%), dexamethasone (1 μM), human 
insulin (5 μg/mL; Insuman Rapid (100 IE/mL), pharmacy), 3-isobuty-l-methyl-xanthine 
(IBMX, 0.5 mM), and rosiglitazone (1 μM; Sanbio B.V, Uden, the Netherlands). Medium 
was refreshed twice a week, until day 10 when differentiation was ended. 
Quantification of lipid accumulation 
At day 10 of adipocyte differentiation, cells cultured in 12-wells plates were fixated with 
4% formalin in PBS for 10 minutes. Cells were washed with PBS and Oil-Red-O dye (3 
mg/mL, 60% isopropanol, 40% distilled water) was added for 10 minutes. After staining, 
cells were washed with water multiple times to remove unbound dye and photographed. 
Subsequently, plates were air-dried. To each well, 350 μL of isopropanol was added to 
extract the Oil-Red-O. After dissolving, two aliquots of 100 μL were transferred to a 96-
well plate and the optical absorbance was measured at 520 nm. Oil-Red-O staining of 
undifferentiated cells grown in parallel culture was used as a negative control and was 
subtracted from the measurements. Differences in lipid accumulation between 5-aza-
dC treatment and the solvent control were calculated using a student’s t-test from four 
independent experiments. 
RNA isolation and cDNA synthesis 
Total RNA was isolated from 60 mm dishes at day 0 (just before differentiation was 
induced), at day 2 and at day 10 of differentiation using Trizol (Invitrogen, Merelbeke, 
Belgium) according to the manufacturer’s instructions (Fig. 1A). RNA was dissolved in 
Milli-Q water and the RNA concentration was measured using a NanoDrop ND-1000 
UV–vis spectrophotometer (Isogen, Maarssen, the Netherlands). First-strand cDNA was 
synthesized from 1 μg of total RNA using the RT2 First Strand Kit (Qiagen, Venlo, the 
Netherlands) following the supplier’s protocol. 
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RT2 profiler™ PCR assay 
The adipogenesis RT2 profiler PCR Array (PAHS-049ZE-4, Qiagen, Venlo, the 
Netherlands) was used according to the manufacturer’s instructions to profile the 
expression of 84 key genes involved in the differentiation and maintenance of mature 
adipocytes plus five housekeeping genes. Expression of genes that needed more than 35 
cycles to reach the threshold was regarded as below the detection limit. Gene expression 
data were normalized against the geometric mean of the references genes B2M and 
HPRT1, because the other 3 reference genes included did not remain stable over time. 
Statistically significant differences between days of differentiation were calculated using 
a student’s t-test on the log-transformed values of the expression normalized for the 
reference gene. Relative changes in gene expression were expressed as fold changes on 
a log2 scale compared to day 0. A log2 fold change of 1 represents a two-fold increase in 
gene expression, whereas a log2 fold change of -1 represents a two-fold reduction in 
expression. When no expression was measured at either day 0, day 2 or day 10 of 
differentiation, fold changes were calculated with a value of 35 cycles. 
Real-Time Quantitative PCR 
Primers (Table S1) were tested for specificity by BLAST analysis using NCBI 
PrimerBLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast). Real-time quanti-
tative PCR (qPCR) was performed using SensiMix SYBR (GC Biotech, Alphen A/D Rijn, 
The Netherlands) and a CFX384 Real-Time PCR detection system (Bio-Rad laboratories 
BV, Veenendaal, The Netherlands). 2 µL cDNA was used in a total volume of 8 µL, with 
a primer concentration of 600 nM. The following thermal cycling conditions were used: 
10 min at 95°C, followed by 40 cycles of 95°C for 10s and 60°C for 15s. Melting curve 
analysis was performed to assure no non-specific signals were detected. Relative 
expression was calculated using a three-fold dilution series of pooled cDNA to correct 
for the efficiency of the PCR reaction. The reactions were performed in duplicate and 
further data analysis was performed similar to the PCR array. 
DNA isolation 
Genomic DNA was isolated from cells in 60 mm culture dishes just before differentiation 
started (day 0) and at day 10 of differentiation (Fig. 1A) using the DNeasy blood and 
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tissue kit (Qiagen, Venlo, the Netherlands). Culture dishes were rinsed twice with PBS, 
followed by adding 500 μL of mastermix, containing PBS, proteinase K (>60mAU/mL), 
and RNAse (200 units/mL), and 500 μL lysis buffer (buffer AL). The following steps of 
the DNA isolation were performed according to the manufacturer’s protocol. DNA was 
eluted in 25 μL AE buffer and the concentration was determined using a NanoDrop ND-
1000 UV–vis spectrophotometer. 
Genome-wide DNA methylation for single probes 
DNA methylation was analyzed using the Illumina Infinium Human Methylation 450K 
BeadChip (Infinium Inc., San Diego, CA, USA), which addresses 485,512 methylation 
sites. DNA samples (500 ng) were prepared in 45 μL and the bisulfite conversion (EZ 
DNA Methylation Kit, Zymo Research, Freiburg, Germany) and the BeadChips were 
processed by the Human Genotyping Facility of the Erasmus University Medical Centre 
(Rotterdam, the Netherlands). DNA from the positive control, 5-aza-dC, was pooled 
from two independent experiments, resulting in two samples measured. From the other 
samples, the four independent experiments were measured separately. To minimize 
batch effects, samples were randomly allocated to two chips. Intensity iDAT files were 
processed using R-based open software (R 3.1.2), including 450K Chip Analysis 
Methylation Pipeline (ChAMP) (version 1.1.2) and Limma (Linear Models for Microarray 
Data) (version 3.22.1). Autosomes and the X and Y chromosomes were included in the 
analysis. ChAMP18 was used for pre-processing and the normalization of the raw data 
with SWAN.19 Probes with a detection p-value of > 0.01 in >1% of the samples were 
filtered out, as well as the probes with a beadcount < 3 in 5% of the samples. Finally, 
483,914 probes were included in the analysis and annotated based on the ilmn12.hg19 
annotation.20 The multidimensional scaling (MDS) plot, based on the 1000 most 
variable probes, showed that one sample clustered separately and was therefore 
excluded from further analysis. The Limma package was used to identify differentially 
methylated CpG sites. DNA methylation at day 10 of differentiation was compared to 
DNA methylation profiles of day 0. The statistical analyses were performed unpaired 
and adjusted for multiple testing with the Benjamini-Hochberg (BH) method.21 A false 
discovery rate (FDR) value of 0.05 was used as the threshold to define statistical 
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significance. The methylation (β) values were constrained to lie between 0 (completely 
unmethylated, equal to 0%) and 1 (completely methylated, equal to 100%). 
Differentially methylated regions (DMRs) 
In addition to the approach of identifying methylation differences in single probes, we 
used the DMRcate package from Bioconductor to detect DMRs.22 This method does not 
use predefined regions, but identifies the most differentially methylated regions across 
the genome based on tunable kernel smoothing of the differential methylation signal. 
The measured probes are identified independent of the direction of the methylation 
change and distance from each other. DMRs are defined as regions of at least 5 probes 
with a distance of consecutive probes less than 1000 nucleotides. To gain more insight 
into the biological relevance regarding the genome-wide approach, we further selected 
DMRs with an absolute difference in methylation of ≥ 5% in at least 1 probe. The 
statistical tests for the DMRs also were adjusted for multiple testing with the BH method 
by applying a FDR of 0.05.  
 
Results 
Differential expression of adipogenic markers in differentiated hMSCs 
To explore gene expression in relation to DNA methylation during adipocyte 
differentiation, adipogenesis was induced in hMSCs (see Fig. 1A for exposure regime). 
Oil-red-O staining of the differentiating cells revealed weak lipid accumulation at day 2 
while at day 10 clear lipid accumulation was observed in the majority of the cells (Fig. 
1B). A panel of 84 adipogenic genes was analyzed with the RT2 profiler PCR Array, but 
expression levels of 10 genes were below the detection limit (Ct value > 35) and therefore 
excluded. Of the remaining 74 genes, 43 showed significant (p < 0.05) differential 
expression at either day 2 and/or day 10 of differentiation compared to day 0. Gene 
expression changes were most pronounced at day 10 compared to day 2 of 
differentiation. The subset of 43 genes included 26 up-regulated (Fig. 1C / Table S3) and 
17 down-regulated genes (Fig. 1D / Table S3) at day 10 of differentiation. The up-
regulated genes included key regulators of adipogenesis (CEBPA and PPARG),  
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Fig. 1. Adipogenic markers in human mesenchymal stem cells (hMSCs) at day 2 and day 
10 of adipocyte differentiation. A) Schematic representation of exposure regime. B) 
Representative pictures of Oil-red-O stained lipid droplets in undifferentiated and 
differentiated hMSCs cells at day 10. C) Adipogenic gene expression at day 2 and day 10 
of differentiation. Only genes that were significantly up-regulated at day 10 of 
differentiation (p < 0.05) are shown. Expression of 84 genes related to adipogenesis was 
measured and expression levels were normalized for HPRT1 and B2M expression. Values 
represent the log2 fold change (mean + SD) compared to day 0 from three independent 
experiments. D) Relative expression changes for genes that were significantly down-
regulated at day 10 of differentiation (p < 0.05), together with the fold changes at day 2. 
Fold changes of all measured genes with their level of significance can be found in Table 
S3. 
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adipokines (ADIPOQ, CFD, and LEP), various PPARG target genes (e.g. FASN, IRS2, 
LIPE) and multiple pro-adipogenic genes relevant for the late stage of adipocyte 
differentiation (e.g. ACACB, FABP4, SLC2A4). Fluctuating results were observed for pro-
adipogenic genes that are important for the commitment or early stage of adipogenesis. 
EGR2, an immediate early gene responsible for up-regulation of CEBPB, was down-
regulated at day 2 and up-regulated at day 10. The early stage anti-adipogenic genes 
CDKN1B and GATA2 were down-regulated upon differentiation as was the late stage 
anti-adipogenic gene ADRB2. Our data revealed that expression of most WNTs, known 
to block induction of key adipogenic transcription factors, was below the detection limit 
and only WNT5A expression levels were measurably reduced during the differentiation 
process.  
In short, hMSCs successfully differentiated into mature adipocytes as shown by the lipid 
accumulation and the expression profiles of the adipogenic genes. 
No clear association between gene expression and DNA methylation of known adipocyte-
related genes 
Genome-wide DNA methylation was examined by applying Illumina 450K BeadChip 
analysis, comparing hMSCs at day 0 to differentiated adipocytes at day 10. Day 10 was 
chosen based on the pronounced gene expression changes and because DNA is expected 
to be a long-term epigenetic mark. None of the 483,914 single probes were statistically 
significant different (adjusted p-value < 0.05) in any of the above described 84 
adipogenic genes after adjusting for the false discovery rate (FDR). We therefore focused 
on DNA methylation of the top 1000 probes with the lowest non-adjusted p-value, and 
located probes annotated to one or more of the 84 adipogenic genes (Table S2). This 
revealed 7 probes that can be allocated to 5 different genes. The probe with the lowest 
non-adjusted p-value (p = 2.4E-05) was detected in the 5’untranslated region (UTR) of 
LEP. 
Although our results did not reveal significantly differentially methylated probes with 
an adjusted p-value < 0.05, we identified 8 DMRs (adjusted p-value < 0.05) with multiple 
consecutive probes in 6 of the 84 earlier mentioned adipogenic genes (Table 1). The 6 
adipogenic genes containing DMRs included 3 down-regulated genes, no up-regulated 
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genes, 2 genes without significant changed expression, and 1 gene with expression below 
the detection limit (Fig. 2). As explained earlier, the relationship between DNA 
methylation and gene expression depends on the specific location within or outside the 
genes. We found that most regions that were differentially methylated during adipocyte 
differentiation were located in the gene body. AXIN1 and PRDM16 contained DMRs with 
increased methylation in the gene body (Table 1) and these genes showed a concordant 
decrease in gene expression (Fig. 1D), while CCND1 showed a decrease in gene body 
methylation (Fig. 3) together with a decrease in gene expression (Fig. 1D). Furthermore, 
we detected three DMRs (FOXC2, GATA3,and IRS1) in close proximity to the TSS or in 
the first exon of the corresponding genes (Fig. 3). Gene expression for FOXC2 and IRS1 
was not significantly changed and below the detection limit for GATA3.   
Overall, a minority of the adipogenic genes were differentially methylated during 
adipocyte differentiation.  DNA methylation changes close to the TSS or in the gene 
body could not be associated with differential gene expression. 
 
 
Fig. 2. Results of changes in gene expression (grey boxes) and differentially methylated 
regions (DMRs) (white boxes) of 84 adipogenesis related genes at day 10 of hMSC 
differentiation compared to undifferentiated cells at day 0. 
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Table 1. Differentially methylated regions (DMRs) found with the DMRcate package in 
the 84 genes related to adipogenesis comparing undifferentiated hMSCs at day 0 to 
differentiated adipocytes at day 10. 
TSS200 /1500 = 200 / 1500 base pairs from the transcription start site. 
1 Annotation according to Ilmn12.hg19 identifiers. 
2 p-value is the mean BH-adjusted p-value of the probes in the DMR 
3  maximal change in DNA methylation (beta %) for the probes within the DMR 
4 ns: no significant change in gene expression was found 
5 na: gene expression levels were below the limit of detection  
 
 
Numerous genome-wide DNA methylation changes were found, spread out over different 
pathways 
The genome-wide DNA methylation analysis of the undifferentiated (d0) and 
differentiated (d10) hMSCs did not reveal significantly differentially methylated single 
probes based on the adjusted p-value. However, we identified 793 statistically significant 
DMRs. The number of probes per DMR for the top 10 most significant DMRs reached 
up to 13 consecutive probes, and the strongest magnitude change in DNA methylation 
was 11.6% (Table 2 / Table S4).  
 
Gene Chromosome: 
position1 
Relation-
ship to 
gene 
No. 
probes 
in DMR 
No. 
probes 
on array 
p-value2 DNA 
methy-
lation 
change3 
(%) 
Gene 
expression 
AXIN1 chr16:367990-
368761 
Body 6 62 1.2E-03 4.1 ↓ d10 
CCND1 chr11:69460638-
69461451 
Body 6 69 1.4E-02 -5.3 ↓ d2/10 
FOXC2 chr16:86598792-
86599976 
TSS1500 9 16 1.3E-02 -8.7 ns4 
GATA3 / 
FLJ45983 
chr10:8095755-
8096650 
TSS1500 
TSS200 
29 29 2.2E-02 6.7 na5 
IRS1 chr2:227661213-
227662083 
1stExon 5 34 1.7E-02 -11.2 ns4 
PRDM16 chr1:3276413-
3276786 
Body 6 636 3.3E-02 5.5 ↓ d10 
PRDM16 chr1:3330724-
3331278 
Body 5 636 2.5E-06 4.6 ↓ d10 
PRDM16 chr1:3347146-
3347994 
Body 5 636 4.1E-03 4.7 ↓ d10 
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Fig. 3. Examples of differentially methylated regions (DMRs) in adipogenic related genes 
after differentiation into mature adipocytes at day 10 (grey line) compared to non-
differentiated hMSCs at day 0 (black line). Each point indicates a single probe and the 
line represents the average of at least three independent experiments. The DMRs were 
identified using the DMRcate package and the location of the probes is based on genome 
h19/GRCh37. 
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Table 2. Differentially methylated regions (DMRs) found with the DMRcate package in 
all measured genes comparing undifferentiated hMSCs at day 0 to differentiated 
adipocytes at day 10. The top 10 is presented of DMRs with a minimum of 5% 
methylation difference for one probe. A table with all 258 DMRs can be found in Table 
S4.  
3’/5’UTR = 3’/5’ untranslated region. TSS200 /1500 = 200 / 1500 base pairs from the transcription start 
site 
1 Annotation according to Ilmn12.hg19 identifiers. 
2p-value is the mean BH-adjusted p-value of the probes in the DMR 
 
Interestingly, a DMR in the top 10 of most significant DMRs was located in TBX15, a 
mesodermal developmental gene, which can influence adipocyte differentiation and 
lipid accumulation23 and is associated with obesity.24 Another DMR was located in 
CRTAC1, which can be used as a marker to distinguish between MSCs and osteoblasts.25 
Besides these genes within the top 10, there were also certain DMRs which consisted of 
15 consecutive probes or more (Table S4). One of these DMRs was locating in SLC1A3, 
previously found to be up-regulated upon differentiation in hMSCs.26 Remarkably, the 
DMR related to HOXA5 consisted of 32 consecutive probes. HOXA5 is a developmental 
gene and its expression in hMSCs was shown before,27 as well as the differential 
Gene Chromosome: 
position1 
Relation-
ship to 
gene 
No. 
probes 
in DMR 
No. 
probes 
on array 
p-value2 DNA 
methylation 
change (%) 
CAND2 chr3:12856409-
12856862 
Body 6 33 9.4E-07 7.6 
TBX15 chr1:119521928-
119522855 
5'UTR 6 61 1.5E-06 -9.3 
- chr4:188953092-
188953969 
- 8 13 1.2E-05 11.2 
HS3ST3B1 chr17:14202916-
14203711 
TSS1500 5 54 2.7E-05 7.4 
LOC388965 chr2:84517321-
84517950 
TSS1500 
TSS200 
Body 
9 10 5.1E-05 -8.2 
CASZ1 chr1:10707454-
10708091 
3'UTR 
Body 
6 176 7.2E-05 6.4 
OCA2 chr15:28344273-
28344730 
5'UTR 
1stExon 
TSS200 
TSS1500 
13 95 1.5E-04 5.3 
LOC100130522 chr18:77905119-
77905947 
TSS1500 
TSS200 
Body 
11 20 2.4E-04 -11.6 
TMEM87B chr2:112811068-
112812167 
TSS1500 7 22 2.5E-04 6.8 
CRTAC1 chr10:99695981-
99696260 
Body 5 46 2.5E-04 5.4 
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expression in adipocytes depending on lipid accumulation.28 Furthermore, a DMR was 
found for DYRK1B which is expected to be involved in adipocyte differentiation in mouse 
cells.29 For more in depth analysis, we performed Ingenuity Pathway Analysis (IPA, 
Qiagen) which revealed the adipogenesis pathway as the most significant (p-value 1.26E-
03) based on the DMRs. However, only 6 (ATG5, EBF1, FGFR4, FOXC2, HDAC4, TNF) 
out of 127 known genes in this pathway were differentially methylated (Fig. 4). To 
determine whether the DMRs annotated to these genes showed differential expression 
we performed additional qPCR analysis (Table 3). We detected differential expression 
for TBX15, CRTAC1, EBF1, and DYRK1B, however altered gene expression was both related 
to increased and decreased methylation levels. 
 
 
Fig. 4. The 5 most significant pathways detected in the differentially methylated regions 
(DMRs; number of genes detected / number of genes present in pathway) upon 
differentiation following Ingenuity Pathway Analysis (IPA). Non-differentiated hMSCs 
(d0) were compared to differentiated adipocytes (d10). In total, 258 DMRs with a 
minimum of 5% methylation difference was included which resulted in 202 unique 
genes. The pathways  are presented as the percentage of overlapping genes between the 
DMRs and the pathway as well as the statistical significance.  
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Table 3. Differentially methylated regions (DMRs) found with the DMRcate package 
with a genome-wide analysis comparing undifferentiated hMSCs at day 0 to 
differentiated adipocytes at day 10. Genes were chosen for additional transcriptional 
analysis based on their possible relevance for hMSCs and adipocytes and had to apply to 
either one of the three following criteria: 1) present in the top 10 of most significant 
DMRs (TBX15 and CRTAC1); 2) detected as relevant for the adipogenesis pathway based 
on the Ingenuity Pathway Analysis (ATG5, EBF1, and HDAC4); 3) genes associated with 
a DMR of minimal 15 probes (SLC1A3, HOXA5, DYK1B). 
3’/5’UTR = 3’/5’ untranslated region. TSS200 /1500 = 200 / 1500 base pairs from the transcription start 
site. 
1 Annotation according to Ilmn12.hg19 identifiers. 
2p-value is the mean BH-adjusted p-value of the probes in the DMR 
3 ns: no significant change in gene expression was found 
 
5-aza-dC treatment induced strong hypomethylation in differentiating hMSCs 
As a positive control for changes in DNA methylation, adipocyte differentiation in 
hMSCs was induced in the presence of 5-aza-dC, a well-known DNMT1 inhibitor. 
Indeed, the Illumina 450K BeadChip analysis revealed significant (FDR adjusted p-value 
< 0.05) differential methylation of 26,982 probes and 13,769 statistically significant 
Gene Chromosome: 
position1 
Relation-
ship to 
gene 
No. 
probes 
in DMR 
No. 
probes 
on 
array 
p-value2 DNA 
methy-
lation 
change 
(%) 
Gene 
expression 
TBX15 chr1:119521928-
119522855 
5'UTR 6 61 1.5E-06 -9.3 ↑ d2/d10 
CRTAC1 chr10:99695981-
99696260 
Body 5 46 2.5E-04 5.4 ↑ d10 
ATG5 chr6:106773518-
106773949 
5'UTR 
1stExon 
TSS200 
TSS1500 
8 22 4.1E-02 -5.0% ns3 
EBF1 chr5:158526263-
158526693 
Body 
1stExon 
5'UTR 
5 57 1.5E-02 10.7% ↑ d2/d10 
HDAC4 chr2:240029626
-240029909 
Body 5 425 2.3E-02 5.8% ns3 
SLC1A3 chr5:36606102-
36607417 
TSS1500 
TSS200 
1stExon 
5'UTR 
19 28 2.0E-02 5.6% ns3 
HOXA5 chr7:27183794-
27184737 
TSS1500 32 51 1.7E-02 -9.4% ns3 
DYRK1B chr19:40324226-
40325405 
5'UTR 
1stExon 
TSS200 
3'UTR 
TSS1500 
Body 
15 16 1.9E-03 6.2% ↓ d10 
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DMRs upon 5-aza-dC-treatment (Table 4). The differentially methylated probes were 
not randomly distributed over the probes present on the BeadChip (Fig. 5A). 5-aza-dC-
treatment predominantly affected methylation in the gene body, while differentiation 
predominantly affected methylation in the IGR. Methylation around the TSS was 
underrepresented for both adipocyte differentiation and 5-aza-dC-treatment. Of the 
1000 most differentially methylated probes upon differentiation at day 10, 664 showed 
an increase in methylation, while 5-aza-dC treatment induced hypomethylation of 
nearly all (99.7%) significantly changed probes. 
 
Table 4. Number of differentially methylated probes and differentially methylated 
regions (DMRs) found, measured with Illumina 450K BeadChip, during adipocyte 
differentiation (comparison of day 0 with day 10) and with 5-aza-dC treatment 
(comparison solvent control and 5-aza-dC treatment at day 10). 
 
 
  
Fig. 5. DNA methylation features. A) Features of the 1000 probes with the highest 
statistical significance after adipocyte differentiation (grey bars), and of the statistically 
significant probes after treatment with 5-aza-dC (black bars) compared to all considered 
probes on the Illumina 450K BeadChip (white bars). TSS = transcription start site. UTR 
= untranslated region. IGR = intergenic region. B) Number of hypo- and 
hypermethylated probes following differentiation (top) or 5-aza-dC treatment (bottom).  
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After establishing that 5-aza-dC successfully induced DNA hypomethylation, we 
investigated the effect of this DNMT inhibitor on the adipocyte differentiation and the 
expression levels of the adipogenic markers. Strong inhibition of adipocyte 
differentiation was observed after 5-aza-dC-treatment, visible as a 31% reduced lipid 
storage compared to the solvent control (Fig. 6A), and the decreased expression levels 
of the key adipogenic regulators CEBPA and ADIPOQ. Gene expression significantly 
changed for 17 of the 84 genes, while 11 genes were below the limit of detection (Fig. 6B). 
Of these 17 genes, 9 were related to a DMR. All DMRs showed a decrease in methylation, 
while gene expression levels were both increased as well as decreased (Fig. 6B). Fig. 7 
shows that, out of the 84 adipogenic genes, 43 genes contained a DMR with a minimum 
beta difference of 5% in at least one of the probes, but DNA methylation changes were 
not related to gene expression levels. DNA hypomethylation occurred in the proximity 
of the TSS for AGT, SFRP1, SFRP5, SIRT2, and TSC22D3, and except for SFRP5, this 
coincided with a decrease in gene expression (Table S5). In summary, 5-aza-dC caused 
strong hypomethylation in most adipogenic genes, but no concomitant change in gene 
expression was found. 
 
Fig. 6. Adipogenic markers in human mesenchymal stem cells (hMSCs) after continuous 
exposure to 5-aza-dC (1 μM). A) Lipid accumulation at day 10 of adipocyte 
differentiation, quantified by Oil-Red-O staining (mean + SD from four independent 
experiments). ** p < 0.001. B) Gene expression changes (all p < 0.05) at day 10 of 
differentiation, normalized for HPRT1 and B2M expression. Values represent the log2 
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fold change (mean + SD from three independent experiments) compared to the solvent 
control at day 10. # indicates that this gene also has a significant differentially 
methylated region (DMR). All DMRs found in any of the 84 adipogenic genes are 
presented in Table S5. 
 
 
Fig. 7. Results of changes in gene expression (grey boxes) and differentially methylated 
regions (DMRs) with a minimum beta difference of 5% (white boxes) of 84 adipogenesis 
related genes found after exposure to 5-aza-dC (1 μM)  at day 10 of differentiation 
compared to non-treated differentiated adipocytes at day 10. All DMRs found in any of 
the 84 adipogenic genes are presented in Table S5. 
 
Discussion 
Primary human mesenchymal stem cells (hMSCs) were used to assess genome-wide 
changes in DNA methylation upon differentiation into mature adipocytes, and to 
explore the relationship between DNA methylation and gene expression of adipogenic 
genes. 
The examined adipogenic markers changed as expected during the differentiation 
process, shown by lipid droplet formation and the gene expression profiles.2 Out of the 
total panel of 84 adipogenic genes, 43 genes revealed differential expression during 
adipocyte differentiation, of which 3 genes had a significant DMR. Furthermore, we 
detected DMRs in 2 genes that were not differentially expressed. In general, we 
predominantly identified an increase of DNA methylation, i.e. hypermethylation, during 
84 adipogenesis related genes
(measured at day 10)
11
Expression below 
detection limit
17
Differentially 
expressed
56
No significant 
different expression
4 Up-regulated 13 Down-regulated
3 genes with DMRs 31 genes with DMRs
2 genes with DMRs 7 genes with DMRs
Effect 5-aza-dC
Gene expression
DNA methylation
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differentiation. Other studies, mostly using mouse cells like 3T3-L1 cells, predominantly 
detected hypomethylation in specific adipogenic genes.9-13 The 3T3-L1 cells, however, are 
already committed to the adipocyte lineage which possibly results in a different initial 
methylation pattern compared to multipotent cells.30  
Our results show that DNA methylation and gene expression changed independently 
from each other during adipocyte differentiation. This is in accordance with the study 
of Takada et al. (2014), who also did not find a clear relationship between the two 
phenomena in adipose-derived stem cells.16 Furthermore, also during myogenic 
differentiation, no association between gene expression and DNA methylation was 
found.31 DMRs in the promoter region are proposed to correlate with gene expression 
changes.5 Since the majority of the observed DNA methylation alterations in this study 
were not located in the proximity of the TSS, it is not surprising that DNA methylation 
changes could not be associated with gene expression alterations. However, also in the 
few DMRs detected in close proximity to the TSS, the association with gene expression 
was lacking. Perhaps the DMRs were too small to influence expression, as other probes 
measured around the TSS were not differentially methylated, as for example showed for 
FOXC2 (Fig. 3). We therefore also investigated gene expression for some DMRs than 
contained a minimum of 15 consecutive probes, however, this did not improve the 
association between gene expression and DNA methylation. Even for our positive 
control, 5-aza-dC-treatment, which caused a strong effect on DNA methylation, no clear 
association with gene expression was observed. It has to be noted that 5-aza-dC does 
not only inhibit DNA methylation as it can also exert other effects, such as inhibition of 
adipocyte differentiation. This could be a reason for the lack of association between DNA 
methylation and gene expression after 5-aza-dC exposure. 
The majority of the identified DNA methylation changes in our study were found in 
IGRs. DNA methylation in the IGR is important for genomic stability, but earlier 
research also found cell-type discriminatory patterns in IGRs outside CpG islands.32 This 
might indicate that methylation in the IGR is important for the differentiation process, 
or alternatively, is the consequence of the differentiation. More research is necessary to 
further elucidate the relationship between differential DNA methylation in IGRs and 
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gene expression levels, and to determine the functional consequences of DNA 
methylation in IGRs.  
The precise role of DNA methylation within the gene body is far from being understood, 
but it has been suggested to be involved in transcript elongation, alternative splicing 
and enhancer activation.7 We found DNA methylation changes in the gene body for 
genes that were not differentially expressed and for genes with increased or decreased 
gene expression levels, suggesting there might be a rather complex interaction.  
No statistically significant changes in methylation were found in single probes with the 
adjusted p-values for multiple testing. This might be explained by small effects and 
limited number of samples, in combination with the variation in heterogeneous cell 
populations after adipocyte differentiation.33 Differentiation of hMSCs results in a 
heterogeneous cell population including, apart from fully differentiated adipocytes, also 
less differentiated cell types with concomitant DNA methylation profiles. Furthermore, 
identification of DMRs is often more sensitive to reveal small changes in DNA 
methylation, because it takes consecutive probes into account. This also makes DMRs 
more biologically relevant than differentially methylated single probes. By exploring 
genome-wide DNA methylation we found 793 DMRs during differentiation, and 258 of 
these DMRs displayed at least a DNA methylation change of 5%. DMRs were not 
strikingly (6 DMRs detected in 127 adipogenic genes), although significantly, 
overrepresented in adipocyte-related genes. EBF1 gene expression was increased 
together with DNA methylation, but ATG5 and HDAC4  expression was not affected. 
This suggests that specific DNA methylation changes might be important for the 
differentiation process, independent from transcriptional regulation. Relevant genes in 
de top 10 of detected DMRs included TBX15 and CRTAC. The methylation status of these 
genes might be important to determine cell fate,23,25 and was associated with increased 
gene expression.  
The limited DNA methylation changes found are in accordance with previous studies.8,16 
Takada et al., however, reported DMRs in ADIPOQ, which we could not detect in our 
experiment because their particular probes are not present on the 450K BeadChip. 
Although we studied DNA methylation extensively by measuring a large number of 
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probes, this only covered about 1% of the CpG sites present in the genome. It is therefore 
possible that DNA methylation changed at one or more of the unmeasured probes. 
Furthermore, the 450K BeadChip cannot distinguish DNA methylation from 
hydroxymethylation. Hydroxymethylation might be an intermediate stage of active 
demethylation and does not necessarily have the same function as DNA methylation. 
However, hydroxymethylation only represents a small fraction of total methylation in 
mammalian tissue34 and in cultured cells.35 
It has been suggested that DNA methylation during adipogenesis is most important in 
the commitment stage, and less in the differentiation phase.16 However, our experiments 
with the hMSCs included both stages, and stable long-term DNA methylation in the 
commitment stage would still be present at the end of differentiation. If DNA 
methylation is not as stable as thought,4 DNA methylation changes in the commitment 
phase might be missed if measured at day 10. For a very limited subset of probes in the 
BRD2 gene it was shown that DNA methylation decreased in the first few days of 
adipogenesis, and increased in mature adipocytes, indicating DNA methylation can be 
a dynamic process.36  
Our data suggest that DNA methylation might not be the most important factor 
regulating adipocyte differentiation, in contrast to differentiation of embryonic stem 
cells.3 Similarly, in hMSCs, differentiating into chondrocytes, DNA methylation in the 
promoter region did not correlate with changes in gene expression, but the chromatin 
structure had changed.37 It has also been shown that during adipocyte differentiation 
the chromatin landscape is modulated38 and that gene expression changes correlated 
with chromatin marks.39,40 PPARG, which is an important regulator in adipogenesis, was 
also found to be related to chromatin structure and histone marks.41 We previously 
showed that also during aging changes in genome-wide DNA methylation and gene 
expression occur independently.42 Taken altogether, these findings suggest that changes 
in DNA methylation are often insufficient to regulate gene expression. The complex 
interaction between DNA methylation, histone modifications and noncoding RNA 
should be studied to fully comprehend epigenetic effects on gene expression. 
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In conclusion, genome-wide DNA methylation analysis showed that DNA methylation 
was relatively stable during adipocyte differentiation, although some significant changes 
were observed. The pronounced differences in gene expression levels of 84 adipocyte-
related genes could not be explained by DNA methylation, suggesting that other 
mechanisms play a more important role. 
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Supplementary data 
Primer sequences and their product length are provided in Table S1. Single probes 
identified for any of the 84 adipogenic related genes from the top 1000 are given in Table 
S2. Gene symbols of the 84 adipogenic genes with their description, followed by the 
average fold change and the p-value, can be found in Table S3. The 258 genome-wide 
detected DMRs, with a minimum beta difference of 5%, are described in Table S4. DMRs 
with a minimum beta difference of 5%, found in the 84 adipogenic genes after 5-aza-dC 
treatment, and the association with gene expression, are provided in Table S5. 
Supplementary information can be found, in the online version, at 
http://dx.doi.org/10.1002/jcb.25568. The data sets supporting the DNA methylation 
results of this article are available in the Gene Expression Omnibus (GEO) with 
accession number GSE74609. 
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Abstract 
Ubiquitous persistent organic pollutants (POPs) can accumulate in humans where they 
might influence differentiation of adipocytes. The aim of this study was to investigate 
whether DNA methylation is one of the underlying mechanisms by which POPs affect 
adipocyte differentiation, and to what extent DNA methylation can be related to gene 
transcription. Adipocyte differentiation was induced in two human cell models with 
continuous exposure to different POPs throughout differentiation. From the seven 
tested POPs, perfluorooctanesulfonic acid (PFOS) and 2,3,7,8-tetrachlorodibenzo-p-
dioxin (TCDD) decreased lipid accumulation, while tributyltin (TBT) increased lipid 
accumulation. In human mesenchymal stem cells (hMSCs), TCDD and TBT induced 
opposite gene expression profiles, whereas after PFOS exposure gene expression 
remained relatively stable. Genome-wide DNA methylation analysis showed that all 
three POPs affected DNA methylation patterns in adipogenic and other genes, but 
without concomitant gene expression changes. Differential methylation was 
predominantly detected in intergenic regions, where the biological relevance of 
alterations in DNA methylation is unclear. This study demonstrates that POPs, at 
environmentally relevant levels, are able to induce differential DNA methylation in 
human differentiating adipocytes. 
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Introduction 
Persistent organic pollutants (POPs) can cause a variety of adverse health effects in 
humans, often because of their endocrine disrupting properties.1 The common route for 
exposure to POPs in the general population is consumption of contaminated food, 
especially fish and seafood.2,3 Most POPs are highly lipophilic, except for perfluorinated 
compounds, and accumulate in adipose tissue. Adipose tissue is not merely an energy 
depot, but has essential endocrine functions.4 Many POPs display obesogenic effects 
leading to alterations in body weight5 and induction of obesity-associated conditions.6 
Previous research has shown that mature adipocytes are marginally responsive to POPs, 
while precursor cells are strongly affected by POP exposure.7 This suggests that POPs 
exert their negative health effects mainly in sensitive early stages, which is supported by 
the observation that numerous POPs are capable of affecting adipocyte differentiation.8-
10 
Early life development is commonly acknowledged to be a critical window of 
susceptibility to adverse health effects,5,11 and early POP exposure in adipose and other 
tissues has been shown to cause effects in a later life-stage or even induce 
transgenerational effects.12,13 Emerging evidence indicates that aberrant epigenetic 
regulation of critical genes during the developmental phase might lead to adiposity later 
in life.14 A well-studied epigenetic modification is DNA methylation. DNA methylation 
refers to the addition of a methyl group to cytosine in a CpG dinucleotide and has a 
complex relationship with gene expression. DNA methylation close to the transcription 
start site (TSS) is expected to inhibit gene expression, although this is dependent on the 
transcription factors that are binding.15,16 Methylation in the gene body is currently 
considered to affect gene expression by stimulating transcription elongation or 
alternative splicing.17 The role of DNA methylation in intergenic regions (IGR) is poorly 
understood, but methylation in repetitive regions is important for genomic stability.15 
Results of previous studies indicate that the observed effects of POPs on adipocyte 
differentiation may be explained by alterations in DNA methylation. TBT has been 
shown to decrease DNA methylation in the promoter/enhancer region of Fabp4, 
increase the expression of this gene, and enhance adipocyte differentiation in mouse 
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stromal cells.18 Furthermore, TBT exposure resulted in decreased global methylation in 
3T3-L1 cells.10 BDE47, on the other hand, did not significantly alter global DNA 
methylation,10 but decreased methylation levels in the Pparg promoter in 3T3-L1 cells.19 
Altogether, these findings suggest that DNA methylation might be an underlying 
mechanism resulting in POP-induced adverse health effects. However, the genome-wide 
effects of POPs on DNA methylation in differentiating adipocytes have not been studied 
in detail before. 
The aim of this study was to investigate the effects of POPs in differentiating human 
adipocytes on genome-wide DNA methylation as well as gene transcription of relevant 
adipogenic genes. We first screened seven ubiquitous POPs with different modes of 
action (namely TCDD, PFOS, TBT, HBCD, PCB153, BDE47, and MeHg) for their effects 
on adipocyte differentiation using two human cell models. Simpson-Golabi-Behmel 
syndrome (SGBS) cells are human preadipocytes that can differentiate into mature 
adipocytes. Human mesenchymal stem cells (hMSCs), derived from bone marrow, are 
primary cells which can differentiate into multiple cell types including adipocytes and 
osteoblasts. The hMSCs first have to commit and become preadipocytes, before they can 
differentiate into mature adipocytes. We first identified which of the seven candidate 
POPs affected adipocyte differentiation in the two cell types. Subsequently, we 
measured the effects of selected POPS on the expression profiles of 84 relevant 
adipogenic genes as well as genome-wide DNA methylation. 
 
Materials and methods 
Chemicals 
TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin, CAS 1746-01-6) was purchased from 
AccuStandard (New Haven, USA). PCB153 (2,2′,4,4′,5,5′-hexachlorobiphenyl, CAS 
35065-27-1), PFOS (heptadecafluorooctanesulfonic acid potassium salt, CAS 2795-39-3), 
TBT (tributyl chlorotin, CAS 1461-22-9), MeHg (methylmercury(II) chloride, CAS 115-
09-3) and differentiation reagents were obtained from Sigma-Aldrich (Zwijndrecht, the 
Netherlands) unless otherwise mentioned. HBCD (hexabromocyclododecane, technical 
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mixture) and BDE47 (2,2′,4,4′-tetrabromodiphenyl ether, CAS 5436-43-1) were kindly 
provided by Professor Åke Bergman (Stockholm University, Sweden). Stock solutions 
for all POPs and differentiation reagents were prepared in dimethyl sulfoxide (DMSO; 
Acros Organics, Geel, Belgium).  
Cell culture, differentiation and exposure 
Human SGBS preadipocytes were kindly provided by Professor Wabitsch (University of 
Ulm, Germany) and cultured and differentiated as described previously.20 PoieticsTM 
human mesenchymal stem cells (hMSC; Lot No 2F3478) were obtained from Lonza 
Walkersville Inc. at passage 2 and cultured in MSCGM growth medium (Lonza, 
Walkersville, USA). Adipogenic induction medium for hMSCs consisted of DMEM 
supplemented with L-glutamine (1%), FCS (10%), dexamethasone (1 μM), human insulin 
(5 μg/mL; Insuman Rapid (100 IE/mL), Sanofi-Aventis, Frankfurt am Main, Germany), 
3-isobuty-l-methyl-xanthine (IBMX, 0.5 mM), and rosiglitazone (1 μM; Sanbio B.V, 
Uden, the Netherlands). Osteogenic induction medium consisted of DMEM 
supplemented with L-glutamine (1%), FCS (10%), dexamethasone (100 nM), ascorbic 
acid (50 μg/mL), vitamin D (10 nM; Merck Chemicals, Amsterdam, the Netherlands), 
and β-glycerophosphate (12.5 mM). Cells were seeded with a density of 3.800 cells/cm2 
and grown until confluency. Both confluent SGBS cells and hMSCs were pre-treated for 
24h with the POPs after which differentiation was initiated (day 0). Exposure medium 
was refreshed twice a week, until day 10 when the experiment was ended. During 
differentiation cells were continuously exposed to POPs or the solvent control (0.1% 
DMSO). All endpoints were assessed in mature adipocytes at day 10 of differentiation 
because the most pronounced differences can be expected towards the end of 
differentiation and after prolonged POP exposure. Gene expression was also measured 
at day 2 because these changes are expected to be highly dynamic. A schematic overview 
of the experimental setup for hMSCs can be found in Fig. 1, because SGBS cells were only 
used for the Oil-Red-O staining to validate pro- and anti- adipogenic effects of POPs 
with another human cell strain.  
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Fig. 1. Experimental set-up for hMSCs. Cells were plated (day -4) and grown to 
confluence. When cells were confluent (day -1) POP exposure started and was continued 
until the experiment ended. Differentiation into adipocytes or osteoblasts was initiated 
at day 0. During the adipocyte differentiation, RNA was isolated at day 2 and day 10, 
DNA was isolated at day 10, and Oil-red-O staining was performed at day 10. The 
alkaline phosphatase (ALP) activity was measured at day 10 of osteoblast differentiation. 
 
Cell viability assays 
For cytotoxicity testing, undifferentiated cells in 96-wells plates were exposed to the 
individual POPs for 48h before 3-(4,5-methylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) was added to the cells and incubated for another hour. Formazan 
crystals were then solubilized with DMSO and the optical density was measured at 562 
nm and corrected for background absorption at 620 nm. Cytotoxic effects of at least 
three independent experiments were compared to the solvent control and TritonX-100 
(0.1%) was included as a positive control. To ensure that further experiments would not 
be performed at cytotoxic concentrations, the viability of the highest exposure 
concentrations included did not deviate more than 20% from the viability of the solvent 
control. 
Lipid accumulation 
At day 10 of adipocyte differentiation, cells in 12-wells plates were stained with Oil-Red-
O (3 mg/mL, 60% isopropanol, 40% distilled water) and photographed. Isopropanol was 
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added to extract the Oil-Red-O and the optical absorbance was measured at 520 nm. 
Oil-Red-O staining of undifferentiated cells grown in parallel was subtracted from the 
measurements. The amount of differentiation of POP-exposed cells was calculated as 
the percentage of the solvent control from at least three independent differentiation 
experiments. Statistical significance of the differences between the treatments and the 
solvent control were determined with a one-way ANOVA followed by Dunnett’s post 
test. 
Alkaline phosphatase assay 
Alkaline phosphatase (ALP) activity was measured in 96-wells plates at day 10 of 
osteoblast differentiation from at least three independent experiments. Cells were 
fixated in paraformaldehyde (4%) before p-nitrophenyl phosphate was added (30 min, 
37°C). The reaction was stopped by sodium hydroxide (0.5 M) and absorbance was 
measured at 405 nm in a microplate reader. ALP activity from undifferentiated cells was 
subtracted from the absorbance measurement. The differentiation of treated cells was 
calculated as percentage of the solvent control, and statistical significance was 
determined with a one-way ANOVA followed by Dunnett’s post test. 
RNA isolation and cDNA synthesis 
Total RNA was isolated from 60 mm dishes at day 2 and at day 10 of hMSC 
differentiation using Trizol (Invitrogen, Merelbeke, Belgium) according to the 
manufacturer’s instructions. RNA was dissolved in RNase-free water and the 
concentration was measured using a NanoDrop ND-1000 UV–vis spectrophotometer 
(Isogen, Maarssen, the Netherlands). First-strand cDNA was synthesized from 1 μg of 
total RNA using the RT2 First Strand Kit (Qiagen, Venlo, the Netherlands) following the 
supplier’s protocol. 
RT2 profiler™ PCR array 
The expression of 84 key adipogenic genes was measured in three independent 
experiments with the adipogenesis RT2 profiler PCR Array (PAHS-049ZE-4, Qiagen, 
Venlo, the Netherlands) according to the manufacturer’s instructions. Genes that 
required more than 35 cycles to reach the threshold were regarded as below the 
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detection limit. Gene expression was normalized against the geometric mean of the 
reference genes B2M and HPRT1 at day 2 and against CFD for day 10, because the other 
reference genes did not remain stable over time. Relative changes in gene expression are 
expressed as fold changes compared to the solvent control of that respective day. When 
no expression was detected for one of the treatments, fold changes were calculated with 
a value of 35 cycles. Differentially expressed genes were identified using a student’s t-
test on the log2-transformed values.  
Genome-wide DNA methylation for differentially methylated single positions (DMPs) 
Genomic DNA was isolated from four independent experiments at day 10 of hMSC 
differentiation using the DNeasy blood and tissue kit according to the manufacturer’s 
protocol (Qiagen, Venlo, the Netherlands). Only cells from passage 9 were used, because 
DNA methylation profiles depend on the passage number.21 DNA concentration and 
quality was determined using a NanoDrop ND-1000 UV–vis spectrophotometer. DNA 
methylation was analyzed using the Illumina Infinium HumanMethylation450 
BeadChip (Infinium Inc., San Diego, USA), which addresses 485,512 cytosine positions, 
and is cross-validated against conventional quantitative pyrosequencing.22 Bisulfite 
conversion, performed with 500 ng DNA using the EZ DNA Methylation Kit (Zymo 
Research, Freiburg, Germany), and processing of the BeadChip was done by the Human 
Genotyping Facility of the Erasmus University Medical Centre (Rotterdam, the 
Netherlands). Intensity iDAT files were processed using R-based open software (R 3.1.2). 
The 450K Chip Analysis Methylation Pipeline (ChAMP) (version 1.1.2) was used for pre-
processing23 and the normalization of the raw data was performed with SWAN.24 After 
filtering positions that did not meet the selection criteria (detection p-value > 0.01 in 
>1% of the samples and bead count < 3 in 5% of the samples), 483,914 positions were 
included in the analysis. The positions were annotated based on the ilmn12.hg19 
annotation.25 The multidimensional scaling (MDS) plot based on the 1000 most variable 
positions showed that one sample in the solvent controls clustered separately and this 
sample was therefore excluded from further analyses. The identification of differentially 
methylated positions (DMPs) after POP exposure was performed using Linear Models 
for Microarray Data (limma, version 3.22.1). The statistical analyses were performed 
unpaired and adjusted for multiple testing with the Benjamini-Hochberg (BH) 
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method.26 A false discovery rate (FDR) value of 0.05 was used as the threshold to define 
statistical significance. Furthermore, we considered potential DMPs with a non-adjusted 
p-value below 1E-04. The methylation (β) values were constrained to lie between 0% 
(completely unmethylated) and 100% (completely methylated). The data sets 
supporting the results of this article are available in the Gene Expression Omnibus 
(GEO) with accession number GSE75133. 
Differentially methylated regions (DMRs) 
In addition to the identification of methylation differences in single positions, we used 
the DMRcate package to identify differentially methylated regions (DMRs).27 This 
method does not use predefined regions, but identifies DMRs across the genome based 
on tunable kernel smoothing of the differential methylation signal, independent of the 
direction of the methylation change and distance from each other. We defined DMRs as 
regions of at least five positions with a distance between consecutive positions less than 
1000 nucleotides. Statistical tests were adjusted for multiple testing using a FDR of 0.05 
with the BH method. Pathway analyses were performed for all genes annotated to the 
DMRs with a FDR < 0.05 using Ingenuity Pathway Analysis (IPA). All canonical 
pathways detected with a p-value < 0.001 (Fisher Exact Test) are described. 
 
Results and discussion 
Adipocyte differentiation was affected by TCDD, PFOS, and TBT 
To investigate the adipogenesis-interfering effects of seven different POPs, adipocyte 
differentiation was induced in two human cell models in the presence of non-toxic POP 
concentrations (Fig. A1). Exposure to TCDD (≥ 0.1 nM) showed a concentration-
dependent decrease in lipid accumulation in both hMSCs and SGBS cells (Fig. 2). This 
result is in accordance with previous studies showing an inhibitory effect of TCDD on 
adipocyte differentiation in human as well as mouse cells.8,9 Also PFOS (≥ 10 μM) 
reduced lipid accumulation in both cell models. Previous studies in 3T3-L1 cells found 
no effect of PFOS on differentiation10 or reported smaller lipid droplets.28 TBT, on the 
contrary, induced adipocyte differentiation in both cell lines, but stronger in hMSCs (≥ 
Chapter 3B 
 
88 
 
3 nM). This effect was expected, because a well-described mechanism of action for TBT 
is activation of PPAR-gamma, which is a key regulator of adipogenesis.29 HBCD, PCB153, 
BDE47, and MeHg did not affect lipid accumulation in both hMSCs and SGBS cells (Fig. 
2). Bastos Sales et al. also did not find effects for HBCD,10 but they and others observed 
PCB153 and BDE47 exposure to modestly induce adipogenesis in 3T3-L1 cells.30,31 It has 
previously been shown that inorganic mercury (HgCl2) (≥ 5 μM) negatively affects 
adipocyte differentiation.32 Organic MeHg, however, is more relevant regarding human 
exposure from seafood. MeHg is more cytotoxic than HgCl2,33 so we could not test 
whether MeHg at higher concentrations than 100 nM would influence adipocyte 
differentiation. In conclusion, we found that three out of the seven tested POPs affected 
lipid accumulation in both human cell models. 
 
 
Fig. 2. (A) Effect of POP-treatment on adipocyte differentiation in hMSCs and SGBS 
cells. Lipid accumulation was measured with an Oil-Red-O staining, which was 
quantified from at least three independent experiments (mean + SD). Statistical 
significance was determined with a one-way ANOVA followed by Dunnett’s post test 
compared to the solvent control. * p < 0.05 ** p < 0.001 (B) Representative pictures of 
stained hMSCs at day 10 of differentiation (original magnitude 100x). 
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Osteoblast differentiation was affected by TCDD, TBT, and HBCD 
To investigate whether the POPs specifically affected adipocyte differentiation, or 
interfered with differentiation in general, osteoblast differentiation was induced in 
hMSCs in the presence of the same seven POPs. Since SGBS cells are preadipocytes that 
cannot be differentiated into osteoblasts they were not included in this experiment. ALP 
activity, a marker of osteoblast differentiation, was decreased due to TCDD (≥ 1 nM) 
exposure (Fig. 3), which is in accordance with previous studies.34 This result suggests 
that TCDD interferes with differentiation in general, possibly through the aryl 
hydrocarbon receptor.35-37 No effect of PFOS exposure on ALP activity was observed, 
suggesting that this compound specifically affects adipogenesis. TBT (≥ 3 nM) decreased 
osteoblast differentiation as expected, given it is a very strong PPAR-gamma inducer.18,38 
PPAR-gamma is an important promoter of adipocyte differentiation and, concomitantly, 
inhibits alternative differentiation pathways.39 Although HBCD (1 μM) did not affect 
adipocyte differentiation, it clearly induced ALP activity, which is, according to our 
knowledge, not reported before with regard to osteoblast differentiation. The increase 
in osteoblast differentiation might be one of the underlying mechanisms by which 
HBCD increases bone mineral density.40 PCB153, BDE47 and MeHg did not affect 
differentiation towards osteoblasts in hMSCs. 
 
Fig. 3. Effect of POP-treatment on osteoblast differentiation in hMSCs as determined 
with alkaline phosphatase (ALP) activity from at least three independent experiments 
(mean + SD). Statistical significance was determined with a one-way ANOVA followed 
by Dunnett’s post test compared to the solvent control. * p < 0.05 ** p < 0.001 
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TCDD and TBT displayed opposite effects on gene expression regulation, while PFOS had 
minor effects  
To gain insight in the molecular mechanisms responsible for the effects of the three 
POPs on adipocyte differentiation, differentiating hMSCs were continuously exposed to 
TCDD (1 nM), PFOS (10 μM), and TBT (10 nM), because at these concentrations the 
POPs had a pronounced effect on lipid accumulation (Fig. 2). hMSCs were chosen over 
SGBS cells because these are primary cells and therefore a representative biological 
model for human health. Gene expression of 84 adipogenic genes was analyzed at day 2 
and day 10 of adipocyte differentiation. Fig. 4 shows that at day 10 of adipocyte 
differentiation, expression of pro-adipogenesis genes was in general down-regulated 
after TCDD exposure, relatively stable after PFOS exposure, and up-regulated after TBT 
exposure. The anti-adipogenesis genes showed the opposite effect and were up-
regulated by TCDD at both time points and mostly inhibited due to TBT exposure at day 
2. Furthermore, TBT caused a striking up-regulation of pro-adipogenesis genes at day 2 
of differentiation, indicating that this POP exerts its effects mainly during early 
adipocyte differentiation.  
Fig. 4. Gene expression of 84 adipogenic genes was measured at day 2 and 10 of 
adipocyte differentiation in hMSCs after continuous exposure to either TCDD (1 nM), 
PFOS (10 μM) or TBT (10 nM). Only genes displaying differentially expression (p-value 
< 0.05, student’s t-test) after exposure to one of the POPs are presented in this heat map. 
Values represent the fold change compared to the corresponding solvent control from 
three independent experiments. Color scale ranges from decreased (blue) to increased 
(red) expression. 
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Differential expression induced by PFOS-treatment was limited to HES1 and LEP at day 
10 (Appendix B). Lipid accumulation was less impaired after PFOS exposure than after 
TCDD exposure. It can be speculated that PFOS does not inhibit the differentiation 
process, but that the decreased lipid content was attributable to a decreased lipid droplet 
size.28 This could be explained by the fatty acid resemblance of PFOS which disturbs 
lipid metabolism.41 In conclusion, the obtained gene expression profiles suggest that all 
three compounds may affect adipocytes by different mechanisms. 
DNA methylation in adipogenic genes was affected by all three POPs 
Genome-wide DNA methylation was measured at day 10 of differentiation, to investigate 
stable DNA methylation differences due to POP exposure. We first searched for 
differentially methylated regions (DMRs) in the panel of 84 adipogenic genes. DMRs in 
response to TCDD, PFOS, and TBT-treatment were observed in 4, 2 and 3 adipogenic 
genes respectively (Fig. 5).  
 
Fig. 5. Schematic overview of the 84 adipogenic genes at day 10 of hMSC differentiation 
after continuous exposure to TCDD (1 nM), PFOS (10 μM) or TBT (10 nM). The number 
of genes which were differentially expressed or contain a differentially methylated 
region (DMR) is displayed. 
 
Of these genes only the pro-adipogenic gene DKK1, which was differentially methylated 
at day 10 after PFOS exposure, displayed differential expression at day 2 but not at day 
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10. The largest DMR, indicating a higher chance of being biological relevant, was 
detected in DLK1 after TCDD exposure (Table 1). DLK1 is a negative regulator of 
adipogenesis and its expression is maintained in undifferentiated hMSCs and decreases 
immediately upon differentiation.42 The detected DMR in DLK1, with in general 
decreased methylation levels, consisted of 21 consecutive positions close to the TSS, 
which supposedly results in enhanced gene expression.15 Theoretically, increased DLK1 
expression would imply inhibition of adipocyte differentiation, which was indeed the 
result of TCDD exposure. However, in our study gene expression levels for DLK1 were 
below the limit of detection, and therefore a possible enhancement in gene expression 
could not be evaluated. 
After TBT exposure DMRs were detected in three brown adipocyte differentiation 
markers, of which the SRC gene contains a DMR close to the TSS (Table 1). However, 
none of the genes displayed a change in gene expression upon TBT exposure. This 
finding might be explained by the observation that TBT affected gene expression mainly 
in the early stage of adipocyte differentiation (i.e. day 2 of differentiation). If DNA 
methylation would be the mechanism of action, this would indicate a very dynamic 
methylation process, since most genes were not differentially expressed anymore at day 
10 of differentiation. Therefore, other mechanisms of action are more likely to be 
responsible for the observed changes in gene expression, such as binding of TBT to 
PPAR-gamma. A previous study, however, reported the relationship between Fabp4 
expression and DNA methylation in adipose derived stem cells of TBT-treated mice.18 
We also found increased expression of FABP4, but no effect on DNA methylation.  
The differential methylation is expected to be an effect of POP exposure, and not the 
result of inhibiting or enhancing adipocyte differentiation, because differential 
methylation in these genes was not found in unexposed cells differentiating towards 
adipocytes.43,44 Overall, the tested POPs affected DNA methylation in multiple 
adipogenic genes but without an associated change in gene expression. Likewise, for the 
differentially expressed genes no change in DNA methylation was detected. This points 
to the complex relationship between DNA methylation and gene expression, which is 
also not straightforward for methylation in the promoter region. 
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Table 1. Differentially methylated regions (DMRs) found with the DMRcate package in 
the 84 adipogenic genes comparing POP exposure to the solvent control at day 10 of 
adipocyte differentiation in hMSCs.  
1 TSS200 /1500 = 200 / 1500 base pairs from the transcription start site. 
2 UTR= untranslated region 
3 Annotation according to Ilmn12.hg19 identifiers. 
4 p-value is the mean BH-adjusted p-value of all positions in the DMR 
5 Maximal change in DNA methylation (beta %) for the positions within the DMR 
 
 
Pathway analysis revealed DMRs in many different gene functions 
After analyzing the DMRs found in the adipogenic genes, we extended our DMR analysis 
with a genome-wide approach. We identified 346, 440, and 303 DMRs for TCDD, PFOS 
and TBT respectively (Appendix C). Pathway analyses, performed on the genes 
annotated to these DMRs, did not reveal the adipogenesis pathway for any of the three 
POPs. For TCDD the significant pathways were ‘p53 signaling’ (p-value = 8.4E-04), 
‘STAT3 pathway’ (p-value = 9.5E-04) , and ‘interferon signaling’ (p-value = 2.3E-03). For 
Gene Relationship to 
gene1,2 
Chromosome: 
position3 
No. 
positions 
in DMR 
No. 
positions on 
BeadChip 
p-value4 Max 
change 
(%)5 
TCDD 
(1 nM) 
      
DLK1 TSS1500,1stExon 
5'UTR 
chr14:101191797-
101193432 
21 41 2.1E-03 -8.9% 
EGR2 Body,5'UTR 
1stExon,TSS200
TSS1500 
chr10:64575442-
64576514 
12 33 1.7E-02 -9.7% 
PRDM16 Body chr1:3303301-
3304131 
6 636 2.1E-02 -7.7% 
SFRP5 5'UTR,1stExon 
TSS200,TSS1500 
chr10:99531645-
99532174 
10 23 2.7E-02 5.9% 
       
PFOS 
(10 μM) 
      
AXIN1 Body chr16:351867-
352684 
6 62 2.5E-02 -3.1% 
DKK1 TSS1500,TSS200 
5'UTR,1stExon 
chr10:54073150-
54074079 
10 19 1.7E-02 -6.1% 
       
TBT 
(10 nM) 
      
INSR Body chr19:7267351-
7268027 
5 42 1.3E-03 -3.7% 
PRDM16 Body chr1:3104999-
3105326 
5 636 3.6E-02 4.8% 
SRC TSS1500,TSS200 
1stExon,5'UTR 
chr20:35972536-
35973318 
7 35 1.4E-02 -5.3% 
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PFOS the most significant pathways were ‘molecular mechanisms of cancer’ (p-value = 
1.4E-04), ‘G1/S checkpoint regulation’ (p-value = 2.7E-04), ‘GADD45 signaling’ (p-value 
= 4.7E-04), and ‘IGF-1 signaling’ (p-value = 6.9E-04). In the early stages of adipogenesis, 
insulin functions mainly through IGF1, but the ratio of receptors for IGF1 and insulin 
shifts as differentiation proceeds.45 This could possibly be affected in PFOS-exposed 
adipocytes resulting in altered insulin sensitivity. For TBT the most significant pathways 
included ‘neuroprotective role of THOP1 in Alzeimer’s disease’ (p-value = 2.4E-03), 
‘caeolar-mediated Endocytosis Signaling’ (p-value = 3.2E-03), and ‘mTOR signaling’ (p-
value = 5.1E-03). Overall, these data suggest that genes with a DMR are randomly 
distributed in the genome and DNA methylation is not overrepresented in adipogenic 
genes. 
Exposure to TCDD and PFOS, but not TBT, induced hypomethylation  
For further in-depth analyses we searched for single differentially methylated positions 
(DMPs). We assessed DMPs based on the non-adjusted p-value (< 1E-04), because after 
adjusting for multiple comparisons all FDRs were above 0.05. For TCDD, we detected 
27 potential DMPs, including a position in DLK1 and eight positions in intergenic 
regions. PFOS exposure resulted in 45 potential DMPs, including a position in DKK1 and 
15 positions in intergenic regions. After TBT exposure, 16 potential DMPs were found, 
for which nine positions are in intergenic regions (Appendix D). 
We determined hypo- and hypermethylation (i.e. decreased and increased levels in 
methylation, respectively) compared to the solvent control based on the top 1000 DMPs 
with the lowest non-adjusted p-values. Exposure to both TCDD and PFOS caused 
hypomethylation of the majority of the positions (Fig. 6A). In contrast, TBT-treatment 
resulted in both hypo- and hypermethylation. Hypomethylation of the promoter region 
might result in a transcriptionally permissive state by making DNA accessible for 
transcription factors. However, without any transcription factors actually binding these 
regions, DNA hypomethylation in itself does not necessarily change the expression of 
these genes.46 Furthermore, hypomethylation also occurred in the gene body, and the 
lack of association with gene expression shows once more the complex relationship.17 
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Hypomethylation in IGRs, on the other hand, might lead to genomic instability, 
increasing the chance of cancer development.15 
 
 
Fig. 6. Genome-wide DNA methylation analysis in differentiated hMSCs. (A) The 
number of hypo- and hypermethylated positions, based on the top 1000 most 
statistically significant positions, after continuous exposure to TCDD (1 nM), PFOS (10 
μM) or TBT (10 nM) at day 10 of adipocyte differentiation. (B) Features of the 1000 
positions with the highest statistical significance after continuous POP exposure at 
differentiation day 10 compared to all considered positions on the Illumina 450K 
BeadChip (indicated with ‘450K BeadChip’). 
 
Subsequently, we explored the location of the top 1000 DMPs in relation to the genes 
(Fig. 6B). In general, all three POPs affected relatively few DMPs close to the TSS and in 
the 1st exon, which is in agreement with the lack of concomitant gene expression 
changes. After POP exposure, there were more DMPs detected in the gene bodies and 
in the IGRs relative to the considered positions on the BeadChip. The function of DNA 
methylation in the IGR is currently unclear, but besides the importance for genomic 
stability, it is relevant for cell-type discriminatory patterns.47 Furthermore, about half of 
the enhancers are present in IGRs48, and differential methylation in enhancers might 
affect expression of multiple genes.49,50 More research is needed to fully understand the 
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implication of differential methylation in IGRs, and subsequently the consequences of 
POPs interfering with DNA methylation. 
Relevance of tested exposure concentrations 
It is complicated to compare in vitro exposure levels to real-life environmental 
exposures, because in vitro studies lack the formation of POP metabolites and feed-back 
mechanisms from e.g. thyroid and steroid hormones.51 Additionally, POP levels in 
humans are usually assessed per gram lipid, in both serum and adipose samples, and not 
in molar concentrations as for in vitro experiments. For determining the real-life 
relevance of the tested POP concentrations, we compared molar concentrations with 
measured blood levels in humans. However, adipose tissue levels of POPs can be a 
thousand fold higher per gram tissue than corresponding concentrations in serum.1 
TCDD levels are reported up to concentrations of 280 pM in human blood, with a 
median of 20 pM based on a 0.5% lipid content.52 Our analysis revealed effects on 
adipocyte differentiation at concentrations of 100 pM and higher. This concentration is 
less than an order of magnitude from human median levels, while higher exposed 
individuals exceed this effect level. Median exposure levels for PFOS are around 100 nM, 
and only occupationally exposed workers have levels above the tested effect 
concentration of 10 μM.53 For TBT, human median levels are around 17 nM in blood,54 
which is above the concentration of 3 nM that affected both adipocyte and osteoblast 
differentiation. This indicates that TCDD and TBT by itself might exert adverse health 
effects in the general environmentally exposed human population. In this study we 
explored the effects of single POPs, while in the real-life situation humans are exposure 
to a combination of POPs, and therefore additive effects cannot be excluded.55 In a 
previous study, it was shown that TBT and TCDD have an agonistic inhibitory effect in 
osteoblast differentiation,34 which might also be the case for other POPs and adipocyte 
differentiation. Therefore, even lower body burdens than the concentrations indicated 
may cause biological effects in adipose tissue due to both additivity and specific 
accumulation of POPs in adipose tissue. This is in agreement with studies demonstrating 
that POPs, at environmental levels, could contribute to obesity and metabolic 
disorders.56 
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Conclusions 
Our data suggest that TCDD, PFOS, and TBT at relevant exposure levels can interfere 
with adipocyte differentiation, gene expression, and DNA methylation. HBCD, PCB153, 
BDE47, and MeHg did not alter adipocyte differentiation in both hMSCs and SGBS cells. 
Although no clear association between DNA methylation and gene expression was 
found, our results support the hypothesis that POPs can interfere with DNA 
methylation.  
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Appendices can be found online after acceptation of this paper. Fig. A.1 shows the results 
of cytotoxicity testing in hMSCs and SGBS cells. Appendix B contains the gene 
description of the 84 adipogenic genes and the expression fold change together with the 
p-values of the POP-exposed cells. The DMRs found after genome-wide DNA 
methylation analyses for all three POPs are presented in Appendix C. The DMPs (p-value 
< 1E-04) detected for TCDD, PFOS, and TBT can be found in Appendix D.   
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Abstract   
Background Globally, many rivers are seriously contaminated with persistent organic 
pollutants (POPs) known to accumulate in aquatic food chains. In the Netherlands, 
toxicological risks of human exposure to dioxins and dioxin-like compounds led to a ban 
on commercial eel fishing in the Rhine-Meuse delta. The necessity of this ban as well as 
expected elevated POP levels resulting from contaminated eel consumption is, however, 
debated. 
Objectives The aim of this study is to investigate differences in serum POP levels in 
consumers of eel from high-polluted areas to consumers of eel from low-polluted areas 
or aquaculture. 
Methods In total 80 Dutch men were included, aged 40 to 70 years and with a habitual 
eel consumption of at least one portion (150 g) per month. Dioxins and dioxin-like 
compounds were measured in serum of all participants with the DR CALUX bioassay, 
validated with GC-MS. For a subgroup of 38 participants extensive POP measurements 
were performed, resulting in 30 POPs for which at least 60% of the participants had 
levels above the detection limit. 
Results Levels of dioxins and dioxin-like compounds, polychlorinated biphenyls (PCBs) 
with their hydroxylated (OH) metabolites, and perfluoroalkyl substances (PFASs) were, 
up to ten times, higher in consumers of eel from pullulated areas compared to controls.  
Conclusions This study is the first to reveal that (past) consumption of eel from 
polluted rivers resulted in high body burdens of dioxins, PCBs, and PFASs. The high 
levels of dioxins and dioxin-like compounds as well as the OH-PCBs are of health 
concern. 
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Introduction 
Persistent organic pollutants (POPs) are a group of mostly lipophilic compounds that 
are resistant to degradation and accumulate in the environment and the food chain. 
POPs include dioxins, polychlorinated biphenyls (PCBs), organochlorine (OC) 
pesticides, brominated flame retardants, and perfluoroalkyl substances (PFASs). These 
chemicals are known for their potency to cause various adverse health effects, including 
endocrine disorders, cancer, and neurodevelopmental problems.1 Many POPs are 
regulated by the Stockholm Convention, and POP levels in the environment have been 
decreasing over the past decades.2 However, their occurrence in the environment is still 
a major concern. A high degree of urbanization and industrialization along European 
rivers have caused the sediments of the main Dutch rivers and estuaries to be highly 
polluted. Over 90% of human exposure to POPs comes from food consumption,3 with 
high contributions from fish caught in polluted areas.4,5 Eel has eco-physiological 
features such as bottom dwelling, being a long-living predator, and having a high lipid 
content, which attributes to high accumulation of contaminants.6-8  
Dioxins (polychlorinated dibenzo-p-dioxins/dibenzofurans (PCDD/Fs)) and dioxin-like 
(DL-) PCBs in food have received considerable attention from the European 
Commission. PCDD/Fs are highly toxic, although with different toxic potencies, as 
expressed in a range of toxic equivalency factors (TEFs).9 DL-PCBs, including non-ortho 
(NO) and mono-ortho (MO) PCBs, have properties similar to PCDD/Fs and therefore 
also assigned TEF values. The NO-PCBs have a higher dioxin-like potency than the MO-
PCBs.9 To reduce levels in food and hence human exposure, maximum levels (MLs) for 
PCDD/Fs and DL-PCBs in various food items have been established using toxic 
equivalents (TEQs) to sum up the different TEF values. The ML for the sum of PCDD/Fs 
and DL-PCBs in eel was set at 10 pg TEQ/g wet weight (ww) in 2012, while other seafood 
items have to comply to 6.5 pg TEQ/g ww.10 Several studies showed that the majority of 
eel from the Rhine-Meuse delta did not comply with the ML.8,11 Following this discovery, 
a risk assessment was performed, including the potential impact on the body burden. 
Long-term consumption of one portion eel (150 gram) per month from these high-
polluted areas (average level of 29 pg TEQ/g eel) was estimated to result in a body 
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burden of 7.6 ng TEQ/kg body weight (bw), compared to the Dutch background body 
burden of 3.0 ng TEQ/kg bw.12 Moderate eel consumers were therefore expected to reach 
POP levels above the safe body burden of 4 ng TEQ/kg bw (extrapolated from rat 
studies), implying that adverse health effects could not be excluded.13,14 After a 
documentary was broadcasted raising awareness, the Dutch government decided on a 
complete ban on eel fishing in the seriously polluted fishing areas from 2011 onwards. 
Despite this ban, it is expected that people who consumed this eel in the past will still 
have elevated levels of PCDD/Fs, PCBs and other POPs in their body due to the long 
half-lives of these pollutants (approximately 10-15 years for PCBs).15 As the necessity of 
the prohibited eel fishing is still debated, we decided to study the actual body burdens 
in eel consumers to verify the expectations expressed in the former risk assessment. The 
aim of this study was to compare blood POP levels in men who consumed eel from high-
polluted areas (now closed for eel fishing) with men consuming eel from aquaculture 
and relatively low-polluted areas (areas open for eel fisheries). 
 
Methods 
Study population 
Eligible participants were all Dutch men aged from 40 to 70, with a habitual eel 
consumption of at least one portion (150 gram) a month since many years (at least until 
the implemented ban on eel fishing). Age range was based on Hoogenboom et al, who 
showed that body burden increases due to eel consumption, but remains relatively 
stable from 40 to 70 years of age.12 Men were invited to participate through professional 
and recreational fishermen associations, because these men are more likely to know the 
origin of the eel, and through advertisements in local newspapers and webpages. A total 
of 80 men were included after checking whether they met the inclusion criteria. This 
study was approved by the Medical Ethical Committee of Wageningen University, and 
written informed consent was obtained from all participants before inclusion in the 
study. 
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Participants filled out a questionnaire at home about their fish consumption habits, 
including the origin of the eel (either aquaculture or the area where the eel was caught). 
Height and weight were measured using standard methods in light clothes. Blood 
samples were obtained by venipuncture after overnight fasting, and serum for the 
persistent organic pollutant (POP) analyses was separated by centrifugation within 6 
hours after collection. Samples were stored at -80⁰C until further analyses. Total 
cholesterol and triglycerides levels were measured in plasma in a clinical chemistry 
laboratory (Hospital Gelderse Vallei, Ede, the Netherlands). 
DR CALUX bioassay 
Total levels of dioxins and dioxin-like compounds were measured for all 80 subjects 
using the DR CALUX bioassay at RIKILT Wageningen UR, which is validated for food 
and feed, as described previously.16 In short, aliquots of 5 mL serum were extracted twice 
with hexane and purified on a column containing 10 g acid silica (33% H2SO4) with 1 g 
dried Na2SO4 on top. The extracts were dried in a SpeedVac with 10 μL DMSO as a 
keeper, which was later mixed with cell culture medium. Control samples of butter fat 
with different levels of a mix of PCDD/Fs and dl-PCBs (0.5; 17; 39; and 88 pg TEQ/g 
lipid), and with a similar absolute amount of fat, were included and extracted in the 
same way. p-GudLuc transfected H4IIE-cells were obtained from Wageningen 
University17 and are similar to those sold by Biodetection Systems (BDS, Amsterdam, 
The Netherlands). Cells were cultured in a 96-wells plate and exposed to the extract (1% 
DMSO) in quadruplicate for 24h. The cells were lysed and the luciferase content was 
measured in a Luminoskan (Labsystems). Total levels of dioxin and dioxin-like 
compounds were estimated from a calibration curve of the reference butter fat samples 
included in each clean-up series. These estimated levels were expressed in bioanalytical 
equivalents (BEQs) to acknowledge the fact that they were determined with a bioassay 
and not with gas chromatography high resolution mass spectrometry (GC-HRMS). In 
the bioassay also other compounds that pass the selective clean-up may contribute to 
the response. BEQ levels were adjusted for lipid content, calculated based on 
triglycerides and total cholesterol levels as described by Philips et al18 and recommended 
by AMAP19, which correlates well to gravimetric determination.20,21 
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Validation bioassay with GC-HRMS and congener patterns 
Eight pooled samples as well as two individual samples with the highest estimated BEQ 
levels (> 100 pg BEQ/g lipid) were measured with GC-HRMS at RIKILT Wageningen UR, 
which is ISO/IEC 17025 accredited for the analysis of PCDD/F and PCB containing 
extracts (L014). GC-HRMS was first of all performed to validate the bioassay results, and 
secondly to compare congener patterns. Pooled serum included samples from all low- 
and high-exposed men (n=34 and n=21, respectively) and the subgroup for which the 
extensive POP measurements were performed (n=14 for low- and n=13 for high-exposed 
men). Furthermore, samples were pooled based on individual BEQ levels to get sub-
groups for the low- and high-exposed group with the same average BEQ levels (20 and 
45 pg BEQ/g lipid). Levels of PCDD/Fs and dl-PCBs were determined in 3 to 12 mL 
serum. Prior to extraction, the samples were spiked with 13C- isotope labelled internal 
standard for each congener. Extraction of lipids was performed as previously 
described.22 After evaporation of the solvents, the residues (lipids) were dissolved in 
hexane and the crude extract was purified using an automated clean-up (PowerPrep 
system, Fluid Management Systems, Waltham, USA). Extracts were purified on an acid 
silica column, a neutral silica column, a basic alumina column and an activated 
carbon/Celite column. For the elution from the columns, custom made solvents and 
mixtures were used, respectively being hexane, hexane/dichloromethane (1:1, v/v), ethyl 
acetate/toluene (1:1, v/v) and toluene. The volume of the final extract was reduced using 
an automated evaporation system with fixed endpoint of 0.5 ml. The recovery standards, 
13C-labelled 1,2,3,4-TCDD and 2,3,4,6,7,8-HxCDF, were added and the volume of the 
extract was again reduced to 0.5 ml. PCDD/F and PCB analyses were performed by GC-
HRMS using an Agilent (Wilmington, USA) 6890 Series gas chromatograph and an 
AutoSpec Ultima high resolution mass spectrometer (Waters, Milford, USA) operated at 
a resolution of 10,000 (10% peak valley). The GC column was a DB5 MS (60 m, 0.25 mm 
i.d., 0.25 μm; J&W, Folson, USA). The mass spectrometer was operated in electron 
impact ionization mode, using selected-ion monitoring. Further GC-HRMS details can 
be found elsewhere.23 A large volume injector (LVI) capable to inject 100 μl was used to 
inject the sample on the GC. Data were converted to TEQ levels using the TEFs of 20059 
and expressed per gram lipid using the calculated lipid content. 
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Extensive POP analyses 
Further analyses for individual POPs were performed for 38 participants. Samples were 
selected based on age and BEQ values. Participants were divided in three age groups 
(40-49, 50-59, 60-70) to ensure age differences between groups would not affect POP 
results as body burden is related to age.24 Based on bioassay results, participants were 
divided in having a low body burden (median around 13 pg BEQ/g lipid), medium body 
burden (median 2x higher than low body burden), and high body burden (median 4x 
higher than low body burden, detailed information in Table S4). After this stratified 
sampling, we used a simple random sampling for each stratum to choose the 38 
participants. 
The individual POP analyses were performed at the Laboratory of Environmental 
Toxicology at the Norwegian University of Life Sciences (NMBU), which is ISO/IEC 
17025 accredited for the analyses of PCBs, organochlorine (OC) pesticides, and 
brominated flame retardants (BFRs) (TEST 137).25 The extraction method for most POPs, 
excluding perfluoroalkyl substances (PFASs), was performed with 4 mL of serum and is 
based on a liquid/liquid lipid extraction with acetone and cyclohexane (3:2), sodium 
chloride (NaCl) and 10 mL 1 M sulphuric acid (H2SO4) which is described by Polder et 
al.26 An additional extraction with potassium hydroxide (1 M) was performed to extract 
the hydroxylated metabolites.27 The analyses were performed with GC, followed by 
Electron-Capture Detection (ECD, for analyzing PCBs and OC pesticides) and by low 
resolution MS (LRMS) quadrupole detector for OH-PCBs, BFRs and for confirmation of 
certain PCBs and OC pesticides. The limit of detection (LOD) was set at three times the 
noise levels and recoveries ranged from 77 to 116%. Lipid determination was done 
gravimetrically and these results correlated well with the calculated lipid content based 
on triglycerides and total cholesterol levels (spearman r = 0.79; calculated fat percentage 
= 0.75*gravimetrically determined fat percentage + 0.15). To make sure the results 
within this study are comparable, the calculated lipid content was used for 
normalization in all experiments. 
The extraction for PFASs analyses was performed with 1 mL of serum using methanol as 
is described by Bytingsvik et al.28 The cleaning of fat and other matrix constituents was 
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performed with a package material called Envi-Carb. The following internal standards 
were added to all samples: 13C4 PFOS, 18O2 PFHxS, 13C8 FOSA, 13C2 PFDoDA, 13C4 PFUdA, 
13C4 PFDA, 13C5 PFNA, 13C4 PFOA, 13C4 PFHxA, and 13C4 PFHpA (Wellington Laboratories, 
Guelph, Canada). 13C2 PFDoA was also used for PFTrDA and PFTeDA, while 18O2 PFHxS 
was also used for PFBS. Control AMAP Ring Test samples were included, following the 
same procedures, and  these samples complied with the quality criteria.19 Quantification 
was performed with LC-MS with ESI ion source (6460 Triple Quadrupole LC-MS, 
Agilent Technologies, Santa Clara, USA) using a Supelco Discovery C18 column (150 mm 
x 2.1 mm, 5 μm, Sigma-Aldrich, Oslo, Norway). Recoveries ranged from 93 to 119% and 
results were normalized for serum wet weight (ww). 
Data analysis 
Only compounds quantified in more than 60% of the samples are reported and used in 
statistical analyses. To ensure that values below the LOD did not affect the overall 
results, they were replaced by random imputed values with a log-normal distribution 
between zero and the LOD, before the contaminant data were normalized to lipid 
content of individual samples.29,30 All POP levels were log10-transformed for statistical 
and graphical purposes. After log-transformation not all POPs were normally distributed 
as verified with the Kolmogorov-Smirnov test. Therefore, non-parametric tests were 
used. The Mann-Whitney U test was performed to compare the low-exposed to the high-
exposed group and the Spearman rank correlation was used to test the statistical 
significance for the correlation between the BEQ levels and age. Differences were 
assumed to be statistically significant when the p-value is below 0.05. To convert the 
well-accepted safe body burden of 4 ng TEQ/kg bw to levels in serum (15.1 pg TEQ/g 
lipid) for comparison reasons, a 26.5% body fat content was used.31,32 
 
Results 
Study characteristics 
In total 80 eligible men responded to our research invitation and eventually participated 
in this study. Of these men, 34 consumed eel exclusively from areas open for eel fishery 
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or aquaculture (low-exposed group) and 21 consumed eel exclusively from high-polluted 
areas where the ban on eel fishing is now implemented (high-exposed group). Other 
participants consumed eel from both areas or were not aware of the origin of the eel. 
The majority of the men consumed eel once or twice per month, and 20% consumed eel 
at least five times per month. Most men also consumed other fish. Age and BMI were 
comparable between the low- and high-exposed groups (Table S1). 
Dioxins and dioxin-like compounds 
Total levels of dioxins and dioxin-like compounds are expressed in bioanalytical 
equivalent (BEQ) when measured with the bioassay, and in toxic equivalent (TEQ) when 
analyzed with GC-HRMS. These values correlated well (Spearman r = 0.95; BEQ = 
0.95*TEQ + 4.0), based on ten samples analyzed with both techniques. The BEQ values 
followed a normal distribution (Fig. 1A) and were in general increased in the high-
exposed men (Fig. 1B), with levels up to 145 pg BEQ/g lipid (164 TEQ/g lipid based on 
GC-HRMS). Based on the pooled samples from the low- and high-exposed men, the 
high-exposed men had on average 2.5 times higher TEQ levels. In the low-exposed 
group, especially the dioxins contributed to the TEQ level (Fig. 1C). For the high-exposed 
group the majority of the TEQ came from DL-PCBs, more specifically the NO-PCBs 
(Table S2). The MO-PCBs, however, showed a higher relative increase, namely 2.3-times 
compared to 1.5-times for the NO-PCBs comparing percentages of high- to low-exposed. 
Also other PCBs were present at relatively higher levels as shown by the ratio of PCB153 
and TEQ (Fig. S1). 
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Figure 1. (A) Frequency distribution of dioxins and dioxin-like (DL) compounds 
determined for all 80 participants. The light orange box presents European background 
levels reported in the 21st century.33 (B) Levels of dioxins and other dioxin-like (DL) 
compounds for the 55 participants that ate eel exclusively from either low- (green 
circles) or high-polluted areas (red squares). The black lines indicate the median with 
the interquartile ranges. The blue line indicates the extrapolated safe blood level.13 (C) 
The contribution of PCDD/Fs (filled bar) and DL-PCBs (clear bar) to TEQ levels in 
pooled blood from men with 20 and 45 pg BEQ/g lipid, and two individual samples 
(>100 pg BEQ/g lipid, presented separately) from men that consumed eel from low- 
(green) and high-polluted areas (red). Details can be found in Table S3.   
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Individual persistent organic pollutants (POPs) 
Of the 48 POPs measured in the subgroup of 38 men (14 low-exposed, 13 high-exposed, 
and 11 with unknown origin of the majority of the consumed eel), 30 POPs had levels 
above the LOD in at least 60% of the samples (Table S3). Levels of the OC pesticides: β-
HCH, mirex, oxychlordane, and trans-nonachlor, did not differ between the two groups 
(Fig. S2). Levels of HCB and DDT, but not DDE, were significantly elevated in the high-
exposed men (Fig. 2). Furthermore, all PCBs (except for PCB 52) were significantly 
higher in the high-exposed men, with fold differences ranging up to 10.6 (Fig. 2). 
Concomitant increases of the internal OH-PCB metabolites were observed, amounting 
to an eight-times increase for the sum of the four measured OH-PCBs (Fig. 3).  
 
Figure 2. DDT, DDE, HCB, and PCB levels in men who ate eel from low- (green circles) 
and high-polluted areas (red squares). The p-value in blue indicates a significant 
difference (Mann-Whitney U test). The fold change (FC) is calculated by dividing the 
median (indicated black line) of the high- by that of the low-exposed group. Samples in 
the grey quadrant are below the limit of detection (<LOD).  
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Figure 3. OH-PCB levels in male consumers of eel from low- (green circles) and high-
polluted areas (red squares), expressed as ng/g ww because OH-PCBs do not accumulate 
in lipids. Blue p-values indicate a significant difference (Mann-Whitney U test). The fold 
change (FC) is calculated by dividing the median (indicated black line) of the high- by 
that of the low-exposed group. ∑ OH-PCBs is the sum of the 4 measured OH-PCBs. 
Samples in the grey quadrant are below the limit of detection (<LOD). The light orange 
area represents world-wide background levels of OH-PCBs in the 21st century, while the 
dark orange represents levels in high-exposed populations (average median high-
exposed levels to  maximum median levels reported in the literature).34 The in vivo as 
well as the in vitro effect concentrations are also based on a literature review.34  
 
Two PBDEs, BDE-47 and BDE-153, were detectable in at least 60% of the men but levels 
were not significantly different between the groups (Fig. S3). Furthermore, two 
perfluorinated alkylsulfates and six perfluorinated alkylacids were detectable (Fig. S4). 
The median levels of most PFASs were significantly elevated, up to 3.5 times in the high-
exposed men. Detailed information for all 30 POPs can be found in Table S4.  
< LOD
In vivo effect concentration 
(growth/behavior)
In vitro effect concentration 
(neuronal/endocrine)
p < 0.001  FC = 7.6
p = 0.002 FC = 5.9
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Discussion 
Our research is the first to reveal that men who consumed eel from high-polluted areas 
in the Netherlands have, up to ten times, higher body burdens of dioxins, (OH-)PCBs 
and PFASs compared to men consuming eel from relatively clean areas or aquaculture. 
Although risk assessment and management mainly focus on dioxins and PCBs, we show 
that also body burden of hydroxylated PCBs might be of health concern. 
The dioxins and dioxin-like levels observed in the low-exposed men are comparable to 
background levels observed in other European studies (orange block, Fig 1A).33 The high-
exposed men had on average 2.5 times higher TEQ levels, which is in agreement with 
the predictions made in a previous risk assessment on eel consumption.12 Total dioxins 
and dioxin-like levels, however, were lower than those reported in fishermen consuming 
fish from the high-polluted Baltic Sea.35 The Baltic Sea herring contains similar to higher 
TEQ levels than eel, and is consumed more frequently, explaining the even higher levels 
in consumers.36 
The median BEQ levels of both groups in our study (18 and 39 pg BEQ/g lipid, for the 
low- and high-exposed respectively), are above the estimated safe level of 15 pg TEQ/g 
lipid. Although fish consumption is considered healthy because of its nutritional value, 
frequent consumption of fish with levels above the ML is expected to result in TEQ body 
burdens that exceed the safe level.12,37 The safe level is derived from reproduction studies 
and aims to protect the developing unborn child.13 The actual safe level for adults may 
be higher but this was not specifically addressed in the risk assessment. 
Men in this study consumed eel for many years, and given the long half-life, the body 
burden could include POPs from even higher contaminated eel consumed in the past 
and from other food. Interestingly, in the low-exposed group the BEQ levels are 
positively correlated with age, but not in the high-exposed group (Fig S5). This could be 
explained by recent intake of high-polluted eel, while the low-exposed group might have 
benefited more from the generally decreased POP levels in food products.  
To confirm that eel is the actual source of the elevated POP levels, we compared the 
POP profiles in men and eel. In general, TEQ exposure from aquatic species mainly 
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originates from DL-PCBs, while in terrestrial sources (such as meat and dairy) PCDD/Fs 
and DL-PCBs have an equal contribution.38 Indeed, for the average Dutch consumer the 
main sources contributing to PCDDD/Fs are dairy products, while fish contributes to 
most of the DL-PCBs.37 In our study the major contribution to the TEQ levels in the 
high-exposed men came from DL-PCBs, indicating fish as a likely source, while in low-
exposed men the PCDD/Fs contributed most to the TEQ. Additional indication for eel 
as the source of the higher TEQ levels is the relatively high contribution of MO-PCBs 
within the DL-PCBs. In farmed eel and other fish, NO-PCBs predominate, but wild eel 
has relatively high levels of MO-PCBs.11 The PCB profiles in the high-exposed men 
followed the eel profiles, while the PCDD/F profiles were different between men and eel 
(Fig. 4). This, together with the increasing PCB153 to TEQ ratio in the high-exposed men 
(Fig. S1), indicates that eel is the most likely source of the elevated TEQ and PCB levels. 
The most pronounced differences between the low- and high-exposed men were 
observed for the PCBs and OH-PCBs, followed by the PFASs. Levels of PFAS in the low-
exposed group are comparable to levels measured in the USA,39 while the high-exposed 
men had PFOS levels well above general population levels.40 It is, however, not yet 
known above which levels adverse effects could occur.41 Brominated flame retardant 
levels did not significantly differ between the groups, which is in accordance with earlier 
reports that regular eel consumptions does not cause health risks from PBDEs and 
HBCD.14 Besides food, significant exposure to PBDEs occurs from house dust due to e.g. 
electronics or carpets releasing flame retardants,42 while PCB exposure is almost fully 
limited to the food chain.3 The highest PCB-exposed populations are found around the 
artic, where traditional foods include marine mammals, such as seal and whale 
blubber.43-45 Interestingly, levels of PCBs and their OH-metabolites were higher in 
Dutch men consuming eel from high-polluted areas than in men consuming marine 
mammals, and were thus among the highest levels measured in the 21st century (orange 
blocks, Fig. 3).34 This could be related to the higher PCB biotransformation capacity in 
mammals compared to fish,46 resulting in higher PCB levels in fish, which will be 
metabolized by the consumers who subsequently retain the OH-metabolites in their 
body. 
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Figure 4. Profiles of (A) PCDD/Fs that occurred in levels higher than 5 pg/g lipid in 
high-exposed men and (B) the seven indicator PCBs in both eel and men. Eel data are 
derived from 360 (pooled) samples, collected between 2001 and 2012. The average levels 
in eel are calculated for both low- (dark green bars) and high-polluted areas (dark red 
bars) (unpublished data from monitoring program). Human data are determined in 
pooled samples for low- (n=34, bright green bars) and high-polluted men (n=21, bright 
red bars) (this study). 
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OH-PCBs have been associated with several adverse health effects in animal studies, 
especially related to development, growth and behavior.34 OH-PCBs can mimic thyroid 
hormones and have a high affinity for thyroid hormone transport proteins.47 In all men 
the sum of the OH-metabolites are expected to give adverse health effects based on in 
vitro studies, and based on animal studies adverse health effects might be expected in 
the majority of the men (Fig 3). Furthermore, the (OH-)PCB levels in the high-exposed 
eel consumers were slightly higher than those reported for Inuit from Canada, where 
negative effects on thyroid hormone parameters were identified, especially a reduction 
of triiodothyronine.48 As already explained, there is a special concern for the most 
vulnerable humans, especially the unborn child exposed through its mother. Unborn 
children of women with a comparable eel consumption as the men in this study are likely 
not only exposed to dioxins but also to OH-PCBs above safe levels.  
Our results show that consumption of eel from high-polluted areas is not safe, and 
therefore we support the ban (in the Netherlands and France) on catching eel in high-
polluted areas. Several other countries (e.g. Belgium and Germany), however, still do not 
have a ban on catching eel from high-polluted areas, only a recommendation not to 
consume this eel. Indications exist that recreational fishermen are still catching high-
polluted eel for consumption, and we recommend more strict regulation to prevent 
consumption of these eels. Most eel sold in the Netherlands nowadays comes from 
aquaculture and to a limited extent from low-polluted areas. Our results reveal that 
consumption of this eel indeed does not lead to a high increase of background POP 
levels, as was predicted before.12 
 
Conclusions 
From a public health perspective, weekly fish consumption as advised by the WHO49 
can be encouraged for all fish with levels well below the legal limits. However, to protect 
human health, appropriate measures should be taken to prevent consumption of fish 
from high-polluted areas world-wide. 
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Supplemental material 
 
Table S1. Characteristics of study population. Values are given as median (min-max) or 
in number of participants per exposure category (percentage).  
* The low-exposed group ate eel exclusively from aquaculture and/or from the areas regarded safe for eel 
consumption. The high-exposed group ate eel exclusively from areas now banned for eel fishing. The 
other participants consumed eel from both areas or were not aware of the origin of the eel. 
 
 
Table S2. Levels of PCDD/Fs, non-ortho (NO) and mono-ortho (MO) PCBs as measured 
by GC-HRMS. Absolute values are given in pg TEQ/g lipid and relative contribution to 
the total TEQ is given between brackets. Numbers above the table indicate the 
approximate total BEQ level based on the bioassay. For the low and middle group (20 
and 45 pg BEQ/g lipid) pooled samples were measured with the same BEQ levels for 
both the low- (green columns) and high-exposed group (red columns). The two 
individuals with BEQ levels above 100 pg BEQ/g lipid were measured separately. 
 ̴ 20 pg BEQ/g lipid ̴ 45 pg BEQ/g lipid >100 pg BEQ/g lipid 
Low-exposed 
(n=8) 
High-exposed 
(n=7) 
Low-exposed 
(n=3) 
High-exposed 
(n=5) 
High-exposed 
(n=1) 
High-exposed 
(n=1) 
PCDD/F 12.0 (61%) 10.9 (51%) 22.7 (70%) 24.1 (46%) 46.3 (46%) 41.9 (26%) 
NO-PCB  6.1 (31%) 8.2 (38%) 7.8 (24%) 20.6 (40%) 39.7 (40%) 85.0 (52%) 
MO-PCB 1.5 (7%) 2.3 (11%) 2.0 (6%) 7.2 (14%) 13.8 (14%) 37.3 (23%) 
 
 
 
  Total Low-exposed* High-exposed* 
Number of participants   80 34 21 
Age (years) Med (min-max) 59 (40-70) 58 (41-70) 62 (40-70) 
Body Mass Index 
(kg/m2) 
Med (min-max) 29.2 (21.4-45.2) 29.3 (21.8-41.3) 29.5 (23.0-35.3) 
Fishermen  
n (%) 
 
Professional 26 (33)  10 (29)  13 (62)  
Sport 27 (34)  9 (26)  8 (38)  
No 27 (34) 15 (44)  0 (0) 
Frequency eel 
consumption 
n (%) 
1-2x per month 51 (64) 23 (68) 10 (48) 
3-4x per month 13 (16) 2 (6) 7 (33) 
>5x per month 16 (20) 9 (26) 4 (19) 
Frequency consumption 
other fatty fish  
n (%) 
<1x per week 44 (55) 17 (50) 14 (67) 
1-2x per week 34 (43) 16 (47) 6 (29) 
3-4x per week 2 (3) 1 (3) 1 (5) 
Frequency consumption 
of semi-fatty fish 
n (%) 
<1x per week 33 (41) 12 (35) 9 (43) 
1-2x per week 44 (55) 20 (59) 12 (57) 
3-4x per week 3 (4) 2 (6) 0 (0) 
Frequency consumption 
of lean fish 
n (%) 
<1x per week 44 (55) 21 (62) 11 (52) 
1-2x per week 34 (43) 13 (38) 10 (48) 
3-4x per week 2 (3) 0 (0) 1 (5) 
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Table S3. List of all 48 persistent organic pollutants (POPs) measured in serum samples, 
together with the limit of detection (LOD), the percentage of samples with levels above 
the LOD and the maximum levels measured. 
 LOD  
(ng/g ww) 
Samples above LOD 
(%) 
Max levels 
(ng/g ww) 
Max levels 
(ng/g lipid) 
OC pesticides     
p,p'-DDE 0.01 100 2.4 353 
p,p'-DDT 0.01 68 0.53 62.6 
HCB 0.01 97 0.86 102 
β-HCH 0.02 100 0.29 36.9 
Mirex 0.01 84 0.23 29.9 
Oxychlordane 0.01 82 0.32 46.1 
Trans-nonachlor 0.01 100 0.39 49.2 
PCBs     
PCB-28 0.02 39 0.12 14.8 
PCB-52 0.01 100 0.29 44.5 
PCB-101 0.02 55 0.65 82.2 
PCB-105 0.01 82 0.63 79.3 
PCB-118 0.02 74 3.9 497 
PCB-138 (/ 163) 0.01 100 22.8 2870 
PCB-153 0.02 100 39.4 4960 
PCB-156 0.01 100 1.9 235 
PCB-170 0.02 100 14.9 1880 
PCB-180 0.01 100 40.3 5080 
PCB-187 0.01 100 17.6 2210 
OH-compounds     
3-OH-CB118 0.02 46 0.38 / 
3'-OH-CB138 0.04 57 1.7 / 
3'-OH-CB180 0.01 57 0.57 / 
4-OH-CB107 0.02 92 2.1 / 
4'-OH-CB130 0.03 0 - / 
4-OH-CB146 0.02 95 4.0 / 
4'-OH-CB159 0.00 51 0.03 / 
4'-OH-CB172 0.01 84 0.91 / 
4-OH-CB187 0.02 100 12.8 / 
6-OH-BDE47 0.02 46 0.13 / 
Brominated compounds     
BDE-28 0.01 0 - - 
BDE-47 0.01 66 0.07 8.3 
BDE-99 0.01 5 0.02 2.7 
BDE-100 0.01 21 0.04 6.9 
BDE-153 0.01 63 0.14 17.7 
BDE-154 0.01 0 - - 
HBCD 0.19 13 0.64 80.7 
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PFASs     
PFOS 0.13 100 259 / 
PFHxS 0.20 100 16.6 / 
PFBS 1.00 0 - / 
FOSA 0.12 0 - / 
PFTrDA 0.04 86 0.56 / 
PFDoDA 0.04 78 1.5 / 
PFUdA 0.20 84 5.2 / 
PFDA 0.05 100 12.8 / 
PFNA 0.06 100 9.4 / 
PFOA 0.20 100 17.8 / 
PFHxA 0.10 0 - / 
PFHpA 0.06 35 0.4 / 
PFTeDA 0.04 46 0.3 / 
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Table S4. Results of extensive POP measurements in all participants as well as in the 
men consuming eel from relatively low- and high-polluted areas. 
All measured participants: all men who consumed eel at least once per month, independent of the origin 
on the eel: 
Low-exposed: men who only consumed eel from aquaculture or wild eel from areas from which 
consumption is regarded to be safe. 
High-exposed: men who only consumed wild eel from areas that are now closed for consumption due to 
high POP levels.  
N (all  / low / high) 25p Median 75p 25p Median 75p 25p Median 75p
DR CALUX (pg BEQ / g l ipid) 80 / 34 / 21 16.3 22.3 32.3 14.5 18.0 27.7 23.8 38.5 52.7
DR CALUX (pg BEQ / g l ipid) 38 / 14 / 13 17.4 27.3 42.5 14.4 18.5 30.8 31.4 49.6 70.7
OC (ng / g lipid)
p,p'- DDE 38 / 14 / 13 51.4 111.7 227.8 46.0 57.7 178.2 97.2 182.1 241.7
p,p' -DDT 38 / 14 / 13 0.9 5.2 21.3 0.4 2.8 7.8 5.5 27.2 35.2
HCB 38 / 14 / 13 10.1 13.8 25.3 8.7 11.3 21.6 13.8 23.3 56.4
β-HCH 38 / 14 / 13 6.3 9.6 16.7 6.3 11.2 17.6 6.9 13.7 19.8
Mirex 38 / 14 / 13 3.4 5.7 9.2 3.4 7.2 11.1 2.8 8.8 23.0
Oxychlordane 38 / 14 / 13 1.8 4.0 8.6 1.5 4.9 7.5 11.8 13.2 18.5
Trans-nonachlor 38 / 14 / 13 7.4 11.8 18.3 7.1 11.3 21.4 3.7 5.7 6.2
PCBs (ng / g lipid)
PCB-52 38 / 14 / 13 11.3 12.6 16.2 12.4 13.3 14.9 12.0 16.0 17.9
PCB-105 38 / 14 / 13 2.5 5.6 12.3 1.8 4.2 5.8 5.9 16.4 20.5
PCB-118 38 / 14 / 13 3.2 25.8 80.8 3.1 11.4 32.0 59.8 121.0 190.2
PCB-138 38 / 14 / 13 42 152 318 34 61 165 217 465 689
PCB-153 38 / 14 / 13 93 317 662 69 142 333 468 896 1340
PCB-156 38 / 14 / 13 7 15 35 5 10 19 29 40 60
PCB-170 38 / 14 / 13 28 58 123 17 35 72 111 126 245
PCB-180 38 / 14 / 13 63 157 306 35 80 183 225 319 617
PCB-187 38 / 14 / 13 16 62 131 14 38 63 91 186 267
OH-PCBs (ng / g ww)
4-OH-CB107 37 / 13 / 13 0.0 0.1 0.4 0.0 0.1 0.1 0.3 0.4 0.6
4-OH-CB146 37 / 13 / 13 0.1 0.3 1.1 0.1 0.2 0.3 0.8 1.2 1.9
4'-OH-CB172 37 / 13 / 13 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.2 0.3
4-OH-CB187 37 / 13 / 13 0.2 0.5 1.9 0.2 0.3 0.5 1.1 2.0 3.3
BDEs (ng / g lipid)
BDE-47 38 / 14 / 13 0.6 1.6 2.6 0.3 1.0 1.9 1.6 2.0 2.7
BDE-153 38 / 14 / 13 1.2 3.1 5.3 0.9 2.4 4.6 2.6 4.5 10.8
PFASs (ng / g ww)
PFOS 37 / 14 / 13 10.6 38.8 82.3 10.6 33.6 55.0 71.8 82.3 104.5
PFHxS 37 / 14 / 13 2.5 3.6 6.5 2.6 3.3 3.9 4.0 6.2 9.5
PFTrDA 37 / 14 / 13 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.3 0.4
PFDoDA 37 / 14 / 13 0.1 0.2 0.4 0.0 0.2 0.2 0.3 0.5 0.9
PFUdA 37 / 14 / 13 0.3 0.6 1.4 0.3 0.7 1.2 0.6 1.4 2.5
PFDA 37 / 14 / 13 0.6 1.7 4.8 0.6 1.9 3.4 1.9 4.8 6.7
PFNA 37 / 14 / 13 1.0 1.5 2.5 0.9 1.4 3.6 1.7 2.2 3.4
PFOA 37 / 14 / 13 2.9 4.2 5.9 2.7 3.6 5.0 4.8 5.5 7.0
All measured participants Low-exposed High-exposed
All measured participants: all  men that consumed eel at least once per month, independent of the origin of the eel
Low-exposed: men that only consumed eel from aquaculture or wild eel from areas from which consumption is regarded to be safe
High-exposed: men that only consumed wild eel from areas that are now closed for consumption due to high POP levels
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Figure S1. The ratio of PCB153, used as indicator PCB, and BEQ levels determined with 
the bioassay from 27 participants (low- and high-exposed men only) for which the 
extended POP measurements were performed comparing the low- (green circles) to the 
high-exposed men (red squares). The black lines indicate the median with the 
interquartile range. 
 
 
 
Figure S2. Levels of OC pesticides in low- (green circles) and high-exposed men (red 
squares). The p-value is calculated with a Mann-Whitney U test and the fold change (FC) 
is calculated by dividing the median (indicated line) of the high- by that of the low-
exposed group. Samples in the grey quadrant are below the limit of detection (<LOD). 
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Figure S3. Levels of polybrominated diphenyl ethers (PBDEs) in low- (green circles) and 
high-exposed men (red squares). The p-value is calculated with a Mann-Whitney U test 
and the fold change (FC) is calculated by dividing the median (indicated line) of the 
high- by that of the low-exposed group. Samples in the grey quadrant are below the limit 
of detection (<LOD). 
 
 
 
Figure S4. Levels of perfluoroalkyl substances (PFASs) in low- (green circles) and high-
exposed men (red squares). The p-value in blue indicates a significant difference 
calculated with a Mann-Whitney U test. The fold change (FC) is calculated by dividing 
the median (indicated line) of the high- by that of the low-exposed group. Samples in 
the grey quadrant are below the limit of detection (<LOD). 
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Figure S5. Relationship between age and BEQ levels for both the low- (green dots) and 
high-exposed (red squares) groups. The p-value in blue indicates a significant difference 
calculated with Spearman’s nonparametric correlation. 
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Abstract 
Background Consumption of polluted fish may lead to high levels of persistent organic 
pollutants (POPs) in humans, where they can cause adverse health effects. The 
underlying mechanisms are yet not fully elucidated, although altered DNA methylation 
has been suggested as a possible contributor to a variety of adverse health effects.  
Objectives The aim of this study was to evaluate the relationship between serum POP 
levels and genome-wide DNA methylation as well as clinical parameters. 
Methods In total, 80 Dutch men were included who regularly consumed eel from either 
high-polluted areas, and subsequently had elevated POP levels, or from low-polluted 
areas. Serum POP levels were determined and clinical parameters related to e.g. 
hormone levels and liver enzymes were included as biomarkers for adverse health 
effects. The Infinium 450K BeadChip was used to measure genome-wide DNA 
methylation in a subset of 34 men. 
Results Most clinical parameters were not associated with serum POP levels. Multiple 
genes, however, were differentially methylated in men with higher POP levels. Several 
of these genes are involved in carcinogenesis (e.g. BRCA1, MAGEE2, HOXA5), the 
immune system (e.g. RNF39, HLA-DQB1), retinol homeostasis (DHRS4L2), or in 
metabolism (CYP1A1). 
Conclusions This is the first human study to investigate genome-wide DNA 
methylation profiles associated with serum POP levels. We conclude that elevated POP 
levels, due to consumption of high-polluted food products, affect DNA methylation 
profiles in adult men, which can potentially be involved in adverse health effects.  
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Introduction 
Persistent organic pollutants (POPs) are widely present in the environment and humans 
are mainly exposed to POPs through the consumption of food, especially fish and 
seafood.1 In Dutch men, serum POP levels were shown to be increased in consumers of 
high-polluted eel, coming from rivers with a high degree of urbanization and 
industrialization.2 Especially polychlorobiphenyls (PCBs) (median increases 4-10 times), 
PFOS (median increase 2.4 times), and the total amount of dioxins and dioxin-like 
compounds (median increase 2.1 times) were found to be elevated in these men 
compared to men consuming eel from relatively low-polluted areas or aquaculture. In 
2011, a ban on eel fishing in the high-polluted areas was implemented after risk assessors 
concluded that the consumption of one portion eel per month would lead to unsafe 
levels of especially dioxins and dioxin-like compounds.3 The safe level is derived from 
animal reproduction studies,4 and there is a lack of information regarding exact safe 
levels in humans. We therefore studied whether the elevated POP levels in adult men, 
related to eel consumption, are associated with clinical parameters as an indication for 
adverse health effects.  
In adults, POPs can cause many adverse health effects of which the majority are related 
to endocrine disruption, neurological disorders, immune function and cancer.5 More 
specifically, hydroxylated (OH-) PCBs might affect thyroid and retinol regulation,6 while 
dioxins and PFOS might affect testosterone levels,7,8 liver enzymes,9,10 hematocrit (Ht) 
and hemoglobin (Hg) levels.11,12 Furthermore, POP mixtures were shown to interfere 
with glucose and HDL cholesterol levels, and possibly attribute to diabetes mellitus type 
II.13 Although some mechanisms behind adverse health related to POP-exposure are 
clear, like dioxins binding to the aryl hydrocarbon receptor,14 OH-PCBs binding to 
thyroid transport proteins,6 and PFOS resembling fatty acids,15 not all adverse health 
effects can be explained by these mechanisms of action. Epigenetic phenomena, such as 
DNA methylation, have been proposed as a possible molecular mechanism underlying 
adverse health effects.16 DNA methylation is a heritable modification, which refers to the 
addition of a methyl group to cytosine in a CpG dinucleotide. Observational studies have 
indeed shown that POPs can affect global DNA methylation, and both hypo- (decrease) 
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and hyper- (increase) methylation have been found.17-20 Furthermore, animal studies 
showed that dioxin,21 PCBs,22 and PFOS23 might cause adverse health effects due to gene-
specific methylation changes. Also in vitro experiments showed that POPs can affect 
gene-specific DNA methylation.24,25  
Therefore, we hypothesized that the higher POP levels in men who consumed eel from 
high-polluted areas might affect DNA methylation and possibly explain adverse health 
effects. In this study, we measured clinical parameters (e.g. hormone levels and liver 
enzymes) as well as DNA methylation in blood collected from male eel consumers and 
associated these outcomes with serum POP levels. This is the first study to investigate 
genome-wide DNA methylation in humans environmentally exposed to POPs. 
 
Material and methods 
Study population 
The population consisted of 80 male Dutch participants aged 40 to 70 years, with a 
habitual eel consumption of at least one portion a month since many years.2 Men were 
invited to participate through professional and recreational fishermen associations, 
because these men are more likely to know the origin of the eel, and through 
advertisements in local newspapers and webpages. Participants filled out a 
questionnaire at home about fish consumption habits (including the origin of the eel 
indicating whether it came from an area where nowadays a ban on catching eel is 
implemented or not), smoking habits, alcohol consumption and medication use. Blood 
samples were obtained by venipuncture after overnight fasting. Furthermore, height and 
weight were measured using standard methods in light clothes. Waist circumference 
was measured midway between the iliac crest and the costal margin at the end of gentle 
expiration and hip circumference was measured over the great trochanters. This study 
was approved by the Medical Ethical Committee of Wageningen University, and written 
informed consent was obtained from all participants before inclusion in the study.  
  
Epigenome-wide DNA methylation and POPs in Dutch men 
 
133 
 
Serum POP levels 
Serum samples were separated by centrifugation within 6 hours after blood collection 
and full details regarding POP measurements are described previously.2 In short, the 
total dioxin-like toxic potency of compounds in blood was measured for all 80 
participants with the DR CALUX bioassay at RIKILT Institute for Food Safety26 and 
expressed in bioanalytical equivalent (BEQ) per gram lipid.  Extensive analyses for 
individual POPs were performed in a subset of 38 participants with an age distribution 
that represents the whole study population. Stratification for age is important because 
POP levels are related to age27 as is DNA methylation.28,29 First, all participants were 
categorized in three age groups (40-49, 50-59, 60-70 years), and secondly by the 
measured BEQ levels with equal numbers of participants for low, medium or high levels 
(Table S1). The 38 participants were randomly selected from each of the categories. 
The extensive POP measurements included 48 individual compounds and were 
performed at the Laboratory of Environmental Toxicology at the Norwegian University 
of Life Sciences (NMBU), according to the requirements of the ISO/IEC 17025 
accreditation (TEST 137). Of the 48 POPs, there were 30 compounds for which levels in 
at least 60% of the participants were above the detection limit, and therefore used in 
the statistical analyses (Table S1).The seven indicator PCBs, recommended by the 
European Union Community Bureau of Reference based on their relatively high 
concentrations in technical mixtures and their wide chlorination range, were measured 
with GC-MS after liquid-liquid extraction and expressed per gram lipid.30 PFOS was 
measured with LC-MS after methanol extraction and expressed per gram wet weight 
(ww).31  
Clinical parameters 
Liver parameters (AST, ALT, GGT), HDL cholesterol, and thyroid hormones (free T4 and 
TSH levels) were determined in venous blood collected in lithium heparin vacutainers. 
Blood collected in a sodium fluoride / potassium oxalate vacutainer was analyzed for 
glucose, while testosterone and retinol were quantified in serum. Whole blood collected 
in an EDTA vacutainer was used to measure hemoglobin (Hb), hematocrit (Ht), and 
white blood cell counts (WBC). All samples were transferred to the clinical chemistry 
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lab at the Hospital Gelderse Vallei (Ede, the Netherlands) within 3 hours after blood 
sampling. 
Associations between total BEQ levels as well as all individual POPs and the clinical 
parameters were investigated using multivariable linear regression analyses. The 
association between log-transformed POP levels and log-transformed parameters was 
assessed while adjusting for age and waist-to-hip ratio, because these covariates had 
statistical significant effects on some of the clinical parameters measured. The 
standardized β coefficients are reported for the linear regression analyses and can be 
used to interpret the influence of the POP levels on the clinical parameters. Participants 
with known or expected diabetes mellitus (6 out of 80) were excluded from the analyses 
regarding the relationship between glucose and POP levels. 
DNA isolation 
Two participants were excluded for DNA methylation analysis since their WBC showed 
deviating ratios (percentage of either monocytes, lymphocytes, or granulocytes outside 
two times the standard deviation of the population). Therefore, a total of 36 participants 
were included, for which extensive POP measurement were performed (Fig. S1). Blood 
was collected in EDTA vacutainers and stored at 4⁰C until processing. The buffy coat 
was separated by centrifugation within 6h after collection and stored at -80⁰C. Genomic 
DNA was isolated from the buffy coat using the DNeasy blood and tissue kit according 
to the manufacturer’s protocol (Qiagen, Venlo, the Netherlands). DNA concentration 
and quality was determined using a NanoDrop ND-1000 UV–vis spectrophotometer. 
DNA methylation measurements 
DNA methylation was analyzed using the Illumina Infinium HumanMethylation450 
BeadChip (Infinium Inc., San Diego, USA), which addresses 485,512 cytosine positions. 
For the 36 participants, a total of 500 ng DNA was sent to the Human Genotyping 
Facility of the Erasmus University Medical Centre (Rotterdam, the Netherlands) who 
performed the bisulfite conversion (EZ DNA Methylation Kit, Zymo Research, Freiburg, 
Germany) and processed the BeadChip. Multidimensional scaling revealed two potential 
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samples mix-ups which were excluded from the analysis, resulting in a total of  34 
remaining samples (Fig S1). 
Data analysis was conducted as described previously.32 In short, the minfi package 
(v1.12.0)33 was used to process the intensity iDAT files in R-based open software (R 3.1.2). 
Autosomes and the X and Y chromosomes were included in the analysis, but positions 
containing a SNP (based on the dbSNP version 137,34 at the CpG interrogation and/or 
the single nucleotide extension with a frequency of at least 1% were excluded. Finally, 
there were 467,974 positions included in the analyses and annotated based on the 
ilmn12.hg19 annotation.35 Differentially methylated positions were identified as a 
function of log-transformed BEQ levels, sum of seven indicator PCBs, and PFOS levels, 
using the dmpFinder function for continuous phenotypes with a linear regression 
analyses adjusted for age and leukocyte counts (percentage of monocytes, lymphocytes, 
and granulocytes). Statistical analyses were adjusted for multiple testing with the 
Benjamini-Hochberg (BH) method.36 A false discovery rate (FDR) value of 0.05 was used 
as the threshold to define statistical significance. Furthermore, we considered positions 
with a non-adjusted p-value below 1E-04. M-values (log2 intensity ratios) were used for 
statistical testing,37 while β-values were used for visualization purposes. These β-values 
range from 0 % (completely unmethylated) to 100 % (completely methylated). All the 
β-values as well as single iDAT files and other relevant information are available through 
the Gene Expression Omnibus (GEO) repository with accession number GSE79329. 
Differentially methylated regions 
Identification of differentially methylated regions (DMRs) was performed with the 
DMRcate package (v1.2.0) from Bioconductor.38 This method identifies DMRs across the 
genome based on tunable kernel smoothing. For this study, DMRs were defined as 
regions of at least 5 positions with a distance of consecutive positions less than 200 
nucleotides. Statistical analyses were adjusted for multiple testing with the BH method 
and a FDR value of 0.05 was used as the threshold to define statistically significant 
DMRs.  
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Results 
The 80 men included in this study showed strong variation in their serum levels of 
dioxins and dioxin-like compounds (range from 4.9 to 145 pg BEQ / g lipid). 
Demographic characteristics and measured POP levels can be found in Table 1. Men with 
‘low’ or ‘high’ levels of dioxins and dioxin-like compounds (based on a median-split) did 
not differ regarding their demographic characteristics. 
Table 1. Characteristics of the men studied. Values are given as median (25-75 
percentile) or in number (plus percentage) of participants. 
* For graphical, but not statistical, purposes participants were divided with a median-split in two groups, 
where low indicates the lower half of the group and high the upper half of the group. BEQ = 
bioanalytical equivalent 
  
  All participants Participants with DNA 
methylation analyses 
Number of participants (n)  80 34 
Age (years)  58.6 (49.0 – 63.9) 57.3 (49.2 – 65.5) 
Body Mass Index (kg/m2)  29.2 (26.5 – 31.0) 29.4 (26.7 – 32.3) 
Waist-to-hip ratio  0.98 (0.93 – 1.02) 0.98 (0.94 – 1.00) 
Smoking habits 
 
Current 11 (14) 5 (15) 
Former 48 (60) 21 (62) 
Never 21 (26) 8 (24) 
Alcohol consumption 
 
Yes 69 (86)  32 (94) 
No 11 (14) 2 (5) 
Medication 
(at least once a month) 
Yes 38 (48) 17 (50) 
No 42 (53) 17 (50) 
Serum levels of persistent 
organic pollutants (POPs) 
   
Dioxins and dioxin-like compounds  
(pg BEQ / g lipid) 
Low* 16.2 (12.8 – 18.6) 17.1 (12.2 – 19.3) 
High* 32.4 (27.4 – 49.7) 49.6 (35.2 – 70.7) 
Sum of 7 indicator PCBs 
(ng / g lipid) 
Low*  246 (115 – 371) 
High*  1635 (1095 – 2484) 
PFOS levels 
(ng / g wet weight) 
Low*  14.3 (6.9 – 33.6) 
High*  96.9 (71.8 – 114) 
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We first analyzed the BEQ levels for all 80 men and the selected panel of clinical 
parameters previously shown to be affected by POP exposure (ALT, AST, GGT, glucose, 
HDL cholesterol, Hb, Ht, testosterone, TSH, free T4, and retinol) and detected no 
statistically significant associations (Table S2). For the 38 participants for whom 
extensive POP analyses were performed (see flow diagram Fig. S1), we analyzed an 
extensive panel of 30 POPs in relation to the same clinical parameters. Again, for most 
POPs no statistically significant associations were detected. Statistically significant 
associations were only found for two organochlorine pesticides, namely HCB levels 
which was inversely associated with HDL cholesterol and trans-nonachlor which was 
inversely associated to both Ht and Hb levels (Table S2). The biological effects, however, 
were moderate with standardized β coefficients ranging from -0.30 to -0.50. 
We continued with genome-wide DNA methylation analyses to determine whether BEQ 
levels, PCBs, and PFOS were associated with differentially methylated positions or 
regions. No statistically significant positions were detected after correction for multiple 
testing (FDR < 0.05). However, we found 22, 17, and 29 positions with a p-value below 
1E-04  that were associated with BEQ levels, PCBs, and PFOS, respectively (Fig. S2-4).  
We further analyzed the DNA methylation differences based on the top 1000 positions 
with the lowest p-value in more detail. Higher levels of all three POP groups were 
associated with hypermethylation of most of the positions (Fig. 1A). Approximately 42% 
of the top 1000 positions associated to either BEQ levels, PCBs, or PFOS, were located 
in CpG islands (CGIs), compared to 31% of the positions on the 450K BeadChip (Fig. 1B). 
With higher levels of POPs, slightly fewer positions were detected in the open sea and 
shelf as compared to all available positions on the 450K BeadChip. 
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Figure 1. General features of genome-wide DNA methylation associations with higher 
POP levels. (A) The fraction of hypo- (inverse association with POP levels) and hyper 
methylated (positively associated with POP levels) positions, based on the top 1000 
most statistically significant positions, determined with a continuous analyses for serum 
levels of dioxins and dioxin-like compounds, the sum of seven indicator PCBs, and PFOS. 
(B) Percentages of positions expressed in relationship to CpG density, for the top 1000 
positions with the highest statistical significance, for the three POP groups (colored 
bars) as well as all considered positions on the Illumina 450K BeadChip (grey bars). 
‘Islands’ indicate the CpG islands (CGI), ‘Shore’ the CGI shores (0-2 kb from CGI), ‘Shelf’ 
the CGI shelves (2-4 kb from CGI) and ‘Open sea’ the single positions outside CGIs. 
 
We continued our analysis by searching for regions, rather than single positions, that 
are differentially methylated upon higher POP levels. In total, we detected 13, 8, and, 37 
DMRs for BEQ levels, PCBs, and PFOS, respectively (Table S3-5). Interestingly, three 
regions were detected for all three POP groups, namely DHRS4L2, ZNF85, and 
BRCA1/NBR2 (Fig. 2). DHRS4L2 encodes for a retinol oxidoreductase protein and ZNF85 
encodes for a zinc finger protein. BRCA1 is a tumor suppressor gene, while NBR2 (the 
neighbor of BRCA1) does not encode a protein. 
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Figure 2. Representative differentially methylated regions detected in leukocytes in 
relation to PFOS (DHRS4L2), the sum of seven indicator PCBs (ZNF85), and to dioxins 
and dioxin-like compounds (BRCA1 / NBR2), although similar DMRs were detected in 
relation to the other POPs (Table S2-4). Each dot represents methylation rate at the 
indicated position of individual samples and the lines show the average methylation 
levels. The light color represents the low-exposed group, while the dark color represents 
the high-exposed group based on the serum levels (median-split). 
5’UTR, five prime untranslated region; Chr, chromosome; TSS200, 200 base pairs from 
the transcription start site; TSS1500, 1500 base pairs from the transcription start site  
 
Most of the detected DMRs are annotated to a known gene, however, these genes are 
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related genes containing a DMR apart from BRCA1, including MAGEE2, NWD1, ZNF300, 
HOXA5, NET1, RHOBTB1, EDNRB, and SFRP2 (summary in Fig. 3). Furthermore, DMRs 
were found in  genes  with an immune-related function (such as RNF39, HLA-DQB1, 
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CYP1A1, which plays an important role in the metabolism of many chemicals (Fig. 4). In 
addition, some genes characteristic for germ-line cells were differentially methylated 
like HFM1 and ESX1, as well as genes associated with neurodevelopment, such as PRRT1 
and SLC6A11. 
 
Figure 3. Differentially methylated regions (DMRs) detected in genes which have a 
relationship with cancer. DMRs were found in relation to dioxins and dioxin-like 
compounds (green lines), sum of PCBs (beige lines), and PFOS (blue lines). Each dot 
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represents methylation rate at the indicated position of individual samples and the lines 
show the average methylation levels. The light color represents the low-exposed group, 
while the dark color represents the high-exposed group (median-split). 
5’UTR, five prime untranslated region; Chr, chromosome; TSS200, 200 base pairs from 
the transcription start site; TSS1500, 1500 base pairs from the transcription start site 
 
 
 
Figure 4. Differentially methylated regions (DMRs) detected in genes related to the 
immune system (RNF39 and HLA-DQB1) and metabolism (CYP1A1) associated with 
PFOS levels. Each dot represents methylation rate at the indicated position of individual 
samples and the lines show the average methylation levels. The light color represents 
the low-exposed group, while the dark color represents the high-exposed group 
(median-split). 
3’UTR, three prime untranslated region; Chr, chromosome; TSS1500, 1500 base pairs 
from the transcription start site 
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Discussion 
The present study showed that higher levels of dioxins and dioxin-like compounds, sum 
of seven indicator PCBs, and PFOS were associated with differentially methylated 
regions in the DNA. These pollutants, however, did not affect the selected clinical 
parameters such as hormone levels and liver enzymes. Altered DNA methylation was 
mostly detected in genes that could be related to other potential adverse health effects, 
such as cancer and immune responses. 
Although thyroid-related health effects are mostly observed in early life stage, we 
expected adverse health effects with these, sometimes very high, POP levels based on 
animal studies39 and a human study with slightly lower (OH-) PCB levels.40 
Furthermore, both PFOS and dioxin were shown before to negatively affect testosterone 
levels,7,8 but we could not reproduce this effect. With regard to the effects of POPs on 
liver enzymes,9,10 Ht, and Hb levels,11,12 the findings in literature are inconsistent. In our 
study, we only found  moderate associations between HCB and HDL cholesterol, and 
trans-nonachlor and both Hb and Ht levels. More pronounced adverse health effects 
could be expected during sensitive stages such as early development. These parameters 
are under tight homeostatic regulation, and the men possibly were able to compensate. 
Furthermore, the small sample size of our study could have attributed to the lack of 
power to detect an association between clinical parameters and POP levels. We conclude 
that in this study POP levels, including very high PCB levels, did not cause measurable 
effects in adult men on the clinical parameters studied.  
We found three DMRs with increased methylation levels associated with higher levels 
of all three POP groups. One of these DMRs was located in the promoter of DHRS4L2, 
relevant for retinol homeostasis, and it has been previously shown that this gene is 
transcriptionally controlled by DNA methylation.41 In our study, retinol levels were not 
affected. In otters, plasma retinol levels were also not correlated to dioxins or PCBs, but 
hepatic retinol levels were dramatically decreased with increasing pollutant levels.42 
Although DHRS4L2 is only one of many genes involved in retinol homeostasis, and we 
measured DNA methylation in leukocytes instead of a more relevant tissue such as the 
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liver, hypermethylation of this region associated with elevated POP levels, could 
theoretically be related to a disturbed retinol balance. 
Also ZNF85 was hypermethylated in men with higher POP levels. Zinc finger (ZNF) 
proteins have many key functions and they are important as transcriptional regulators.43 
ZNF85 is especially expressed in testicular tissues, with the highest expression levels 
described in germ-cell tumors and fetal tissue.44 This gene might have a developmental 
function, and due to its interaction with many nuclear receptors, differential 
methylation could potentially lead to a diverse range of adverse health effects. 
The third encoding gene detected for all three POP groups was BRCA1. Dioxin-exposed 
rat offspring shows hypermethylation of this gene and reduced gene expression.45 Also 
in human breast cancer cells, hypermethylation of BRCA1 was detected after dioxin 
exposure.24 However, while we detected the hypermethylation in the CGI, Papoutsis et 
al. reported enhanced methylation in the shore. BRCA1 expression is frequently silenced 
in breast carcinomas, while somatic mutations of this gene are not reported. Promoter 
hypermethylation of BRCA1 is associated with tumor progression,46 and it was shown 
that BRCA1 hypermethylation in leukocytes is associated with an increased breast cancer 
risk.47 Another gene that was differentially methylated was HOXA5, which is best known 
for its developmental role during embryogenesis, but its protein has been shown to be 
able to increase the expression of  the tumor suppressor p53. Methylation of HOXA5 
results in loss of expression of both HOXA5 and p53 and is also related to human breast 
cancer.48 Although men are not very likely to develop breast cancer, similar results can 
be expected in women, and our results suggest that DNA methylation changes might be 
an underlying mechanism in breast cancer development due to POP exposure.49  
In addition, we also detected DMRs in other genes possibly related to cancer 
development. NWD1, with the highest expression in male reproductive organs, is related 
to androgen receptor levels and might be involved in prostate cancer.50 Melanoma 
antigen gene (MAGE) belongs to the larger family of cancer-germline antigens that are 
frequently overexpressed in cancer. ZNF300 hypermethylation is related to 
downregulation of this gene during toxicant-induced malignant formation,51 and 
hypermethylation of NET1 might affect DNA repair. The association between POPs and 
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DNA methylation in cancer-related genes might explain part of the carcinogenic 
mechanisms these compounds have without being genotoxic.52 Interestingly, also a 
DMR in CYP1A1 was detected. A relationship between the role of PFOS and CYP1A1 in 
breast cancer has been proposed, possibly explained by the important role of CYP1A1 in 
the metabolism of many pollutants.53 DNA methylation of CYP1A1 has been described to 
influence expression levels, which subsequently could both affect the half-lives of 
pollutants and alter the amount of carcinogenic metabolites produced.54 
Furthermore, dioxins and PCBs are known to suppress immune function.55 A relatively 
large DMR with a distinct profile in the high-exposed men was detected for RNF39, a 
transcription factor in the major histocompatibility complex. For both RNF3956 and 
HLA-DQB157 methylation status might be related to poor immune responses. 
The cross-sectional nature of our study makes it impossible to determine whether the 
DNA methylation profiles are a direct result of the elevated POP levels. Furthermore, 
most differentially methylated genes are not primarily relevant in leukocytes but in 
other tissues. Additionally, we must consider that the different POPs investigated are 
correlated with each other, and therefore the interpretation of the results with regard to 
which POP exerts which effect should be done with caution. Linking DNA methylation 
and clinical parameters to POP levels is difficult due to the latency between exposure 
and the manifestation of health consequences. POP levels are very persistent in the 
body, making current exposure levels a good estimate of past exposures, but significant 
changes in life style habits interfering with POP levels cannot be excluded. A strength of 
our study, on the other hand, is the large variation in POP levels in our population, 
enabling us to investigate DNA methylation in low- to high-exposed men. 
 
Conclusions 
Persistent organic pollutants in environmentally exposed men are associated with DNA 
methylation patterns, but not clinical parameters. Genes containing differentially 
methylated regions were involved in different biological functions, and health 
conditions among which cancer and immune functioning. These findings may imply 
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that DNA methylation might indeed be an underlying mechanism of POP-induced 
health effects and this will be a good starting point for future research. 
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Figure S1. Flow diagram for the selection of the participants. 
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Table S1. Results of the extensive POP measurements. Participants were split in three 
groups, based on the total BEQ body burden (pg BEQ/g lipid), for stratified selection. 
Based on this selection 38 participants (out of the total of 80) were chosen for extensive 
POP measurements. 
 
N 25p Median 75p 25p Median 75p 25p Median 75p
DR CALUX
(pg BEQ/g lipid) 38 11.6 13.6 17.1 22.1 25.8 30.8 40.6 54.4 77.7
Organochlorine
pesticides (ng / g 
lipid)
p,p' -DDE 38 43.6 54.5 83.6 66.5 111.7 156.2 137.8 240.2 277.1
p,p' -DDT 38 0.5 2.0 4.1 0.5 6.5 12.7 2.6 22.7 34.8
HCB 38 7.0 9.8 11.9 12.9 13.8 21.3 14.7 30.7 55.3
β-HCH 38 6.0 9.2 11.9 6.4 9.0 14.2 7.3 13.3 22.0
Mirex 38 3.2 4.9 7.1 3.5 5.9 10.3 4.1 5.9 10.8
Oxychlordane 38 1.6 2.0 3.7 2.2 4.0 12.4 3.7 6.2 12.0
Trans- nonachlor 38 4.8 9.0 11.9 7.7 11.0 21.2 12.1 14.4 18.3
PCBs (ng / g lipid)
PCB-52 38 8.7 11.4 13.0 11.9 12.5 17.0 11.9 15.4 17.5
PCB-105 38 1.4 2.5 3.7 3.7 5.3 7.0 6.3 16.4 19.9
PCB-118 38 1.4 2.4 15.6 11.1 24.4 48.2 26.4 117.4 177.1
PCB-138 38 20 30 65 78 161 217 197 456 673
PCB-153 38 44 66 139 170 317 441 418 851 1309
PCB-156 38 3 5 10 11 19 30 14 35 57
PCB-170 38 13 23 39 32 58 104 77 129 210
PCB-180 38 28 43 80 76 157 229 194 322 484
PCB-187 38 5 15 44 28 56 93 64 149 209
Sum 7 indicator
PCBs 38 108 171 301 352 686 982 858 1771 2686
OH-PCBs
(ng / g ww)
4-OH-CB107 37 0.0 0.0 0.1 0.1 0.1 0.3 0.3 0.5 0.6
4-OH-CB146 37 0.0 0.1 0.2 0.2 0.4 0.7 0.5 1.2 1.9
4'-OH-CB172 37 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.2
4-OH-CB187 37 0.1 0.2 0.3 0.3 0.7 0.9 0.6 1.9 2.1
BDEs (ng / g lipid)
BDE-47 38 0.5 0.9 1.5 0.2 1.5 2.0 1.9 2.7 3.6
BDE-153 38 1.0 1.5 3.0 1.2 2.4 4.7 3.7 5.8 10.2
PFASs (ng / g ww)
PFOS 37 5.8 7.0 21.1 38.1 55.0 89.6 35.4 74.8 164.8
PFHxS 37 2.7 4.3 7.1 2.7 3.5 5.2 2.0 3.6 7.0
PFTrDA 37 0.0 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3
PFDoDA 37 0.0 0.0 0.1 0.2 0.2 0.5 0.2 0.3 0.9
PFUdA 37 0.1 0.2 0.3 0.6 0.9 1.8 0.5 1.0 2.2
PFDA 37 0.3 0.4 1.0 1.6 2.8 5.1 1.6 3.4 8.9
PFNA 37 0.6 0.8 1.1 1.6 2.1 2.6 1.5 2.3 4.3
PFOA 37 2.6 3.3 4.1 4.6 5.5 7.5 4.1 4.9 6.9
Low body burden (BEQ) Medium body burden (BEQ) High body burden (BEQ)
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Table S2. Summary of the association (standardized β coefficients of linear regression) 
between several (groups of) persistent organic pollutants (POPs) and biomarkers related 
to health. All β estimates are corrected for age and waist-to-hip ratio. * p-value < 0.05 
a Association based on n = 80. 
b Association based on n = 38. 
c Association based on n = 37. 
 
  
Biomarker Dioxin(-like)a Sum 7 PCBsb PFOSc HCBb Trans- 
nonachlorb 
ALT 0.009 0.039 0.011 -0.071 -0.073 
AST -0.029 0.129 0.190 0.061 0.164 
GGT 0.135 0.094 0.129 0.033 -0.051 
Glucose -0.035 -0.333 -0.104 -0.068 -0.059 
HDL cholesterol -0.121 -0.128 0.005    -0.304 * 0.199 
Hb -0.180 -0.257 -0.112 -0.225    -0.501 * 
Ht -0.197 -0.269 -0.095 -0.273    -0.457 * 
Testosterone -0.173 -0.116 -0.209 -0.192 -0.014 
TSH 0.145 -0.100 0.015 0.226 -0.351 
Free T4 -0.128 -0.070 -0.116 -0.002 0.100 
Retinol 0.174 0.224 0.205 -0.055 0.154 
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Figure S2. Differentially methylated positions (p-value < 1E-04) with increasing levels 
of dioxins and dioxin-like compounds. BEQ = bioanalytical equivalent (sum of dioxins 
and dioxin-like compounds) 
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Figure S3. Differentially methylated positions (p-value < 1E-04) with increasing levels 
of the seven indicator PCBs. 
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Figure S4. Differentially methylated positions (p-value < 1E-04) with increasing levels 
of PFOS. ww = wet weight 
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Table S3. Differentially methylated regions (DMRs) in leukocytes in relation to the sum 
of dioxins and dioxin-like compounds as measured with the bioassay. 
3’UTR, three prime untranslated region; 5’UTR, five prime untranslated region; Chr, chromosome; 
TSS200, 200 basepairs from the transcription start site; TSS1500, 1500 basepairs from the transcription 
start site 
a Position of start and end of the DMR according to Hg19 annotation 
b The maximum DNA methylation change within the DMR 
 
 
  
Gene Relation 
to gene 
Chr Starta Enda Nr. 
probes 
Mean 
p-value 
Changeb 
LOC284798 TSS1500 
TSS200 
Body 
20 25,129,400 25,129,562 7 7.2E-04 4.5% 
NIPAL4 TSS200 5 156,886,970 156,887,005 5 8.2E-04 5.7% 
BRCA1 
NBR2 
TSS1500 
Body 
17 41,277,974 41,278,444 14 4.6E-03 14.3% 
ZNF85 TSS200 
5'UTR 
1stExon 
19 21,106,002 21,106,120 7 4.7E-03 6.9% 
MAGEE2 5'UTR 
1stExon 
TSS200 
X 75,005,028 75,005,131 6 5.5E-03 9.4% 
PUS7L 
IRAK4 
1stExon 
5'UTR 
TSS1500 
TSS200 
12 44,152,509 44,152,715 7 6.1E-03 5.2% 
- - 5 71,146,767 71,146,876 6 7.1E-03 -8.0% 
NWD1 TSS200 
1stExon 
5'UTR 
19 16,830,613 16,830,859 5 7.7E-03 9.3% 
GJB6 5'UTR 
TSS200 
13 20,805,380 20,805,487 6 9.9E-03 7.9% 
- - 6 29,818,086 29,818,300 6 1.1E-02 12.2% 
PLOD2 TSS1500 3 145,879,568 145,879,710 5 1.7E-02 10.1% 
DHRS4L2 TSS200 
5'UTR 
1stExon 
Body 
14 24,457,993 24,458,299 6 1.9E-02 13.7% 
CYorf15A TSS1500 
TSS200 
Y 21,728,952 21,729,069 5 2.3E-02 4.9% 
Epigenome-wide DNA methylation and POPs in Dutch men 
 
159 
 
Table S4. Differentially methylated regions (DMRs) in leukocytes in relation to the sum 
of seven  indicator PCBs. 
3’UTR, three prime untranslated region; 5’UTR, five prime untranslated region; Chr, chromosome; 
TSS200, 200 basepairs from the transcription start site; TSS1500, 1500 basepairs from the transcription 
start site 
a Position of start and end of the DMR according to Hg19 annotation 
b The maximum DNA methylation change within the DMR 
  
Gene Relation 
to gene 
Chr Starta Enda Nr. 
probes 
Mean 
p-value 
Changeb 
MAGEE2 5'UTR 
1stExon 
TSS200 
17 41,277,974 41,278,563 7 5.6E-04 6.9% 
BRCA1 
NBR2 
TSS1500 
Body 
X 75,004,943 75,005,131 16 7.2E-03 10.3% 
DHRS4L2 TSS200 
5'UTR 
1stExon 
14 24,457,993 24,458,208 5 9.0E-03 8.3% 
ESX1 5'UTR 
1stExon 
TSS200 
X 35,937,617 35,937,949 6 1.5E-02 3.1% 
CXorf22 TSS1500 
TSS200 
5'UTR 
1stExon 
4 1,004,609 1,004,703 9 1.7E-02 4.2% 
FGFRL1 TSS1500 8 1,765,217 1,765,387 5 1.8E-02 0.7% 
MIR596 TSS200 X 103,499,545 103,499,650 7 1.9E-02 1.9% 
ZNF85 TSS200 19 21,106,002 21,106,043 5 
 
4.2E-02 2.8% 
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Table S5. Differentially methylated regions (DMRs) in leukocytes in relation to PFOS. 
Gene Relation 
to gene 
Chr Starta Enda Nr. 
probes 
Mean 
p-value 
Changeb 
SERPINB6 TSS200 6 2,972,097 2,972,195 6 3.6E-05 3.8% 
RNF39 3'UTR 
Body 
6 30,038,791 30,039,600 36 1.3E-04 14.5% 
ZNF300 5'UTR 
1stExon 
TSS200 
TSS1500 
5 150,284,302 150,284,60
0 
8 4.0E-04 5.9% 
MPZL2 1stExon 
5'UTR 
TSS200 
11 118,134,959 118,135,203 5 2.0E-03 3.5% 
MIR596 TSS1500 
TSS200 
Body 
8 1,765,066 1,765,477 11 2.1E-03 4.2% 
- - 6 106,441,441 106,441,618 5 2.3E-03 5.8% 
HAS3 5'UTR 
TSS200 
1stExon 
16 69,141,250 69,141,478 7 2.3E-03 3.7% 
HLA-DQB1 Body 6 32,632,848 32,633,163 10 3.2E-03 12.1% 
HCG9 Body 6 29,943,209 29,943,480 9 4.3E-03 4.8% 
BRCA1 
NBR2 
TSS1500 
Body 
17 41,277,847 41,278,622 20 4.9E-03 10.8% 
ZNF85 TSS200 
5'UTR 
1stExon 
19 21,106,002 21,106,120 7 5.3E-03 4.4% 
HOXA5 5'UTR 
1stExon 
TSS200 
TSS1500 
7 27,183,262 27,184,821 44 5.7E-03 9.3% 
NET1 TSS1500 
Body 
TSS200 
5'UTR 
1stExon 
10 5,488,225 5,488,628 8 7.2E-03 5.1% 
CLDN9 TSS200 
1stExon 
5'UTR 
16 3,062,349 3,062,795 7 7.6E-03 8.8% 
C10orf26 TSS200 
Body 
5'UTR 
1stExon 
10 104,535,792 104,536,052 8 7.9E-03 4.5% 
SUOX TSS1500 
TSS200 
5'UTR 
1stExon 
12 56,390,798 56,391,077 10 8.9E-03 4.6% 
TFCP2 TSS200 
TSS1500 
12 51,566,731 51,566,990 8 9.0E-03 -7.0% 
LY6G5C TSS1500 6 31,648,544 31,648,767 11 9.0E-03 1.9% 
HCG9 Body 6 29,944,917 29,945,155 12 9.7E-03 3.2% 
- - 6 29,818,154 29,818,300 5 1.1E-02 6.7% 
DHRS4L2 TSS200 
5'UTR 
1stExon 
14 24,457,893 24,458,208 7 1.2E-02 6.8% 
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3’UTR, three prime untranslated region; 5’UTR, five prime untranslated region; Chr, chromosome; 
TSS200, 200 base pairs from the transcription start site; TSS1500, 1500 base pairs from the transcription 
start site 
a Position of start and end of the DMR according to Hg19 annotation 
b The maximum DNA methylation change within the DMR 
 
C5orf35 TSS1500 
TSS200 
5 56,204,834 56,204,925 5 1.3E-02 4.7% 
RHOBTB1 Body 
TSS200 
TSS1500 
10 62,704,143 62,704,289 6 1.3E-02 1.6% 
CYP1A1 TSS1500 15 75,019,070 75,019,376 10 1.3E-02 6.0% 
C10orf53 TSS1500 
TSS200 
10 50,887,472 50,887,578 5 1.4E-02 4.1% 
EDNRB 5'UTR 
TSS200 
TSS1500 
13 78,493,100 78,493,365 16 1.5E-02 2.5% 
HORMAD2 TSS1500 
TSS200 
22 30,476,206 30,476,345 7 1.6E-02 5.1% 
ZNF880 TSS200 
5'UTR 
1stExon 
19 52,873,019 52,873,173 6 1.7E-02 1.6% 
POT1 TSS200 7 124,570,047 124,570,181 6 2.1E-02 1.1% 
SFRP2 TSS1500 4 154,711,563 154,711,675 5 2.5E-02 4.2% 
MIR7-3 
C19orf30 
TSS1500 
Body 
19 4,769,592 4,769,690 6 2.6E-02 3.3% 
TRPC6 5'UTR 
1stExon 
TSS200 
11 101,454,626 101,454,733 5 2.8E-02 4.3% 
ZNF416 1stExon 
5'UTR 
TSS200 
19 58,090,229 58,090,357 5 3.2E-02 0.6% 
PRRT1 3'UTR 
Body 
6 32,116,918 32,117,049 6 3.4E-02 4.1% 
C22orf45 
UPB1 
TSS200 
TSS1500 
22 24,890,794 24,890,833 6 3.8E-02 4.1% 
TSTD1 5'UTR 
1stExon 
TSS200 
1 161,008,705 161,008,826 5 4.0E-02 -2.0% 
SLC6A11 TSS1500 
TSS200 
3 10,857,688 10,857,719 5 4.0E-02 3.9% 
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General discussion 
This thesis studied the hypothesis that DNA methylation might be an underlying mode 
of action by which persistent organic pollutants (POPs) exert some of their delayed or 
long-lasting adverse health effects. The thesis consists of 2 parts: 1) in vitro studies with 
eight abundant seafood POPs to identify gene expression and DNA methylation changes 
related to functional endpoints and 2) a human observational study in men to 
investigate whether consumption of eel from polluted areas lead to higher POP levels 
than considered safe and whether these POP levels were associated with aberrant DNA 
methylation. 
A short overview of the results from this thesis is presented in Table 1. The in vitro studies 
(part 1) were performed using H295R cells for steroidogenesis-related effects and with 
SGBS cells and hMSCs for determining effects on adipocyte differentiation. We detected 
only minor effects for TCDD and the dioxin-like PCB126 on steroidogenesis, but TCDD 
was a strong inhibitor of adipocyte differentiation. The non-dioxin-like PCB153 
decreased steroid hormone levels, but did not affect adipocyte differentiation. PFOS had 
the strongest impact on steroidogenesis, and affected 9 out of 13 measured hormone 
levels. PFOS also inhibited lipid accumulation in differentiating adipocytes, although 
not as strong as TCDD. Both flame retardants as well as MeHg did not affect 
steroidogenesis or adipocyte differentiation, but HBCD was the only compound to 
induce osteoblast differentiation. TBT, on the other hand, had minor effects on 
steroidogenesis and strong effects on adipocyte and osteoblast differentiation. In 
chapter 2, two POP mixtures were investigated in addition to the single compounds 
tested, and revealed the occurrence of additive effects, expected to be relevant to 
humans. Besides the functional endpoints, chapter 2 showed that all increased hormone 
levels were accompanied by increased gene expression levels, while decreased hormone 
levels did not coincide with decreased gene expression. Gene expression profiles in 
chapter 3B supported the effects on functional endpoints for TCDD and TBT. Pro-
adipogenesis genes were down-regulated after TCDD exposure and up-regulated after 
TBT exposure, and anti-adipogenesis genes were up-regulated after TCDD exposure. 
Although differentiation in embryonic stem cells is frequently attributed to DNA 
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methylation changes,1 the differentiation of hMSCs to adipocytes was only associated 
with minor changes in DNA methylation (Chapter 3A). Even though DNA methylation 
was not severely altered during adipocyte differentiation, POP exposure was associated 
with DNA methylation changes (Chapter 3B). These changes in DNA methylation could, 
however, not be linked to gene expression changes. 
The human study (part 2) showed that consumers of eel from high-polluted areas had 
2.5 times higher levels of dioxin and dioxin-like compounds than consumers of eel from 
low-polluted areas or aquaculture, confirming predictions of a risk assessment 
performed in 2007 (Chapter 4).2 PCB levels were up to ten times higher in eel consumers 
from high-polluted areas and were among the highest measured world-wide, and also 
PFAS levels were increased. DNA methylation in leukocytes was therefore investigated 
in relation to these three POP groups (dioxin and dioxin-like compounds, sum of seven 
indicator PCBs, and PFOS levels) in chapter 5. Serum POP levels were associated with 
DNA methylation of genes related to cancer, the immune system, early development 
and neurological disorders. The aberrant DNA methylation in leukocytes with elevated 
blood dioxin levels were different from the DNA methylation effects in TCDD exposed 
adipocytes. For PFOS, differentially methylated regions (DMRs) were detected in a gene 
within the major histocompatibility complex class I region (RNF39) and one gene with 
an unknown function (C10orf26) in both adipocytes and leukocytes (chapters 3B and 5). 
In our human study, hormone levels and liver enzymes were not associated with any of 
the POP levels. 
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Table 1. Summary of the results from the different chapters. 
Compound Chapter 2a 
Steroidogenesis 
Chapter 3a 
Adipocyte 
differentiation 
Chapter 4c 
Fold elevated  
in poll. eel 
consumers 
Chapter 5 
Aberrant DNA 
methylation in 
eel consumers 
TCDD ↑ Progesterone ↓ Adipocyte diff 
↓ Osteoblast diff 
Expr: 8 genes 
DMRs: 4 adipogenic 
genes 
↑2.8x 13 DMRse 
↔ Clinical 
parameters 
PCB126 ↑ Estradiol -  ↑3.4x - 
PCB153 ↓OH-Progesterone, 
androstenedione, 
testosterone, 
deoxycortisol 
↔ ↑6.3x 8 DMRsf 
↔ Clinical 
parameters 
PFOS ↓ (OH-)pregnenolone, 
deoxycorticosterone 
↑ androstenedione, 
testosterone, estradiol, 
corticosterone, (deoxy-) 
cortisol 
↓ Adipocyte diff 
↔ Osteoblast diff 
Expr: 2 genes 
DMRs: 2 adipogenic 
genes 
↑2.4x 37 DMRs 
↔ Clinical 
parameters 
BDE-47 ↔ ↔ ↔ - DMRs 
↔ Clinical 
parameters 
HBCD ↔ ↔ Adipocyte diff 
↑ Osteoblast diff 
-d - 
TBT ↓ Pregnenolone, (OH-) 
progesterone 
↑ Adipocyte diff 
↓ Osteoblast diff 
Expr: 4 genes 
DMRs: 3 adipogenic 
genes 
- - 
MeHg ↔ ↔ - - 
↔ No significant effect; – Not measured; Expr = Significantly differential gene expression in 
adipogenic gene; DMR = differentially methylated region; diff = differentiation 
a Measured in human H295R Adrenocortical Carcinoma Cells 
b Measured in SGBS (Simpson-Golabi-Behmel syndrome) cells and hMSCs (human mesenchymal 
stem cells) 
c Men consuming eel from high-polluted areas were compared to men consuming eel from low-
polluted areas or aquaculture. 
d In the majority of the samples HBCD levels were below the detection limit 
e Based on sum of dioxins and dioxin-like compounds 
f Based on the sum of seven indicator PCBs 
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Accumulation of POPs in frequent eel consumers and potential 
health effects 
The serum levels of dioxins and dioxin-like compounds in men who consumed eel from 
high-polluted areas were 2.5 times higher than in men consuming eel from low-polluted 
areas or aquaculture, which confirmed the predictions made in the risk assessment that 
was relevant for the implementation of the ban in 2011.2 The consequence of the 
accumulation of these compounds is that levels in these men are above the levels 
regarded as safe, derived from animal reproduction and developmental studies. It can 
be speculated that the actual safe level for adults may be higher, however, endometriosis 
was found in adult rhesus monkeys at levels just above the level considered safe.3 Safe 
levels are not specifically quantified for adults, and it is difficult to predict at which levels 
adult men are susceptible to adverse health effects. 
Also PFAS levels were higher in the high-exposed men and well above background levels 
in the general population,4 however it is not known whether these levels could cause 
adverse health effects.5 Based on the in vitro experiments we performed, adverse health 
effects would be expected at much higher levels than we detected in these men. The 
most pronounced in vitro effects regarding steroidogenesis were detected after PFOS 
exposure (200 µM ≈ 100 µg/mL) such as up-regulation of testosterone. The maximum 
levels of PFOS detected in the human study were much lower (260 ng/mL), and no 
significant association with testosterone was detected. The experiments with the H295R 
cells show a possible mechanism of action by which PFOS may exert adverse health 
effects, e.g. by stimulating hormone production by inducing CYP enzymes.  
Two POPs that were studied in the in vitro experiments could not yet be measured in 
the human study within the available time. TBT levels still are of interest, because 
potential adverse effects were detected after exposing cells to concentrations that could 
be reached in humans. For MeHg no effects were detected during the in vitro testing. 
Although MeHg is the most abundant metal in seafood, levels in eel were decreased 
during the last decade and are well-below the established consumption levels.6 
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The most striking results in the human study were the, up to ten times, higher PCB levels 
(and subsequently the hydroxylated (OH)-PCBs) in the eel consumers from the high-
polluted areas. We showed that it is highly likely that eel is the source of the increased 
POP levels due to the profiles of the PCBs in combination with TEQ levels. Interestingly, 
levels of PCBs and their OH-metabolites were higher in Dutch men from our study 
consuming eel from high-polluted areas than in men consuming marine mammals, and 
were among the highest levels measured world-wide.7 OH-PCBs have been associated 
with several adverse health effects in animal studies, especially during early 
development.7 POP levels in women are comparable8 or only slightly different9 than 
POP levels in men, and it is therefore a reasonable assumption that women with a similar 
frequency of eel consumption have POP levels within the same range as these men. 
Approximately 50% of the OH-PCBs in maternal plasma are transferred across the 
placenta to the fetus.10 These levels are quite high and fall within the range were adverse 
health effects are to be expected based on animal studies.7 Thyroid disturbance in 
animals is expected to be mainly due to the binding of the OH-PCBs to transthyretin 
(TTR), facilitating active transport throughout the whole body, and subsequently 
exerting a broad range of adverse health effects.11 OH-BDEs were not significantly 
elevated due to consumption of eel from high-polluted areas in our study, while they 
may have a higher potency than OH-PCBs for thyroxine-binding globulin (TBG) 
binding, the main thyroid hormone transporter in humans.12 Effects of hydroxylated 
metabolites on the thyroid hormone regulation have been observed in infants13 as well 
as in adults.14,15  
We did not observe a marked correlation between POP levels and thyroid hormone 
levels in the adult men in our human study. The sample size of the human study was 
based on expected variation and differences in serum POP levels between eel consumers 
from low- and high-polluted areas. Based on the number of participants included, the 
minimal detectable effect regarding the clinical parameters can be calculated. Including 
80 participants, a correlation coefficient of 0.31 can be detected for the association 
between clinical parameters and POP levels, and for the sub-group of 38 participants for 
which extensive POP measurements were performed, a correlation coefficient of 0.44 
can be detected. A correlation coefficient below 0.3 (=r2 of 0.09, indicating that 9% of 
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the variance in the relationship can be accounted for by these variables) may be 
considered to be not biologically relevant, while a correlation coefficient between 0.3 
and 0.5 (=r2 of 0.25) indicates a moderate effect. We can therefore conclude that the 
high POP levels do not have strong effects on thyroid hormone levels, however, due to 
the sample size, small and moderate effects cannot be excluded. The biological 
endpoints, however, are under homeostatic control and moderate effects might still be 
relevant due to the broad range of adverse health effects that could be related to a 
disturbed homeostasis. However, due to feed-back mechanisms regulating homeostasis 
no health effects have to occur in exposed men. Also for in utero exposed children, 
affected thyroid hormones were described to be transient,16 in contrast with 
neurodevelopmental problems,17 indicating adaptation is possible. 
In addition to the thyroid hormone related biomarkers, other clinical parameters were 
measured. In previous epidemiological studies, PFOS and dioxins were shown to 
negatively affect testosterone levels,18,19 liver enzymes,20,21 Ht, and Hb levels.22,23 
Previous studies, however, were inconsistent, and effects were relatively small. We 
conclude that in this study POP levels, including high PCB levels, did not cause strong 
effects in adult men on the clinical parameters studied. 
Clinical health-related parameters assessed in this thesis may be influenced by many 
factors. Blood may not reflect effects in tissues of interest as POP-related health effects 
can be exerted in different organs. Three of the tested POPs affected in vitro adipocyte 
differentiation, but this was not an endpoint in the human study. We did not study other 
functional endpoints upon differentiation such as adipokines. For PCB77 it was shown 
in 3T3-L1 cells that differentiation was induced as well as various proinflammatory 
cytokines, which might explain metabolic disorders in humans.24 These cytokines can 
be measured in human blood, although small effects are likely obscured by the high 
variability. Other human studies have associated POPs to obesity and the metabolic 
syndrome,25-27 but glucose levels in our study were not affected. However, a glucose 
tolerance test or a full metabolomics approach would provide more insight. 
Furthermore, clinical parameters to predict e.g. future cancer do not exist. Chronic 
exposure to dioxins has been shown to increase several types of cancer,28 and the 
elevated levels in our consumers of eel from high-polluted areas might cause an increase 
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in cancer incidence.29 Therefore, adverse health effects due to the elevated POP levels 
cannot be excluded based on our results. 
 
Aberrant DNA methylation 
The human study as well as the in vitro differentiation experiment showed an association 
between POP levels and aberrant DNA methylation. To investigate DNA methylation 
we used the Infinium 450K BeadChip, which is a commonly applied method for genome-
wide DNA methylation analysis, because it is informative, not very expensive, and there 
are well-developed statistical pipelines ensuring standardized analysis. This method 
correlates well with whole-genome bisulfite sequencing30 and is cross-validated against 
conventional quantitative pyrosequencing.31 A limitation of the 450K BeadChip is the 
low (1-2%) coverage of the total CpG sites, although 99% of the known genes are 
included. The CpGs present on the BeadChip are biased towards regions with high CpG 
content, where inter-individual and inter-tissue variation is expected to be low 
compared to CpG-poor areas, which are underrepresented in the 450K BeadChip.32 
Relatively many DNA methylation changes were detected in intergenic regions upon 
adipocyte differentiation. Intergenic regions (IGRs) are relevant with regard to cell-type 
discriminatory patterns33 and about half of the enhancers are present in IGRs.34 
Enhancers can show differential methylation near genes with tissue-specific expression35 
and underrepresentation of the enhancer areas might have attributed to the fact that we 
only detected minor DNA methylation changes during adipocyte differentiation in vitro. 
However, a previous study which used a more elaborate DNA methylation analysis also 
did not detect pronounced effects on DNA methylation in differentiating adipocytes and 
no concomitant gene expression changes.36 Furthermore, DNA methylation might be 
more dynamic than expected.37 To test this, future research should include more time 
points during adipocyte differentiation. 
DNA methylation analysis in our adipocyte study was performed in a heterogeneous cell 
population including, besides the differentiated adipocytes, also undifferentiated 
hMSCs, and possibly spontaneous differentiated osteoblasts. Isolation of differentiated 
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adipocytes by e.g. fluorescence activated cell sorting (FACS) would provide a 
homogenous cell population, ensuring aberrant DNA methylation is not the 
consequence of cell-specific DNA methylation patterns. Cell sorting would most likely 
not affect DNA methylation, however, this procedure may induce stress and affect gene 
expression.38-40 Genes that were differentially methylated after POP exposure, were, 
however, not differentially methylated during differentiation and therefore the different 
cell composition has likely not affected the results. In the human study, DNA 
methylation was measured in leukocytes. We measured the leukocyte composition in 
each participant to statistically adjust for different cell compositions. 
In vitro DNA methylation versus methylation in the human study 
Most genes that were found to be differentially methylated upon POP-exposure during 
in vitro adipocyte differentiation, were not differentially methylated in the human study. 
This is not necessarily surprising as DNA methylation is tissue-specific (even though 
both cell types originate from the mesoderm), and DNA methylation changes can occur 
in one tissue but not in another.41,42 There were two genes for which DMRs were 
associated with PFOS levels in both studies. The function of one gene is yet unknown, 
the other gene, RNF39, had a DMR containing 36 positions and was hypermethylated in 
the human study. The DMR within RNF39 in vitro contained 5 probes and was 
hypomethylated upon PFOS exposure. Methylation status of this gene has been related 
to immune responses,43 which is a relevant outcome for leukocytes, and will be 
explained in more detail below.  
In vitro POP-exposure  mainly resulted in hypomethylation, while higher POP-levels in 
our human study were mainly related to hypermethylation. This may be explained by 
the differences in the location of the aberrant DNA methylation. In vitro exposure had 
the most significant effects in CpGs located in the open sea and were either related to 
the gene body or detected within IGRs, while most significant effects in the human study 
were detected in CGIs and were annotated close to the TSS or 5’UTR. DNA methylation 
in CGIs is in general less abundant compared to methylation in the open sea. Overall, 
hypermethylation is more likely to occur in CGIs, where hypomethylation mainly occurs 
in the gene body and open sea.44 
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The majority of the men in our study were either professional or recreational fishermen 
who started fishing at a young age. It is possible that they already consumed the highly 
contaminated eel since their childhood and possibly their parents too. Therefore 
prenatal exposure in these men might be expected, and we cannot exclude that aberrant 
DNA methylation already was established during sensitive early stages and continued 
during their adult life. 
Implications of altered DNA methylation for health 
Most of the detected differentially methylated regions (DMRs) were not related to the 
clinical parameters measured. We detected a DMR in the promoter of DHRS4L2, 
relevant for retinol homeostasis, and it has been previously shown that this gene is 
transcriptionally controlled by DNA methylation.45 We did not find differences in 
retinol levels between the low- and high-exposed men. Interestingly, all men had 
generally high retinol levels, probably due to the frequent eel consumption. Also liver 
enzymes were not altered due to the higher POP levels, but CYP1A1 was differentially 
methylated. CYP1A1 belongs to the phase I xenobiotic metabolizing enzymes which play 
important roles in detoxification as well as biosynthesis of endogenous steroid 
hormones.46 CYP1A1 is especially important for metabolizing the aromatic lipophilic 
compounds, such as dioxins and dioxin-like compounds. These compounds have a 
strong affinity for the AH receptor and are therefore potent inducers of CYP1A1 enzymes. 
Some of the PCBs, however, may become more harmful after being hydroxylated during 
this phase I metabolism (that also includes other CYP enzymes), until they are detoxified 
by phase II enzymes. Increased DNA methylation in CYP1A1 might alter expression47 and 
subsequently affect the half-lives of some pollutants and alter the amount of metabolites 
produced. 
The most striking differences in DNA methylation between the low- and high-exposed 
men were observed in genes related to cancer, the immune system, and neurological and 
developmental regulation. These are adverse health effects that can be expected upon 
POP-exposure,48 but we did not measure clinical parameters related to these health 
outcomes. We observed promoter hypermethylation of BRCA1 in men with high POP 
levels, which is associated with tumor progression.49 It was shown that BRCA1 
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hypermethylation in leukocytes is associated with breast cancer related molecular 
changes.50 Also HOXA5 was hypermethylated, which is related to loss of expression of 
the tumor suppressor gene p53 and to breast cancer.51 Although men do not often 
develop breast cancer, similar results can be expected in women. Our results suggest 
POPs could be involved in breast cancer development due to aberrant DNA 
methylation.52 Aberrant methylation in these and other genes related to cancer 
development could be one of the mechanisms by which POPs cause cancer since they 
are not genotoxic28 and could partly explain the increased cancer risk as calculated by 
the EPA.29 Since DNA methylation was measured in leukocytes, and not the relevant 
tissue for many cancers, this finding only has biological meaning when other tissues 
show the same aberrant DNA methylation. Leukocytes are the relevant tissue for the 
immune response and differential methylation in leukocytes has been related to 
antibody response.53 Dioxins and PCBs have also been related to immune suppression,54-
56 and we detected multiple genes with aberrant DNA methylation related to the 
immune system. Both RNF3943, with an especially distinct profile between the low- and 
high-exposed men, and HLA-DQB157 were detected amongst other genes, and the 
methylation status of these genes might be involved in immune responses. Whether 
these changes in DNA methylation cause health effects in these men could be tested by 
measuring the immune response, such as antibody levels, after a vaccination.  
Association between DNA methylation, other epigenetic marks, and gene expression 
The trending field of epigenetic research has exploded in the last years, with to date 
15,567 publications filed in the Medline database with the keyword ‘epigenetics’, of 
which 11,228 are new publications since the start of this PhD thesis project. The amount 
of research that is currently performed regarding epigenetics brings an enormous 
advancement in understanding the role of epigenetics and its biological meaning. The 
main focus in this thesis was DNA methylation, however, other epigenetic marks include 
histone modifications and non-coding RNAs (ncRNAs) and might also affect gene 
regulation.58,59 
The relationship between DNA methylation and gene expression is highly complex, 
depending on many factors such as the CpG content and the region within the genome. 
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Promoter methylation in the CGI and gene expression is extensively-studied, where 
increased methylation decreases gene expression, although decreased methylation does 
not induce expression.60 This is the case for the approximately 70% of the promoter 
regions that contain CGIs, while high methylation in CpG-poor promoters does not 
inhibit expression. Gene body methylation,  on the other hand, might still regulate 
expression in these genes. It has recently been suggested that gene body methylation 
might be more predictive towards gene regulation than promoter methylation.61 In 
general, Lou et al. found that DNA methylation was well-correlated to gene expression 
when methylation levels are high (indicating very low expression levels) or when gene 
expression levels are extremely high (indicating very low methylation levels). However, 
the majority of the genes have both low methylation and low expression. Lacking clear 
signatures from DNA methylation alone, genes with medium expression are difficult to 
classify. 
The relationship between DNA methylation and gene expression is also dependent on 
histone modifications and ncRNAs. There is a complex interplay between DNA 
methylation and histone modifications. Genome-wide DNA methylation profiles 
suggest that DNA methylation is well-correlated with histone methylation patterns, and 
that the establishment of new DNA methylation is, in part, regulated by histone 
methylation.58,62 Some histone methylation marks may protect from active 
demethylation, while other marks prevent the binding of DNA methyltransferases, 
thereby blocking DNA methylation.58 
Certain histone modifications are reasonable predictors of gene expression by 
themselves, and can better predict which genes have medium expression levels than 
DNA methylation can predict this. However, the combination of both DNA methylation 
and histone modifications increases the accuracy of predicting gene expression.61 This 
suggests that understanding aberrant DNA methylation in genes is relevant to predict 
gene expression and possibly health related effects, however, elucidating the 
combination of DNA methylation and histone modifications could lead to better 
predictive models. Strong indications have been published that histone modifications 
might be affected by POP levels, even without affecting DNA methylation,63-65 
supporting the notion that follow-up research should include both epigenetic marks.  
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Also non-coding (nc) RNAs can regulate chromatin structure and can mediate the 
recruitment of histone and DNA methyltransferases.66 The exact mechanisms by which 
ncRNAs interact with other epigenetic marks is, however, not fully understood. ncRNAs 
provide a fast way of altering gene expression67, and the implications for long-term 
adverse health effects are not yet known. At this point, the best method to predict gene 
expression is probably by applying a combined analysis of histone modification and DNA 
methylation, without including ncRNAs. Methylation, on the other hand, can also 
influence the expression of ncRNAs and this might be one of the possible ways in which 
differential methylation might exert health effects.68 This shows once more the complex 
interplay between the different epigenetic marks which are all associated with each 
other. Expression of multiple ncRNAs were shown to be induced in Chinese chemical 
workers exposed to elevated levels of PFAS,69 and ncRNAs were also affected by different 
POPs in animal studies.70-73 POPs are therefore expected to be not only associated with 
DNA methylation, but also with other epigenetic marks. 
With this in mind, the question remains whether DNA methylation is merely a 
biomarker of exposure, an adaptation to this exposure (non-adverse, or even potentially 
beneficial), or an actual adverse health effect (either direct or indirect). Direct effect of 
POPs on DNA methylation could include affecting DNMT activity, which is suggested 
to be under hormonal control,74 or altering SAM availability. Some of these POPs can 
bind to steroid receptors and subsequently also affect histone enzymes (e.g. Jarid1b) 
which in their turn can affect histone marks.75 Indirectly these histone modifications 
could affect DNA methylation. In summary, POPs may alter the epigenetic state by 
regulating the activity of various transcription factors, subsequently changing 
expression or activity of DNA or histone methyltransferases. 
 
Overall conclusion 
The aim of this thesis was to elucidate whether seafood-related POPs can induce 
aberrant DNA methylation in high-exposed eel consumers, potentially causing adverse 
health effects. With the use of in vitro models it was shown that TCDD and TBT affected 
both steroidogenesis and adipocyte differentiation at environmentally relevant 
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concentrations. Although PFOS exerted even more pronounced effects, the in vitro 
concentrations needed to induce these effects were approximately 400 times higher 
than found in blood. This thesis does, however, show possible modes of action of PFOS 
that were not shown before. For these three POPs we also detected a few DNA 
methylation changes in differentiating adipocytes, but this could not be related to 
differential gene expression in the adipocytes. 
In the human study we revealed that consumption of eel from the polluted areas indeed 
caused high internal levels of certain POPs: especially dioxins, PCB and PFAS levels were 
elevated. We detected differential methylation in a number of genes, with strong 
differences and large DNA regions in multiple genes related to cancer and the immune 
system. We measured general clinical parameters that were not specifically related to 
these endpoints, including e.g. hormone levels and liver enzymes. These parameters 
were not affected. In short, POP levels are seriously elevated in men consuming polluted 
eel and POPs are associated with aberrant DNA methylation. Further clarifications are 
needed to determine the possible role of DNA methylation in health implications. 
 
Implications for public health 
Implications for consumers 
The frequent consumption of eel from the high-polluted areas, where currently a ban is 
implemented, causes high accumulation of certain POPs. Although we did not find 
effects on the clinical parameters measured, adverse health effects cannot be excluded 
based on the current literature as safe levels were exceeded. The safe level is set to 
protect unborn and developing children. Therefore, especially girls and women of 
childbearing age should not consume high-polluted eel. The safe level for adults is not 
exactly known, for example for tumor promoting effects. Exceedance of the safe level 
does not mean that adverse health effects attributed to the higher POP levels will be 
encountered. It does, however, mean that an increased risk of developing certain health 
effects cannot be excluded. We showed that higher POP levels were associated with 
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aberrant DNA methylation patterns. The biological meaning of DNA methylation at this 
point is unknown, however, it could be related to cancer and immune disorders. 
There is no action to take for people who consumed this eel in the past. POP levels are 
excreted slowly from the body (half-life of 4 to 15 years), and besides limiting new 
exposures, the process of elimination cannot be accelerated. The consumption of food 
products, including eel, from regulated markers (e.g. supermarket, and not from own 
catch) will generally have low POP levels due to strict regulations and controls. When 
consuming products low in POPs, this gives the body a chance to excrete more POPs 
than are newly accumulated, eventually lowering the POP levels in the body. 
Implications for policy makers 
The internal POP levels measured in frequent eel consumers were clearly elevated for 
dioxins and dioxin-like compounds, (OH-)PCBs, and PFASs. Up to now, the focus of risk 
assessors was mainly on dioxins and dioxin-like compounds. Our study was the first to 
actual measure POP levels in frequent consumers of high-polluted eel, and we could 
validate the predictions made in an earlier performed risk assessment.2 This confirms 
that the ban on eel fishing was implemented on correct assumptions. As long as the 
levels in eel are above the European legal limit, a ban on consumption of this eel is 
advisable. 
We established that men consuming eel just below the European levels, mainly from 
Lake IJssel, had a body burden of dioxins and dioxin-like compounds just above the safe 
level. The European  Commission (EC) established maximum levels of 6.5 pg TEQ/g ww 
for fish, whereas wild eel has to comply to 10 pg TEQ/g ww.76 Meat and dairy products 
have to comply to lower limits than set for fish, because of more frequent consumption 
in the general population. For most Dutch consumers the main contribution to dioxins 
and dioxin-like compounds comes from dairy products,77 while for Belgium consumers 
fish is the main source.78 The levels set by the EC protect the majority of the Dutch 
population. Frequent fish and/or eel consumers, however, could still accumulate POP 
levels above the accepted safe level, when the fish or eel consumed have levels just below 
the EC limit. The low-exposed men from our study had levels just above the safe level, 
with the consumption of at least one portion eel per month. It is not ideal to 
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communicate a maximum fish consumption to prevent people from exceeding the safe 
level, since weekly consumption of fatty fish has also many beneficial health effects, and 
this might give the impression that products on the market are not actual safe. Ideally, 
legal levels of pollutants in eel should be lowered to levels found in other fish (6.5 pg 
TEQ/g ww) to protect frequent consumers from accumulating high levels of POPs. 
The EC legal limit for the sum of the six indicator PCBs (excluding PCB118) is set at 75 
ng/g ww in wild eel. Adverse health effects of PCBs can especially be expected from their 
OH-metabolites. This is relevant because the main pollutants present in eel are PCBs 
and not dioxins. OH-PCBs are formed in the consumers, not in the eel, and therefore 
the legal limit should indeed be set for PCB levels. Policy makers and scientists should 
take the formation and toxicity of OH-PCBs into account for future risk assessments, to 
ensure that set levels indeed guarantee consumer safety. 
In the Netherlands, a ban on eel fishing in the high-polluted areas is implemented and 
eel from these areas do not reach the market since 2011. Indications exist that 
recreational fishermen are still catching highly-polluted eel for consumption, and we 
recommend additional measures to prevent consumption of these eels. Belgium and 
Germany do not have such a ban, while POP levels in eel are similar, but it is highly 
advisable to make anglers aware of the possible risks associated with frequent 
consumption of polluted eel.79,80 The information obtained in this study is also 
applicable for other high-polluted areas, such as the Baltic Sea and the Great Lakes, 
where fish is equally or even higher polluted. 
The policy measures to decrease POP levels in the environment seem to be effective, as 
multiple POP levels in the environment, in food, and in humans are decreasing.81 It will, 
however, still take years before POP levels in the Dutch river sediments are low enough 
to ensure safe fish again. Sanitation of rivers is a possibility to manually remove POP 
levels, although this is not cheap and might temporarily disturb ecosystems. 
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Future perspectives 
The main findings of this study are the accumulation of POPs due to eel consumption 
and the association between POP levels and aberrant DNA methylation. In the in vitro 
studies, DNA methylation and gene expression could not be related, but gene expression 
was not measured in the human study. As most DNA methylation differences were 
detected in CGIs, of which many are close to the TSS, gene expression analysis in the eel 
consumers could provide additional insight into a possible association between DNA 
methylation, gene expression and possibly health effects. Now that we revealed that 
POPs are associated with gene-specific DNA methylation, it would be highly informative 
to measure histone modifications as well as other DNA marks. The bisulfite conversion 
used in this thesis does not distinguish between methylation and hydroxymethylation, 
while the two have different functionalities.82 Additional measurements of histone 
modification and DNA hydroxy-methylation could first of all be done for the genes that 
were differentially methylated, before a more expensive and elaborate genome-wide 
analysis is performed. There is a need for a model that can predict gene expression based 
on DNA methylation profiles and histone modifications. The NIH Roadmap 
Epigenomics Program is a good example of an effort to provide an epigenome map, by 
combining human reference epigenomes from many different tissues.35 With the help of 
a comprehensive overview, epigenetic marks might become predictive for gene 
regulation. 
The next step is elucidating the potential health effects related to these epigenetic 
marks. First, the knowledge to translate epigenetic marks measured in blood to other 
relevant tissues should be obtained. The epigenome map, including over 100 different 
human tissues and cell-types, might be a good step forward to interpret DNA 
methylation in blood with regard to health effects related to other tissues. Subsequently, 
an association between epigenetic marks and health effects can be established by 
measuring health outcomes related to these marks. In our human study this could be 
done by measuring the immune response in these men. Current biomarkers related to 
cancer are not conclusive, and our sample size is far too small to perform a follow-up 
study to determine how many participants eventually develop cancer. An option would 
Chapter 6 
 
  
180 
 
be to use existing cohort studies with established biobanks and follow people over time, 
measuring a whole-range of possible adverse health outcomes. As POPs remain very 
stable, POP levels could be measured in stored blood from these biobanks. However, to 
measure a broad range of POPs, a relatively large amount of blood is needed. It is 
therefore important to use very sensitive techniques and to establish the most relevant 
POPs to use the available material sparingly. 
The use of a prospective cohort study can also help to eliminate the question whether 
DNA methylation is a cause or consequence of the adverse health effects, however, this 
may still be difficult when DNA methylation is an adaptive protective mechanism and 
the disease still occurs. To determine a causal relationship, in vitro experiments or 
animal studies can be performed. When gene-specific DNA methylation can be 
artificially altered, the consequences can become clear. 
Our human study focussed on men between 40 and 70 years old, which is a relatively 
homogenous group and not representative for the whole population. Results might be 
different in women due to differences in hormonal responses. Research with pregnant 
women and later their children might provide more information about the safe level in 
humans for the unborn and developing child. This is, however, also more challenging 
because lactation is a known factor to lower POP levels in these women, and therefore 
the number of pregnancies influences the outcome.83 Detailed epigenomics in 
combination with metabolomics to determine a broad range of potential adverse health 
effects could be used to test whether sex-specific effects can be expected and to translate 
the data from this study to other populations. 
Before epigenetic marks can be included in standard risk assessments, more information 
about the biological relevance is needed. At this point epigenetic marks raise more 
questions, than they give clear answers. It should become clear that there is a causal, 
and preferably a dose-response, relationship between epigenetic marks and a certain 
health outcome, or the epigenetic marks should lead to increased susceptibility of 
disease in certain populations. Epigenetic marks in risk assessment are most important 
for compounds who do not show immediate toxicity, but can exert health effects after 
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long-term exposure, and should therefore be able to predict adverse health effects before 
they arise. 
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Summary 
Wild caught fish, especially marine fish, can contain high levels of persistent organic 
pollutants (POPs). In the Netherlands, especially eel from the main rivers have high POP 
levels. This led to a ban in 2011 on eel fishing due to health concerns. Many of the marine 
POPs have been related to adverse health effects such as endocrine disruption, 
neurodevelopmental problems, immune suppression and cancer. Although some 
mechanisms of action of POPs are clear, like dioxins binding to the aryl hydrocarbon 
receptor and OH-PCBs binding to thyroid transport proteins, not all adverse health 
effects can be explained by these mechanisms of action. Epigenetic phenomena, such as 
DNA methylation, have been proposed as a possible molecular mechanism underlying 
adverse health effects. DNA methylation is a heritable modification, which refers to the 
addition of a methyl group to cytosine in a CpG dinucleotide. Observational studies have 
indeed shown that POPs can affect global DNA methylation, although results are 
inconsistent. Some animal studies as well as in vitro experiments suggest that POPs can 
affect gene-specific DNA methylation, however, the biological significance and 
relevance for humans is not clear. Therefore, this thesis aimed to 1) study the 
accumulation of POPs in men consuming eel from high-polluted areas 2) elucidate 
whether seafood-related POPs can induce aberrant DNA methylation and 3) to 
determine whether DNA methylation is related to functional endpoints and gene 
expression in vitro. 
For this purpose eight POPs that are abundantly present in seafood were chosen, namely 
2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), polychlorobiphenyl (PCB) 126 and 153, 
perfluorooctanesulfonic acid (PFOS), hexabromocyclododecane (HBCD), 2,2′,4,4′-
tetrabromodiphenyl ether (BDE-47), tributyltin (TBT), and methylmercury (MeHg). 
Chapter 2 describes the in vitro effects of these POPs and mixtures thereof in H295R 
adrenocortical carcinoma cells. Relative responses for 13 steroid hormones and 7 genes 
involved in the steroidogenic pathway, and CYP1A1, were analysed. PFOS induced the 
most pronounced effects on steroid hormone levels by significantly affecting 9 out of 13 
hormone levels measured, with the largest increases found for 17β-estradiol, 
corticosterone, and cortisol. Furthermore, TCDD, both PCBs, and TBT significantly 
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altered steroidogenesis. Increased steroid hormone levels were accompanied by related 
increased gene expression levels. The differently expressed genes were MC2R, CYP11B1, 
CYP11B2, and CYP19A1 and changes in gene expression levels were more sensitive than 
changes in hormone levels. The POP mixtures tested showed mostly additive effects, 
especially for DHEA and 17β-estradiol levels. This study shows that some seafood POPs 
are capable of altering steroidogenesis in H295R cells at concentrations that mixtures 
might reach in human blood, suggesting that adverse health effects cannot be excluded. 
DNA methylation was not measured in this study due to the short exposure time, which 
was expected not to be sufficient for long-term epigenetic marks. Therefore, in chapters 
3A and 3B a differentiation experiment was performed enabling long-term exposure to 
POPs. Human mesenchymal stem cells (hMSCs) were differentiated into mature 
adipocytes over a time-course of 10 days. The transcriptional regulatory cascade involved 
in adipocyte differentiation has been extensively studied, however the mechanisms 
driving the transcription are poorly understood. In chapter 3A we therefore first 
explored the involvement of DNA methylation in transcriptional regulation during 
adipocyte differentiation. Genome-wide changes in DNA methylation were measured as 
well as the expression of adipogenic genes. The majority of these genes showed 
significant expression changes during the differentiation process. There were, however, 
only a couple of these differentially expressed genes that were differentially methylated. 
Genome-wide DNA methylation changes were most often located in intergenic regions, 
and underrepresented close to the transcription start site. This suggested that changes 
in DNA methylation are not the underlying mechanism regulating gene expression 
during adipocyte differentiation. Nevertheless, we explored DNA methylation 
differences after continuous exposure to POPs to investigate whether this could be an 
underlying mechanism by which POPs affect adipocyte differentiation. TCDD and PFOS 
decreased lipid accumulation, while TBT increased lipid accumulation. TCDD and TBT 
induced opposite gene expression profiles, whereas after PFOS exposure gene expression 
remained relatively stable. Genome-wide DNA methylation analysis showed that all 
three POPs affected DNA methylation patterns in adipogenic and other genes, but 
without concomitant gene expression changes. Differential methylation was again 
predominantly detected in intergenic regions, where the biological relevance of 
alterations in DNA methylation is unclear. This study demonstrated that POPs, at 
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environmentally relevant levels, are able to induce differential DNA methylation in 
differentiating adipocytes. However, the biological relevance of this aberrant DNA 
methylation remains unclear. 
The in vitro results showed a proof of principle that POPs could be capable of altering 
DNA methylation. To this date, no human studies were performed investigating the 
relationship between POP levels and genome-wide DNA methylation. In order to 
investigate this, we first measured POP levels in eel consumers from the high-polluted 
areas (areas with a ban on eel fishing) and compared these levels to men consuming eel 
from low-polluted areas or aquaculture (chapter 4). We aimed to investigate the 
accumulation of these POPs and determine whether the predictions made in an earlier 
risk assessment were valid. This was indeed the case as levels of dioxins and dioxin-like 
compounds were on average 2.5 times higher in men consuming eel from high-polluted 
areas. Furthermore, PCBs with their hydroxylated metabolites, and perfluoroalkyl 
substances (PFASs) were, up to ten times, higher in these consumers. Especially the high 
levels of dioxins and dioxin-like compounds as well as the OH-PCBs are expected to be 
of health concern. We continued this research in chapter 5 by associating all the 
measured POPs to clinical parameters related to e.g. thyroid hormones and liver 
enzymes, but found no relationship. Subsequently, we investigated the association 
between dioxins and dioxin-like compounds, the sum of seven indicator PCBs, and PFOS 
with genome-wide DNA methylation. We detected a number of differentially 
methylated regions (DMRs) related to genes involved in carcinogenesis (e.g. BRCA1, 
MAGEE2, HOXA5), the immune system (e.g. RNF39, HLA-DQB1), in retinol homeostasis 
(DHRS4L2), or in metabolism (CYP1A1). In contrast to the in vitro data, most significant 
effects were detected in CpG islands and were annotated close to the promoter region. 
This suggests that the differential methylation might be related to differential expression 
and possibly induce adverse health effects. The hypermethylation of some of these gene 
related to cancer could be an explanation of the carcinogenic effects that are observed 
with POP exposure. 
Based on the results of this thesis we can conclude that the consumption of eel from 
high-polluted areas lead to accumulation of POPs above safe levels and that POP levels 
are associated with gene-specific DNA methylation in vitro as well as in environmentally 
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exposed men. More research, however, is needed to fully elucidate the biological 
implications of this aberrant DNA methylation. A first step can be to measure histone 
modifications, as these two epigenetic marks together are likely better in predicting gene 
expression. The second step can be to investigate the potential health effects related to 
these epigenetic marks and to determine whether there is a causal relationship. 
Although at this point there is a lack of knowledge with regard to health effects caused 
by DNA methylation, the consumption of eel from these high-polluted areas is ill-
advised, because adverse health effects cannot be excluded based on our results and can 
even be expected based on literature. 
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Nederlandse samenvatting 
Wild gevangen vis, voornamelijk zeevis, kan hoge gehaltes bevatten van persistente 
organische verontreinigingen (afgekort tot POPs, gebaseerd op het Engelse ‘Persistent 
Organic Pollutants’). In Nederland heeft voornamelijk paling uit de grote rivieren hoge 
POP gehaltes. Dit heeft in 2011 geleid tot een vangstverbod op paling in bepaalde 
gebieden, omdat POPs schadelijk voor de gezondheid kunnen zijn. Verschillende van 
deze POPs zijn gerelateerd aan negatieve gezondheidseffecten zoals hormoon-
verstoring, neurologische ontwikkelingsproblemen, onderdrukking van het immuun-
systeem en kanker. Ook al zijn sommige werkingsmechanismen van deze POPs bekend, 
zoals dioxines die binden aan de aryl hydrocarbon receptor en OH-PCBs die binden aan 
schildklier transporteiwitten, niet alle nadelige gezondheidseffecten kunnen hiermee 
verklaard worden. Epigenetische processen, zoals DNA methylatie, zijn mogelijke 
moleculaire mechanismen die ten grondslag liggen aan de negatieve 
gezondheidseffecten. DNA methylatie is een erfelijke verandering, waarbij een 
methylgroup bindt aan cytosine in een CpG dinucleotide. Observationeel onderzoek 
heeft inderdaad aangetoond dat POPs effect hebben op globale DNA methylatie, ook al 
zijn de resultaten niet consistent. Experimentele dierstudies en in vitro (letterlijk in glas, 
heeft betrekking op gekweekte lichaamscellen) onderzoek heeft aanwijzingen 
opgeleverd dat POPs gen-specifieke DNA methylatie kunnen beïnvloeden, maar de 
biologische betekenis en de relevantie voor mensen is nog niet duidelijk. Deze 
dissertatie heeft daarom als doel om 1) de opstapeling van POPs in mannen te 
bestuderen die paling hebben geconsumeerd uit sterk verontreinigde gebieden 2) 
uitzoeken of deze POPs voor veranderingen in DNA methylatie kunnen zorgen en 3) 
bepalen of DNA methylatie gerelateerd is aan functionele gezondheidsmetingen en gen 
expressie in vitro. 
Om dit doel te bereiken hebben we acht POPs gekozen die relatief veel voorkomen in 
vis, namelijk 2,3,7,8-tetrachloor-dibenzo-p-dioxine (TCDD), polychloorbifenyl (PCB) 
126 en 153, perfluoroctaansulfonzuur (PFOS), hexabromocyclododecaan (HBCD), 
2,2′,4,4′-tetrabromodifenyl ether (BDE-47), tributyltin (TBT), en methylkwik (MeHg). 
Hoofdstuk 2 beschrijft in vitro effecten van deze POPs en 2 mixen hiervan in H295R 
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bijnierschorscellen. De relatieve effecten op 13 steroïdhormonen en 7 steroïdhormoon-
gevoelige genen en CYP1A1 zijn geanalyseerd. PFOS induceerde de meest opvallende 
effecten op de steroïdhormonen en veranderde de niveaus van 9 van de 13 gemeten 
hormonen, met de grootste veranderingen op oestradiol, corticosteron en cortisol. 
TCDD, beide PCBs en TBT hadden ook significante effecten op de steroïdhormonen. 
Verhoogde hormoon niveaus gingen samen met verhoogde genexpressie. De door de 
POPs beïnvloede genen waren MC2R, CYP11B1, CYP11B2 en CYP19A1. Veranderingen in 
genexpressie waren gevoeliger dan veranderingen in hormoon niveaus. De geteste POP  
mixen lieten additieve effecten zien, voornamelijk voor DHEA en oestradiol niveaus. 
Deze studie laat zien dat sommige POPs, bij gehaltes die in humaan bloed bereikt 
kunnen worden, in staat zijn om niveaus van steroïdhormonen in H295R cellen te 
veranderen, en negatieve gezondheidseffecten kunnen daarom niet worden uitgesloten. 
DNA methylatie was niet gemeten in deze studie omdat het hier een kortdurende 
blootstelling betreft, en de verwachting was dat de blootstelling te kort was om 
chronische epigenetische veranderingen te meten. In hoofdstuk 3A en 3B is daarom 
een differentiatie experiment uitgevoerd die een langdurige blootstelling aan POPs 
mogelijk maakte. Humane mesenchymale stamcellen (hMSCs) zijn gedurende 10 dagen 
gedifferentieerd in volwassen vetcellen. De genexpressie betrokken bij deze 
vetceldifferentiatie is al uitgebreid onderzocht, maar het mechanisme achter deze 
genexpressie is nog niet bekend. In hoofdstuk 3A is daarom als eerste onderzocht of 
DNA methylatie betrokken is bij het reguleren van genexpressie tijdens deze 
vetceldifferentiatie. Genoom-brede veranderingen in DNA methylatie zijn gemeten 
tegelijkertijd met de expressie van genen gerelateerd aan vetcellen. Het merendeel van 
deze genen lieten significante genexpressie veranderingen zien tijdens de differentiatie. 
Slechts enkele van deze genen waren echter anders gemethyleerd. Genoom-brede DNA 
methylatie veranderingen werden voornamelijk gevonden in regio’s tussen genen, en 
werden niet vaak gevonden dicht bij de promotor regio van genen. Deze resultaten laten 
zien dat veranderingen in DNA methylatie waarschijnlijk niet het onderliggende 
mechanisme zijn om genexpressie te sturen tijdens vetceldifferentiatie. Desalniettemin 
hebben we DNA methylatie veranderingen onderzocht na continue blootstellingen aan 
verschillende POPs om te onderzoeken of DNA methylatie een relevant mechanisme 
kan zijn waarmee POPs vetceldifferentiatie beïnvloeden. TCDD en PFOS verminderden 
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vetopslag in vetcellen, terwijl TBT zorgde voor een toename in de vetopslag. TCDD en 
TBT hadden ook een tegenovergesteld effect op genexpressie, terwijl er na de PFOS 
blootstelling weinig verschillen te zien waren. Genoom-brede DNA methylatie analyses 
laten zien dat alle drie deze POPs DNA methylatie beïnvloeden in zowel vetcel 
gerelateerde genen als ook in andere genen. Deze DNA methylatie verschillen kwamen 
niet overeen met veranderingen in genexpressie. Ook in deze studie zijn de verschillen 
in DNA methylatie voornamelijk gevonden in regio’s tussen genen, en op deze locatie in 
het genoom is de biologische relevantie van een veranderd DNA methylatie patroon nog 
niet duidelijk. Dit onderzoek laat zien dat POPs, bij relevante concentraties, in staat zijn 
om veranderingen aan te brengen in DNA methylatie tijdens vetceldifferentiatie. De 
biologische relevantie van dit afwijkende DNA methylatie patroon blijft onduidelijk. 
De in vitro resultaten geven aanwijzingen voor de hypothese dat POPs in staat zijn om 
veranderingen in DNA methylatie aan te brengen. Er zijn echter nog geen humane 
onderzoeken uitgevoerd om te onderzoeken wat de relatie is tussen POP gehaltes in 
mensen en genoom-brede DNA methylatie. Om dit te kunnen onderzoeken, hebben we 
eerst POP gehaltes gemeten in palingconsumenten uit verontreinigde gebieden 
(namelijk gebieden waar een vangstverbod geldt). Deze POP gehaltes hebben we 
vergeleken met POP gehaltes gemeten in mannen die paling consumeren uit relatief 
schonen gebieden of kweekpaling (hoofdstuk 4). Het doel was om de opstapeling van 
de POPs in het lichaam te onderzoeken en te bepalen of de schattingen die in eerdere 
risico-evaluaties gemaakt zijn kloppen. Dit bleek inderdaad te kloppen aangezien de 
gehaltes van dioxines en dioxine-achtige stoffen gemiddeld 2,5 maal hoger waren in 
mannen die paling uit verontreinigde gebieden geconsumeerd hadden vergeleken met 
mannen die paling hebben geconsumeerd uit relatief schone gebieden. Verder waren 
PCBs, met hun gehydroxyleerde (OH) metabolieten, en de geperfluoreerde stoffen 
(zoals PFOS) tot wel tien maal hoger in de consumenten uit de verontreinigde gebieden. 
Voornamelijk de hoge gehaltes van de dioxines en dioxine-achtige stoffen als ook de 
OH-PCBs zijn mogelijk schadelijk voor de gezondheid. Dit onderzoek hebben we 
voortgezet in hoofdstuk 5 door het effect van alle gemeten POPs te bekijken op 
klinische bloedwaarden zoals schildklierhormonen en leverenzymen, maar we vonden 
hier geen effect op. Vervolgens hebben we gekeken of dioxines en dioxine-achtige 
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stoffen, het totaal van zeven indicator PCBs, en PFOS een effect hadden op genoom-
brede DNA methylatie. We vonden verschillende regio’s in het DNA die anders 
gemethyleerd waren en deze genen waren voornamelijk gerelateerd aan kanker (BRCA1, 
MAGEE2, HOXA5), het immuunsysteem (RNF39, HLA-DQB1), retinol homeostase 
(DHRS4L2), of bij de metabolisme van deze stoffen (CYP1A1). In tegenstelling tot de in 
vitro resultaten vonden we de meeste significante effecten in CpG eilanden en waren de 
meeste effecten dicht in de buurt van de promotor regio. Deze veranderde DNA 
methylatie patronen kunnen dan ook gerelateerd zijn aan genexpressie en mogelijk 
kunnen ze ten grondslag liggen aan negatieve gezondheidseffecten. De hypermethylatie 
van sommige van deze genen gerelateerd aan kanker kunnen een verklaring zijn voor de 
verhoogde kans op kanker die geobserveerd is met hogere gehaltes van deze POPs in het 
lichaam. 
Gebaseerd op de resultaten beschreven in deze dissertatie kunnen we concluderen dat 
de consumptie van paling uit de verontreinigde gebieden leidt tot hogere gehaltes van 
POPs die boven het veilige niveau uitkomen en dat deze POP gehaltes gerelateerd zijn 
aan gen-specifieke DNA methylatie in vitro en in de mannelijke palingconsumenten. 
Meer onderzoek is nodig om de volledige biologische consequenties van deze 
veranderde DNA methylatie te ontrafelen. Een eerste stap hiervoor kan zijn om histon 
modificaties te meten, omdat die samen met de DNA methylatie waarschijnlijk een 
betere voorspelling zijn voor genexpressie. Een tweede stap zou kunnen zijn om de 
potentiele gezondheidseffecten gerelateerd aan deze epigenetische mechanismen te 
bestuderen om vast te stellen of er een oorzakelijk verband is. Ook al is er op dit moment 
nog een gebrek aan kennis betreffende de gezondheidseffecten veroorzaakt door een 
veranderd DNA methylatie profiel, de consumptie van paling uit de verontreinigde 
gebieden is sterk af te raden. Negatieve gezondheidseffecten kunnen namelijk niet 
worden uitgesloten gebaseerd op onze resultaten en kunnen zelfs worden verwacht op 
basis van de literatuur. 
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List of abbreviations 
 
3’UTR: 3’ untranslated region 
5-aza-dC: 5-aza-2′-deoxycytidine 
5’UTR: 5’untranslated region 
AH: aryl hydrocarbon 
ALP: alkaline phosphatase 
ALT: Alanine aminotransferase 
AST: Aspartate aminotransferase 
BDE47: 2,2′,4,4′-tetrabromodiphenyl ether 
BEQ: bioanalytical equivalent 
BH method: Benjamini-Hochberg method 
CGI: CpG Island 
ChAMP: Chip Analysis Methylation 
Pipeline 
CV: coefficient of variation 
DHA: docosahexaenoic acid 
DHEA: dehydroepiandrosterone 
DL: dioxin-like 
DMP: differentially methylated position 
DMR: differentially methylated region 
DMSO: dimethyl sulfoxide 
DNA: deoxyribonucleic acid 
DNMT1: DNA methyltransferase 1 
DR CALUX: dioxin responsive chemical-
activated luciferase gene expression 
EC: European Commission 
EIA: enzyme immunoassay 
ELISA: Enzyme-Linked Immuno Sorbent 
Assay 
EPA: eicosapentaenoic acid 
FDR: false discovery rate 
GC-MS: gas chromatography mass 
spectrometry 
GEO: Gene Expression Omnibus 
GGT: gamma-glutamyl transferase 
HBCD: hexabromocyclododecane 
HDL: high density lipoprotein 
Hg: hemoglobin 
HgCl2: inorganic mercury 
hMSCs: human mesenchymal stem cells 
HPA: hypothalamic-pituitary-adrenal 
Ht: hematocrit 
IBMX: 3-isobuty-l-methyl-xanthine 
IGR: intergenic region 
IPA: Ingenuity Pathway Analysis 
LC-MS: liquid chromatography mass 
spectrometry 
Limma: Linear Models for Microarray Data 
LINE-1: long interspersed nuclear element 1 
LUMA: LUminometric Methylation Assay 
LOD: limit of detection 
LOQ: limit of quantification 
MC2R: melanocortin 2 receptor 
MeHg: methylmercury 
MTT: 3-(4,5-methylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide 
MDS: multidimensional scaling 
MeDIP: methylated DNA immune-
precipitation 
ML: maximum levels 
MO: mono-ortho 
MS-HRM: Methylation-Sensitive High 
Resolution Melting 
NO: non-ortho 
OC: organochlorine 
OECD: organization for economic co-
operation and development 
OH: hydroxylated 
PBDE: polybrominated diphenyl ether 
PCB: polychlorobiphenyl 
PCB153: 2,2′,4,4′,5,5′-hexachlorobiphenyl 
PCDD: polychlorinated dibenzo-p-dioxin 
PCDF: polychlorinated dibenzofurans 
PCR: polymerase chain reaction 
PFAS: perfluoroalkyl substance 
PFOS: perfluorooctanesulfonic acid 
POPs: persistent organic pollutants 
RNA: ribonucleic acid 
mRNA: messenger RNA 
ncRNA: non-coding RNA 
SC: solvent control 
SGBS, Simpson-Golabi-Behmel syndrome 
S/N: signal-to-noise ratio 
SPE: solid-phase extraction 
TBT: tributyltin 
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TBG: thyroxine-binding globulin 
TCDD: 2,3,7,8-tetrachlorodibenzo-p-dioxin 
TEF: toxic equivalency factor 
TEQ: toxic equivalents 
TSH: thyroid stimulating hormone 
TSS: transcription start site 
TTR: transthyretin 
UTR: untranslated region 
WBC: white blood cell count 
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